data_6dhr_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6dhr _Structure_validation_residue.Date_analyzed 2019-04-12 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 114.041 0.377 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.4 mt -110.95 148.27 38.26 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 117.438 0.619 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.93 48.8 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.449 2.766 . . . . 0.0 112.185 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.97 -25.3 34.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 124.579 1.152 . . . . 0.0 111.035 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 16.7 m -62.83 -37.47 86.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.431 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.26 34.85 44.78 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -131.86 149.74 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.717 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -111.69 150.59 29.97 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.5 p -132.3 82.02 1.99 Allowed 'General case' 0 N--CA 1.404 -2.77 0 CA-C-O 122.529 1.157 . . . . 0.0 110.927 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.4 tp -84.07 -36.38 23.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.575 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.6 mt -82.77 -30.19 29.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.403 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.5 30.07 3.95 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.767 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -135.35 135.36 40.67 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.75 0.775 . . . . 0.0 112.06 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 m -120.9 141.43 50.63 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.25 -29.53 13.14 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 112.172 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -55.82 130.4 72.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 123.618 0.574 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.94 135.2 43.16 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.399 2.066 . . . . 0.0 111.596 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.57 30.48 60.04 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.6 t -118.38 131.89 56.28 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -112.25 134.77 53.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 t -77.51 129.29 35.49 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.118 0.485 . . . . 0.0 110.333 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 76.0 ttt180 -134.23 86.71 2.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -44.94 135.87 4.82 Favored Pre-proline 0 C--O 1.244 0.774 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.973 -170.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -98.73 27.5 16.69 Favored 'Cis proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.394 -1.503 . . . . 0.0 114.193 3.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.9 150.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 121.726 -0.609 . . . . 0.0 110.472 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.695 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 77.5 m -90.96 141.32 28.97 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.682 -0.636 . . . . 0.0 109.717 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 90.0 m-85 -131.17 135.9 47.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.198 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 64.6 tttp -111.0 103.17 11.61 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.347 1.059 . . . . 0.0 111.526 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.51 140.03 21.13 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.21 68.7 5.01 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.297 1.998 . . . . 0.0 111.83 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.89 -46.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.8 m -73.47 -56.08 5.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.016 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.57 14.34 82.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.145 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.46 154.67 19.47 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p -97.15 134.32 40.63 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.387 0.613 . . . . 0.0 111.22 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.06 78.99 1.79 Allowed 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 122.412 1.101 . . . . 0.0 109.838 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.69 -19.59 59.01 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.133 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.58 -21.09 59.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.451 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.56 -0.65 39.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.724 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.58 144.38 35.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 62.0 m -85.3 169.47 13.72 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -103.19 -23.57 13.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.925 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -85.44 119.5 72.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.16 132.53 19.7 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.282 1.988 . . . . 0.0 111.562 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.89 6.23 46.34 Favored Glycine 0 C--N 1.308 -0.992 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.7 t -121.38 127.42 51.2 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.7 t -88.72 138.62 31.25 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.481 0.657 . . . . 0.0 110.282 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 45.4 t -95.98 117.09 29.97 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.317 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -114.33 84.47 2.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -44.99 134.83 5.05 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.665 -170.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -95.18 15.77 40.22 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.476 -1.468 . . . . 0.0 114.863 2.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -112.56 135.34 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.064 -175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.8 t -91.27 124.54 35.55 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.012 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -123.98 143.96 50.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.42 0.629 . . . . 0.0 111.325 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -109.29 108.37 18.94 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.807 1.243 . . . . 0.0 111.658 -177.639 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.003 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.62 148.11 37.08 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.48 39.38 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.995 2.464 . . . . 0.0 112.196 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.8 -30.24 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.495 1.118 . . . . 0.0 111.184 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 32.2 m -72.12 -31.42 66.01 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.358 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.33 1.57 60.94 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.69 -0.686 . . . . 0.0 113.48 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.42 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 41.8 mt-10 -89.64 159.58 17.06 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.276 0.56 . . . . 0.0 110.686 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -118.17 130.89 56.37 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.417 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 25.3 p -111.67 77.55 1.05 Allowed 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.082 0.944 . . . . 0.0 112.78 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.3 mt -77.38 -30.2 53.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.84 -17.97 60.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.904 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -10.54 61.11 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.037 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -133.8 139.12 46.09 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.9 m -97.32 162.34 13.38 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 124.073 0.858 . . . . 0.0 108.838 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -98.55 -9.78 24.41 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.736 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.5 m -86.27 119.22 71.45 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.91 133.85 20.65 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.587 2.191 . . . . 0.0 110.513 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.54 20.48 40.82 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.5 t -120.25 140.98 50.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 t -104.22 121.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.506 0.67 . . . . 0.0 110.395 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.2 t -79.16 110.23 14.23 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.213 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -121.06 85.56 2.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -52.86 142.91 32.75 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.868 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.28 15.86 45.7 Favored 'Cis proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.208 -1.58 . . . . 0.0 116.052 4.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 52.4 t -122.29 144.96 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.73 1.15 . . . . 0.0 112.394 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 72.7 m -89.1 117.01 27.78 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.412 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.456 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.8 m-85 -114.73 121.44 43.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.627 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 41.3 ttmt -90.19 108.69 19.9 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 124.411 1.084 . . . . 0.0 112.62 -178.253 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.406 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.55 139.56 20.23 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.64 42.46 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.853 3.035 . . . . 0.0 113.04 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.13 -27.94 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 124.536 1.134 . . . . 0.0 111.111 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 6.7 m -66.0 -45.67 80.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.71 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.27 28.34 37.0 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -141.16 161.77 37.08 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 122.794 0.438 . . . . 0.0 110.05 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 24' ' ' PRO . 30.8 p -118.85 -179.8 3.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -121.21 79.68 1.55 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.51 -26.76 17.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.14 -21.57 18.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.688 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 16.06 27.3 Favored Glycine 0 C--O 1.239 0.415 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.3 tttm -140.95 141.15 34.49 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 75.1 m -90.88 159.08 16.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -113.58 -26.77 8.12 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 120.986 0.422 . . . . 0.0 110.047 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -82.78 127.62 69.25 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.84 145.16 61.59 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.512 2.141 . . . . 0.0 111.934 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.78 1.22 80.51 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.813 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 99.5 m -103.14 126.09 50.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -93.28 124.34 37.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.513 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.01 126.63 31.43 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.969 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -137.26 94.41 2.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -52.36 137.93 39.54 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.4 Cg_endo -98.38 28.68 15.38 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.57 2.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.488 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 6.9 t -124.19 166.17 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.535 -0.728 . . . . 0.0 109.322 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 42.4 t -113.12 133.32 55.08 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.488 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 94.0 m-85 -130.94 135.89 48.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.045 0.45 . . . . 0.0 111.462 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 87.2 tttt -103.73 108.79 20.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.495 1.784 0 C-N-CA 124.339 1.055 . . . . 0.0 110.605 -176.251 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.926 -0.07 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.82 148.3 36.65 Favored Pre-proline 0 C--N 1.312 -1.042 0 O-C-N 122.378 -0.483 . . . . 0.0 110.437 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.66 50.7 3.31 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.723 2.282 . . . . 0.0 111.508 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.37 -28.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.112 1.365 . . . . 0.0 111.434 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.1 m -78.1 -19.27 54.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.75 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.87 -44.24 2.29 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 113.639 0.216 . . . . 0.0 113.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.95 154.21 31.15 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.839 0.856 . . . . 0.0 111.468 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -108.72 179.2 4.25 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.626 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 77.1 m -118.18 74.02 0.93 Allowed 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.776 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.7 tp -84.95 -30.69 24.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.55 -30.39 15.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.619 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 9' ' ' CYS . . . 100.88 29.83 6.33 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -134.86 135.89 42.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.319 -0.441 . . . . 0.0 109.968 -174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 92.7 m -109.4 123.89 50.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -84.67 -31.19 24.28 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.031 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.9 m -69.13 119.8 72.46 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.35 134.21 24.24 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.025 1.817 . . . . 0.0 110.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.72 23.48 23.28 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.836 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 1.1 t -122.93 153.26 39.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -113.29 122.7 48.2 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.312 0.577 . . . . 0.0 110.205 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 51.4 t -80.81 110.98 16.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.979 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.25 81.49 1.62 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 174.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -47.52 132.43 10.48 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.385 -171.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -96.69 26.34 19.86 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 N-CA-C 116.076 1.529 . . . . 0.0 116.076 6.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.585 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 20.5 t -127.54 151.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.802 -1.186 . . . . 0.0 109.933 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.0 t -102.43 121.22 41.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.585 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 98.2 m-85 -118.62 142.1 47.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.404 0.621 . . . . 0.0 111.844 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 61.4 tttp -126.04 117.52 23.38 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 122.355 1.074 . . . . 0.0 109.746 177.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mp -108.31 142.28 25.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 117.032 0.416 . . . . 0.0 111.09 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.82 43.21 1.21 Allowed 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 123.693 2.929 . . . . 0.0 112.28 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -72.8 -28.29 26.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.462 1.105 . . . . 0.0 111.303 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 9.6 m -61.76 -34.81 76.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.55 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.62 69.29 Favored Glycine 0 CA--C 1.494 -1.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.922 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 10.9 pt-20 -140.52 160.84 39.13 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.128 0.489 . . . . 0.0 110.849 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p -108.71 166.71 10.59 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.275 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.93 83.82 1.45 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 122.162 0.982 . . . . 0.0 110.652 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.94 -15.05 60.24 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.291 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -86.8 -17.71 32.82 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.294 0.569 . . . . 0.0 110.271 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.81 18.98 41.95 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.01 119.95 13.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.7 t -81.1 149.53 29.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -80.03 -36.06 36.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.441 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.1 m -84.42 128.68 60.74 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.679 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.1 136.16 43.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.643 2.229 . . . . 0.0 110.54 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.75 -16.27 56.3 Favored Glycine 0 C--N 1.304 -1.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.59 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.33 119.92 33.02 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 m -76.24 134.08 39.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -91.7 110.49 21.83 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.621 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -107.51 86.26 2.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 18.4 ptt180 -43.89 129.7 4.21 Favored Pre-proline 0 C--N 1.316 -0.848 0 O-C-N 124.71 1.256 . . . . 0.0 113.422 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.0 Cg_endo -101.27 31.14 10.16 Favored 'Cis proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.031 -1.237 . . . . 0.0 113.595 1.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.97 141.15 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.771 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 92.7 m -84.48 135.47 34.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.779 0.323 . . . . 0.0 110.947 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.38 115.79 16.02 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttm -93.45 114.98 27.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.349 1.06 . . . . 0.0 109.646 -177.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.995 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.5 mt -94.46 157.43 37.29 Favored Pre-proline 0 C--N 1.309 -1.196 0 O-C-N 122.821 -0.223 . . . . 0.0 110.597 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 66.1 Cg_endo -72.19 48.6 1.22 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 123.639 2.892 . . . . 0.0 112.36 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mm -59.53 -35.94 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 125.45 1.5 . . . . 0.0 112.704 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.6 m -69.19 -36.89 77.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.845 0.355 . . . . 0.0 110.423 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.82 -12.93 55.83 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.498 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.491 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 42.9 mt-10 -74.43 159.4 32.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.121 0.486 . . . . 0.0 110.838 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.3 p -118.73 132.26 56.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.79 75.5 10.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.3 mt -80.42 -40.61 26.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.75 -29.1 24.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.137 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.59 -4.53 7.58 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.793 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -122.73 136.04 54.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 t -90.75 139.56 30.61 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -92.16 -19.59 22.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.761 0.315 . . . . 0.0 111.161 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.4 m -81.37 120.92 79.52 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.17 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 138.97 39.07 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.589 2.193 . . . . 0.0 110.785 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.44 19.96 70.27 Favored Glycine 0 C--N 1.314 -0.671 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.0 t -122.08 133.26 54.78 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 m -90.41 119.91 31.08 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.645 0.736 . . . . 0.0 110.475 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.4 t -77.06 114.74 16.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.44 85.03 2.32 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -47.82 134.06 11.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 123.845 0.716 . . . . 0.0 111.769 -171.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -97.18 25.98 20.14 Favored 'Cis proline' 0 CA--C 1.558 1.721 0 C-N-CA 123.453 -1.478 . . . . 0.0 114.766 3.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 40.6 t -128.37 149.57 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.952 1.251 . . . . 0.0 112.051 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 84.0 m -89.89 115.96 27.61 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 120.948 0.404 . . . . 0.0 111.457 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.412 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 33.7 m-85 -110.52 133.88 52.89 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 65.1 tttm -120.27 122.71 41.48 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.319 -0.721 0 C-N-CA 124.895 1.278 . . . . 0.0 110.67 -179.538 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.449 0 N-CA-C 112.696 -0.162 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 4' ' ' ILE . 83.8 mt -102.0 143.22 26.16 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.46 33.92 0.4 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.648 2.899 . . . . 0.0 112.621 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.403 ' H ' ' C ' ' A' ' 2' ' ' LEU . 49.0 mm -59.95 -44.25 94.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 123.669 0.788 . . . . 0.0 110.397 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.7 m -66.09 -55.56 15.89 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.935 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.08 12.48 83.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -89.16 170.67 10.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-O 121.056 0.455 . . . . 0.0 110.37 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.5 p -128.1 131.8 49.02 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.682 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.55 63.37 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.31 -38.98 85.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.26 1.36 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.57 -36.0 2.31 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 119.299 -1.429 . . . . 0.0 114.035 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.0 tttm -116.06 153.41 31.75 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 43.3 t -81.04 142.27 33.53 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.64 -24.29 27.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.985 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 m -89.51 122.02 68.7 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.336 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.04 140.04 27.82 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.215 1.944 . . . . 0.0 111.177 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.55 21.35 60.22 Favored Glycine 0 C--N 1.319 -0.409 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 34.9 t -135.05 126.6 28.78 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -83.76 137.64 33.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.506 0.669 . . . . 0.0 111.593 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.3 t -87.52 131.02 34.51 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.708 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -133.28 74.24 1.55 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -46.3 130.64 7.72 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.672 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -93.66 17.07 41.22 Favored 'Cis proline' 0 CA--C 1.551 1.374 0 N-CA-C 116.338 1.63 . . . . 0.0 116.338 6.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.06 145.7 20.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 119.913 1.233 . . . . 0.0 111.872 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 89.5 m -94.34 121.65 36.09 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -117.87 122.66 43.91 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.126 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttp -92.45 111.18 22.66 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 122.482 1.134 . . . . 0.0 109.714 -178.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.036 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt -132.77 144.43 52.87 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 116.883 0.342 . . . . 0.0 110.72 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -77.85 90.92 1.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.207 1.938 . . . . 0.0 110.244 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.3 mm -113.62 -32.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.537 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 m -66.77 -33.63 76.04 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.738 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.91 39.66 23.63 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.18 150.32 52.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.846 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -131.37 141.5 49.9 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -84.73 73.05 10.66 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.395 0.617 . . . . 0.0 109.786 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -89.02 -32.67 17.48 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.31 -24.4 22.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.784 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.04 -13.23 10.53 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.482 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -141.55 147.3 37.49 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 122.393 -0.475 . . . . 0.0 110.839 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.4 m -89.95 167.4 12.83 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -105.14 -36.03 7.4 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.668 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.9 m -69.64 122.05 84.49 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -68.98 131.66 22.85 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.444 2.096 . . . . 0.0 109.282 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.09 38.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.9 t -132.44 120.45 21.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 m -90.48 147.44 23.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.003 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -96.57 118.68 33.57 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.14 0.495 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.427 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 8.4 tpt180 -124.56 84.49 2.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -47.52 134.66 10.15 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.398 -172.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -94.46 24.19 25.19 Favored 'Cis proline' 0 CA--C 1.556 1.617 0 N-CA-C 115.46 1.292 . . . . 0.0 115.46 2.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.71 145.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.725 -1.234 . . . . 0.0 111.169 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 70.7 m -89.86 136.97 32.72 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 94.3 m-85 -129.83 125.24 35.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.897 0.379 . . . . 0.0 110.188 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.64 113.03 23.78 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m120 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 125.687 1.595 . . . . 0.0 109.133 -173.301 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 N-CA-C 113.452 0.141 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.27 152.63 46.14 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 117.24 0.52 . . . . 0.0 110.441 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 85.4 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.977 1.785 . . . . 0.0 110.905 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 47.2 mm -104.07 -33.7 3.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.578 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 37.9 m -65.7 -35.0 79.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 -32.92 2.87 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.146 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.0 171.08 12.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.509 0.671 . . . . 0.0 111.533 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 p -133.27 156.11 48.17 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.904 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 72.9 m -90.8 67.18 6.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.236 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.33 -26.43 65.61 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.695 0.76 . . . . 0.0 109.962 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -87.31 -2.28 58.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.476 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.4 -13.34 65.53 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -132.41 145.92 51.57 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 25.0 t -91.1 139.39 30.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -93.9 -9.67 36.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.251 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -83.13 120.6 76.21 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.25 133.79 42.28 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.881 2.387 . . . . 0.0 111.046 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.33 -15.05 64.06 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.621 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -93.67 125.07 38.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.558 0.694 . . . . 0.0 111.198 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -80.7 127.32 32.36 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.5 105.73 17.99 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 121.49 0.662 . . . . 0.0 111.772 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -113.91 76.2 0.97 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -49.32 139.62 13.8 Favored Pre-proline 0 C--O 1.245 0.827 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.688 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.72 16.78 37.97 Favored 'Cis proline' 0 CA--C 1.553 1.46 0 N-CA-C 115.374 1.259 . . . . 0.0 115.374 3.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.91 143.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.154 1.343 . . . . 0.0 112.979 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.97 120.14 32.35 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.157 0.503 . . . . 0.0 110.22 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -110.59 160.03 17.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.004 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.4 tttm -141.67 122.99 14.84 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 123.729 0.812 . . . . 0.0 110.776 -178.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.663 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.24 152.14 37.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 74.3 Cg_endo -75.71 51.45 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.175 2.584 . . . . 0.0 112.002 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 48.4 mm -59.84 -24.73 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.089 1.355 . . . . 0.0 110.703 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.2 m -64.84 -32.99 74.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.024 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.73 31.26 70.34 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.346 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -140.84 156.36 46.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -114.45 156.06 25.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.132 0.491 . . . . 0.0 111.664 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 92.1 m -90.84 72.29 6.58 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.5 -40.53 29.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.325 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -88.69 -30.04 19.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.86 25.74 5.0 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.464 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.08 148.57 40.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.72 145.12 31.52 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.03 -33.39 10.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.2 m -73.0 129.0 87.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.35 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.36 141.34 55.99 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.94 2.427 . . . . 0.0 111.655 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.75 4.4 79.39 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 121.388 -0.435 . . . . 0.0 112.878 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.561 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 87.4 m -97.69 149.32 22.41 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -111.36 119.79 40.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.0 t -82.02 115.5 21.2 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.006 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -126.66 78.99 1.83 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.403 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 21.9 ptt180 -50.49 135.41 24.97 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -87.45 10.68 58.91 Favored 'Cis proline' 0 CA--C 1.565 2.043 0 N-CA-C 117.641 2.131 . . . . 0.0 117.641 7.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.03 152.86 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.254 -1.529 . . . . 0.0 111.588 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 43.6 t -106.73 114.64 28.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 96.6 m-85 -109.22 148.11 31.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.036 0.446 . . . . 0.0 111.056 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 88.5 tttt -118.64 108.74 15.29 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 124.596 1.159 . . . . 0.0 111.296 -173.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.55 143.77 27.05 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.448 0.624 . . . . 0.0 110.929 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.59 50.42 2.98 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.06 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.4 mm -59.06 -44.12 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.583 1.153 . . . . 0.0 111.559 -175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.89 -41.9 95.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.81 14.53 75.62 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.274 -0.421 . . . . 0.0 113.213 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.27 146.2 24.92 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -93.72 131.6 38.89 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-O 121.122 0.487 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.7 p -111.16 75.18 0.9 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.308 1.051 . . . . 0.0 111.161 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.32 -31.48 62.48 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.533 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.95 7.51 27.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.264 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.93 77.81 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.031 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -140.4 140.49 35.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -110.93 149.09 31.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -96.55 -15.73 21.46 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 120.688 0.28 . . . . 0.0 110.915 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -94.13 119.46 66.66 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.58 140.73 40.26 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.781 1.654 . . . . 0.0 110.393 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.18 67.58 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -130.7 130.85 44.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 t -113.99 147.3 38.85 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.519 0.676 . . . . 0.0 111.314 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.48 118.3 23.67 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.349 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.503 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 30.6 tpt180 -123.45 77.62 1.51 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -46.38 137.54 6.78 Favored Pre-proline 0 C--O 1.24 0.577 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.834 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -91.72 15.08 47.91 Favored 'Cis proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.205 -1.581 . . . . 0.0 115.16 5.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.91 140.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 121.496 -0.752 . . . . 0.0 110.848 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.2 t -95.24 127.46 41.3 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.503 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 59.3 m-85 -115.83 144.08 44.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.336 -174.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -113.41 99.17 7.57 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.206 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.79 144.68 54.26 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.82 48.91 2.06 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.959 2.439 . . . . 0.0 112.109 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.2 mm -59.08 -42.2 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 36.7 m -62.9 -33.37 75.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.94 -21.6 5.55 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.658 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.96 164.66 25.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.395 0.678 . . . . 0.0 110.152 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 5.1 p -129.9 166.79 19.29 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.064 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 82.3 m -111.91 75.61 0.93 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -83.69 -41.2 17.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.6 -12.02 60.0 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.523 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.51 -20.64 27.33 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.138 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -112.18 144.21 41.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 38.0 t -106.64 129.53 54.54 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.76 3.95 54.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -107.44 119.74 49.74 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.846 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.46 132.96 18.31 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.671 2.247 . . . . 0.0 111.355 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.52 -8.45 43.93 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 24.2 t -117.65 119.79 36.04 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 p -82.76 133.98 35.13 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.598 0.713 . . . . 0.0 111.277 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.27 106.91 16.25 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.519 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 26.6 ttm180 -114.02 92.98 4.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -50.28 135.33 23.57 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.066 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.03 27.03 17.78 Favored 'Cis proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.818 -1.326 . . . . 0.0 114.655 3.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.553 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 25.7 t -128.39 152.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.801 -1.187 . . . . 0.0 111.865 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 78.1 m -86.44 113.08 22.1 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.553 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 56.8 m-85 -108.59 117.66 34.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 86.2 tttt -86.78 118.12 25.97 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.318 -0.763 0 C-N-CA 125.138 1.375 . . . . 0.0 108.804 -176.635 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.9 mt -102.9 150.49 37.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -74.64 45.06 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.786 2.991 . . . . 0.0 112.328 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.6 mm -64.4 -41.61 92.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 124.059 0.944 . . . . 0.0 110.972 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 56.5 m -68.2 -33.56 74.66 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.926 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.27 11.63 84.03 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -106.06 170.89 7.65 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 121.622 0.725 . . . . 0.0 111.285 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -120.82 170.79 9.13 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.658 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -120.45 80.2 1.58 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.05 -33.4 19.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.33 0.586 . . . . 0.0 109.64 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.53 10.99 25.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.33 1.02 80.21 Favored Glycine 0 N--CA 1.461 0.338 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -140.35 153.92 46.56 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.1 m -79.24 153.83 29.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.474 0.655 . . . . 0.0 110.775 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -82.22 -25.33 34.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -102.79 120.62 52.11 Favored Pre-proline 0 N--CA 1.433 -1.286 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.436 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.51 134.82 23.1 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.798 2.332 . . . . 0.0 110.564 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.23 -1.0 29.69 Favored Glycine 0 C--N 1.307 -1.082 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -106.81 169.29 8.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -114.66 119.11 35.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.06 134.2 34.62 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -142.13 82.49 1.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -43.76 135.46 3.68 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.372 -174.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -94.86 23.98 25.54 Favored 'Cis proline' 0 CA--C 1.558 1.717 0 C-N-CA 123.835 -1.319 . . . . 0.0 114.53 3.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.24 157.45 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.417 -0.802 . . . . 0.0 110.124 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -112.3 128.82 56.38 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -121.97 170.39 9.87 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.067 0.461 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.4 tttp -146.82 113.49 6.03 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.76 0.824 . . . . 0.0 110.06 -177.579 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.24 145.68 30.66 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 122.736 -0.273 . . . . 0.0 110.375 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.76 50.94 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.288 2.658 . . . . 0.0 110.876 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.1 mm -59.49 -44.89 93.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.555 1.142 . . . . 0.0 110.316 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 m -74.7 -39.31 62.03 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.036 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.22 31.65 74.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.149 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.74 158.01 16.8 Favored 'General case' 0 CA--C 1.466 -2.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.482 ' O ' ' HE1' ' A' ' 15' ' ' TYR . 8.7 p -99.31 128.59 45.45 Favored 'General case' 0 C--N 1.263 -3.179 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.0 p -107.67 70.8 0.79 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.081 0.943 . . . . 0.0 110.345 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.77 -33.86 72.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.744 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.8 -27.76 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 111.534 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.95 -11.44 11.8 Favored Glycine 0 CA--C 1.487 -1.689 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -117.1 153.11 33.34 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.016 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 t -91.86 152.82 19.92 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.482 ' HE1' ' O ' ' A' ' 8' ' ' THR . 41.6 m-85 -96.75 -26.69 15.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.128 0.489 . . . . 0.0 110.347 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -83.54 129.09 61.34 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.197 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 137.1 21.72 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.361 2.041 . . . . 0.0 110.216 175.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.3 56.11 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.8 t -139.32 156.28 47.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 152.65 46.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 118.283 0.492 . . . . 0.0 111.707 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.18 99.86 12.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.581 0.705 . . . . 0.0 111.199 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -105.34 85.18 2.21 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -43.77 135.96 3.61 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 114.181 -1.372 . . . . 0.0 113.165 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -95.37 18.51 35.2 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.086 -1.631 . . . . 0.0 114.347 3.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.51 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 48.7 t -123.6 146.1 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.745 0.783 . . . . 0.0 112.874 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.543 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 37.3 m -79.56 115.67 19.31 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.586 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.51 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 83.9 m-85 -115.96 147.02 41.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.851 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -130.32 115.32 16.77 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 122.208 1.004 . . . . 0.0 110.133 177.429 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.9 mt -110.56 139.18 21.33 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.89 44.43 0.96 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 123.19 2.593 . . . . 0.0 112.92 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mm -67.75 -42.15 85.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.118 0.567 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 78.3 m -60.03 -44.95 94.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.99 3.5 81.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.783 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -83.16 170.43 14.75 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.142 0.496 . . . . 0.0 109.961 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.627 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.0 m -83.43 77.02 9.88 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.769 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.92 -50.6 10.93 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.8 10.76 12.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.475 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.88 21.94 78.87 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.463 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -140.11 142.51 36.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -91.51 137.87 32.02 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.932 0.396 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.05 -37.37 78.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.262 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.7 m -82.21 119.97 76.12 Favored Pre-proline 0 N--CA 1.432 -1.372 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.118 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.53 134.17 32.23 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.132 2.555 . . . . 0.0 112.278 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.6 -0.23 88.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.907 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 11.6 t -92.35 139.81 30.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 m -81.98 121.82 26.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.754 0.788 . . . . 0.0 111.509 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.19 107.57 19.22 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -126.43 90.87 3.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -50.34 139.02 20.13 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -94.52 18.45 36.98 Favored 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.491 -1.462 . . . . 0.0 115.206 2.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.477 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 61.2 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 121.193 -0.942 . . . . 0.0 111.791 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 21.0 t -93.47 111.16 22.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.477 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.5 m-85 -110.56 119.56 39.57 Favored 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.478 0.711 . . . . 0.0 111.44 -174.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.61 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.6 tttm -90.47 112.59 24.29 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 17.6 m120 . . . . . 0 C--N 1.318 -0.797 0 C-N-CA 124.53 1.132 . . . . 0.0 110.109 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.8 mt -106.98 146.08 32.42 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.86 77.66 3.35 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.281 1.987 . . . . 0.0 111.776 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.88 -39.29 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.53 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.68 -39.89 21.41 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.592 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.4 29.68 75.28 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -117.64 170.67 8.58 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.128 0.49 . . . . 0.0 111.503 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -116.43 157.69 24.73 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 p -132.94 75.24 1.61 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.967 0.889 . . . . 0.0 109.9 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.182 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.26 12.4 36.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.585 0.707 . . . . 0.0 111.307 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.09 -5.4 79.94 Favored Glycine 0 CA--C 1.502 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.696 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -130.83 143.41 50.71 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -91.35 157.0 17.36 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.418 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -95.2 -20.46 19.21 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.5 m -80.31 119.07 75.31 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.17 127.41 14.23 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.454 2.103 . . . . 0.0 111.598 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.67 30.34 10.71 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.43 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -136.44 131.21 33.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.8 m -93.71 142.94 26.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 0.0 112.127 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.5 124.68 30.97 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.252 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -121.72 66.22 0.9 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -41.05 131.12 1.96 Allowed Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.512 -1.222 . . . . 0.0 114.153 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -89.59 5.99 68.86 Favored 'Cis proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.422 -1.491 . . . . 0.0 115.435 4.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.72 147.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 18.3 t -98.58 136.24 38.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -135.1 129.99 34.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.417 0.627 . . . . 0.0 111.169 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -92.62 109.58 21.0 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 N--CA 1.479 0.976 0 O-C-N 123.775 0.672 . . . . 0.0 110.827 -177.426 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.386 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.4 mt -89.8 151.86 46.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 C-N-CA 122.207 0.203 . . . . 0.0 111.367 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.28 94.86 0.83 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 121.579 1.52 . . . . 0.0 109.048 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.91 -32.2 2.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.398 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.9 m -71.89 -45.42 61.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.94 14.94 Favored Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.354 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.24 166.99 15.22 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.782 0.801 . . . . 0.0 112.25 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -119.53 145.53 46.26 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.468 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.77 51.59 1.23 Allowed 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.766 0.793 . . . . 0.0 109.155 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.17 -25.67 33.97 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.054 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.02 11.73 28.75 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 122.111 -0.368 . . . . 0.0 111.949 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.01 89.57 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 121.35 -0.453 . . . . 0.0 112.166 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.91 138.46 48.4 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -94.68 156.72 16.28 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -113.62 13.2 18.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.699 0.762 . . . . 0.0 111.537 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 m -120.1 119.07 31.11 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.468 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 133.22 56.12 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 123.267 2.644 . . . . 0.0 111.132 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.39 -6.78 75.21 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.137 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -102.32 148.95 24.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.8 t -108.01 141.27 39.94 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.36 119.15 28.52 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.032 0.444 . . . . 0.0 110.62 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 4.7 tpm_? -127.32 84.84 2.3 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 171.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -41.38 130.88 2.18 Favored Pre-proline 0 C--O 1.249 1.032 0 CA-C-N 114.013 -1.449 . . . . 0.0 114.351 -170.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -97.71 19.0 28.94 Favored 'Cis proline' 0 CA--C 1.556 1.609 0 C-N-CA 123.587 -1.422 . . . . 0.0 114.588 1.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.93 144.7 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 121.601 0.715 . . . . 0.0 112.726 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.1 m -88.81 115.19 26.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.858 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 48.5 m-85 -103.95 157.89 16.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 82.1 tttt -129.37 117.68 21.0 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 125.266 1.426 . . . . 0.0 110.644 -176.27 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.96 145.04 55.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.931 0.365 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.33 66.48 5.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.187 2.591 . . . . 0.0 111.266 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.13 -37.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.095 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.1 m -68.51 -27.97 66.59 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.62 17.37 79.95 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.125 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -110.35 170.36 8.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.5 p -123.86 154.79 39.15 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.278 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 p -138.58 81.78 1.87 Allowed 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.961 0.886 . . . . 0.0 110.316 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.07 -24.63 63.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.274 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.71 6.54 34.3 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 120.8 0.333 . . . . 0.0 111.329 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 80.99 20.36 65.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.002 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.15 119.69 24.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -89.5 145.88 24.99 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.525 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -84.81 -25.54 28.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.102 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -86.99 125.82 65.17 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.211 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.34 146.42 50.6 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.547 2.164 . . . . 0.0 110.436 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.64 29.25 71.42 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.573 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.0 t -145.86 130.65 18.07 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -99.62 173.15 6.86 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.543 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 39.0 t -109.1 132.44 54.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.168 0.509 . . . . 0.0 110.314 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.65 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 31.5 tpt180 -135.28 84.95 2.13 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -39.96 134.47 1.39 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.693 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -96.01 21.16 29.53 Favored 'Cis proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.568 0.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.59 150.52 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 121.771 -0.581 . . . . 0.0 111.728 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.573 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 88.4 m -79.37 139.32 37.78 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 121.962 -0.461 . . . . 0.0 110.452 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.65 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 13.0 m-85 -127.62 137.13 52.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.055 0.455 . . . . 0.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.91 118.65 24.01 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.406 0.622 . . . . 0.0 111.508 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.02 143.63 26.99 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 122.787 -0.243 . . . . 0.0 110.371 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.35 86.98 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.035 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.4 mm -123.13 -12.37 6.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.731 0.777 . . . . 0.0 110.195 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 8.7 m -81.55 -36.9 28.57 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.1 53.93 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -126.8 159.69 33.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.63 0.729 . . . . 0.0 111.861 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -110.97 174.11 6.01 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.975 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 64.1 m -126.9 70.08 1.28 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.82 -33.28 21.38 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.48 -31.17 37.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.988 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.46 10.12 17.96 Favored Glycine 0 CA--C 1.496 -1.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.298 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.06 162.35 35.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.747 -0.226 . . . . 0.0 111.179 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.71 141.9 33.86 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.082 0.864 . . . . 0.0 110.449 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -105.37 -8.27 18.29 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.492 0.663 . . . . 0.0 109.44 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -87.1 120.63 71.53 Favored Pre-proline 0 N--CA 1.428 -1.562 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.942 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.16 129.7 21.09 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.258 1.972 . . . . 0.0 111.532 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.98 4.73 58.66 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.8 m -117.2 151.15 37.48 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 t -124.66 141.31 52.2 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.92 136.68 33.52 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -132.3 82.1 2.0 Allowed 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -49.29 138.98 14.3 Favored Pre-proline 0 C--O 1.24 0.587 0 O-C-N 123.58 0.55 . . . . 0.0 112.353 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -92.54 24.5 24.47 Favored 'Cis proline' 0 CA--C 1.559 1.743 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 4.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 21.8 t -126.76 152.7 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 O-C-N 121.077 -1.015 . . . . 0.0 110.367 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t -99.5 139.78 34.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.0 m-85 -132.67 151.03 52.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.525 0.602 . . . . 0.0 111.95 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.3 tttp -114.72 104.26 11.79 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 . . . . . 0 C--N 1.317 -0.813 0 C-N-CA 124.512 1.125 . . . . 0.0 110.275 -175.839 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 114.041 0.377 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.4 mt -110.95 148.27 38.26 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 117.438 0.619 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.93 48.8 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.449 2.766 . . . . 0.0 112.185 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.97 -25.3 34.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 124.579 1.152 . . . . 0.0 111.035 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 16.7 m -62.83 -37.47 86.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.431 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.26 34.85 44.78 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -131.86 149.74 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.717 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -111.69 150.59 29.97 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.5 p -132.3 82.02 1.99 Allowed 'General case' 0 N--CA 1.404 -2.77 0 CA-C-O 122.529 1.157 . . . . 0.0 110.927 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.4 tp -84.07 -36.38 23.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.575 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.6 mt -82.77 -30.19 29.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.403 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.5 30.07 3.95 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.767 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -135.35 135.36 40.67 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.75 0.775 . . . . 0.0 112.06 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 m -120.9 141.43 50.63 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.25 -29.53 13.14 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 112.172 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -55.82 130.4 72.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 123.618 0.574 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.94 135.2 43.16 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.399 2.066 . . . . 0.0 111.596 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.57 30.48 60.04 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.6 t -118.38 131.89 56.28 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -112.25 134.77 53.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 t -77.51 129.29 35.49 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.118 0.485 . . . . 0.0 110.333 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 76.0 ttt180 -134.23 86.71 2.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -44.94 135.87 4.82 Favored Pre-proline 0 C--O 1.244 0.774 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.973 -170.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -98.73 27.5 16.69 Favored 'Cis proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.394 -1.503 . . . . 0.0 114.193 3.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.9 150.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 121.726 -0.609 . . . . 0.0 110.472 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.695 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 77.5 m -90.96 141.32 28.97 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.682 -0.636 . . . . 0.0 109.717 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 90.0 m-85 -131.17 135.9 47.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.198 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 64.6 tttp -111.0 103.17 11.61 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.347 1.059 . . . . 0.0 111.526 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.51 140.03 21.13 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.21 68.7 5.01 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.297 1.998 . . . . 0.0 111.83 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.89 -46.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.8 m -73.47 -56.08 5.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.016 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.57 14.34 82.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.145 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.46 154.67 19.47 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p -97.15 134.32 40.63 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.387 0.613 . . . . 0.0 111.22 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.06 78.99 1.79 Allowed 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 122.412 1.101 . . . . 0.0 109.838 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.69 -19.59 59.01 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.133 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.58 -21.09 59.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.451 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.56 -0.65 39.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.724 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.58 144.38 35.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 62.0 m -85.3 169.47 13.72 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -103.19 -23.57 13.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.925 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -85.44 119.5 72.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.16 132.53 19.7 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.282 1.988 . . . . 0.0 111.562 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.89 6.23 46.34 Favored Glycine 0 C--N 1.308 -0.992 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.7 t -121.38 127.42 51.2 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.7 t -88.72 138.62 31.25 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.481 0.657 . . . . 0.0 110.282 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 45.4 t -95.98 117.09 29.97 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.317 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -114.33 84.47 2.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -44.99 134.83 5.05 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.665 -170.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -95.18 15.77 40.22 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.476 -1.468 . . . . 0.0 114.863 2.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -112.56 135.34 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.064 -175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.8 t -91.27 124.54 35.55 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.012 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -123.98 143.96 50.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.42 0.629 . . . . 0.0 111.325 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -109.29 108.37 18.94 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.807 1.243 . . . . 0.0 111.658 -177.639 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.003 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.62 148.11 37.08 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.48 39.38 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.995 2.464 . . . . 0.0 112.196 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.8 -30.24 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.495 1.118 . . . . 0.0 111.184 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 32.2 m -72.12 -31.42 66.01 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.358 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.33 1.57 60.94 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.69 -0.686 . . . . 0.0 113.48 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.42 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 41.8 mt-10 -89.64 159.58 17.06 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.276 0.56 . . . . 0.0 110.686 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -118.17 130.89 56.37 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.417 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 25.3 p -111.67 77.55 1.05 Allowed 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.082 0.944 . . . . 0.0 112.78 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.3 mt -77.38 -30.2 53.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.84 -17.97 60.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.904 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -10.54 61.11 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.037 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -133.8 139.12 46.09 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.9 m -97.32 162.34 13.38 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 124.073 0.858 . . . . 0.0 108.838 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -98.55 -9.78 24.41 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.736 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.5 m -86.27 119.22 71.45 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.91 133.85 20.65 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.587 2.191 . . . . 0.0 110.513 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.54 20.48 40.82 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.5 t -120.25 140.98 50.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 t -104.22 121.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.506 0.67 . . . . 0.0 110.395 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.2 t -79.16 110.23 14.23 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.213 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -121.06 85.56 2.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -52.86 142.91 32.75 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.868 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.28 15.86 45.7 Favored 'Cis proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.208 -1.58 . . . . 0.0 116.052 4.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 52.4 t -122.29 144.96 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.73 1.15 . . . . 0.0 112.394 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 72.7 m -89.1 117.01 27.78 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.412 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.456 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.8 m-85 -114.73 121.44 43.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.627 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 41.3 ttmt -90.19 108.69 19.9 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 124.411 1.084 . . . . 0.0 112.62 -178.253 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.406 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.55 139.56 20.23 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.64 42.46 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.853 3.035 . . . . 0.0 113.04 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.13 -27.94 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 124.536 1.134 . . . . 0.0 111.111 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 6.7 m -66.0 -45.67 80.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.71 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.27 28.34 37.0 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -141.16 161.77 37.08 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 122.794 0.438 . . . . 0.0 110.05 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 24' ' ' PRO . 30.8 p -118.85 -179.8 3.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -121.21 79.68 1.55 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.51 -26.76 17.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.14 -21.57 18.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.688 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 16.06 27.3 Favored Glycine 0 C--O 1.239 0.415 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.3 tttm -140.95 141.15 34.49 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 75.1 m -90.88 159.08 16.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -113.58 -26.77 8.12 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 120.986 0.422 . . . . 0.0 110.047 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -82.78 127.62 69.25 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.84 145.16 61.59 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.512 2.141 . . . . 0.0 111.934 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.78 1.22 80.51 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.813 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 99.5 m -103.14 126.09 50.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -93.28 124.34 37.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.513 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.01 126.63 31.43 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.969 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -137.26 94.41 2.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -52.36 137.93 39.54 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.4 Cg_endo -98.38 28.68 15.38 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.57 2.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.488 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 6.9 t -124.19 166.17 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.535 -0.728 . . . . 0.0 109.322 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 42.4 t -113.12 133.32 55.08 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.488 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 94.0 m-85 -130.94 135.89 48.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.045 0.45 . . . . 0.0 111.462 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 87.2 tttt -103.73 108.79 20.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.495 1.784 0 C-N-CA 124.339 1.055 . . . . 0.0 110.605 -176.251 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.926 -0.07 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.82 148.3 36.65 Favored Pre-proline 0 C--N 1.312 -1.042 0 O-C-N 122.378 -0.483 . . . . 0.0 110.437 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.66 50.7 3.31 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.723 2.282 . . . . 0.0 111.508 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.37 -28.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.112 1.365 . . . . 0.0 111.434 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.1 m -78.1 -19.27 54.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.75 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.87 -44.24 2.29 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 113.639 0.216 . . . . 0.0 113.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.95 154.21 31.15 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.839 0.856 . . . . 0.0 111.468 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -108.72 179.2 4.25 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.626 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 77.1 m -118.18 74.02 0.93 Allowed 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.776 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.7 tp -84.95 -30.69 24.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.55 -30.39 15.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.619 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 9' ' ' CYS . . . 100.88 29.83 6.33 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -134.86 135.89 42.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.319 -0.441 . . . . 0.0 109.968 -174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 92.7 m -109.4 123.89 50.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -84.67 -31.19 24.28 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.031 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.9 m -69.13 119.8 72.46 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.35 134.21 24.24 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.025 1.817 . . . . 0.0 110.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.72 23.48 23.28 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.836 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.42 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 1.1 t -122.93 153.26 39.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -113.29 122.7 48.2 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.312 0.577 . . . . 0.0 110.205 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 51.4 t -80.81 110.98 16.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.979 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.25 81.49 1.62 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 174.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -47.52 132.43 10.48 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.385 -171.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -96.69 26.34 19.86 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 N-CA-C 116.076 1.529 . . . . 0.0 116.076 6.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.585 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 20.5 t -127.54 151.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.802 -1.186 . . . . 0.0 109.933 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.0 t -102.43 121.22 41.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.585 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 98.2 m-85 -118.62 142.1 47.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.404 0.621 . . . . 0.0 111.844 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.42 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 61.4 tttp -126.04 117.52 23.38 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 122.355 1.074 . . . . 0.0 109.746 177.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mp -108.31 142.28 25.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 117.032 0.416 . . . . 0.0 111.09 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.82 43.21 1.21 Allowed 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 123.693 2.929 . . . . 0.0 112.28 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -72.8 -28.29 26.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.462 1.105 . . . . 0.0 111.303 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 9.6 m -61.76 -34.81 76.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.55 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.62 69.29 Favored Glycine 0 CA--C 1.494 -1.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.922 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 10.9 pt-20 -140.52 160.84 39.13 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.128 0.489 . . . . 0.0 110.849 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p -108.71 166.71 10.59 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.275 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.93 83.82 1.45 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 122.162 0.982 . . . . 0.0 110.652 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.94 -15.05 60.24 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.291 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -86.8 -17.71 32.82 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.294 0.569 . . . . 0.0 110.271 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.81 18.98 41.95 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.01 119.95 13.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.7 t -81.1 149.53 29.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -80.03 -36.06 36.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.441 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.1 m -84.42 128.68 60.74 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.679 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.1 136.16 43.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.643 2.229 . . . . 0.0 110.54 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.75 -16.27 56.3 Favored Glycine 0 C--N 1.304 -1.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.59 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.33 119.92 33.02 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 m -76.24 134.08 39.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -91.7 110.49 21.83 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.621 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -107.51 86.26 2.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 18.4 ptt180 -43.89 129.7 4.21 Favored Pre-proline 0 C--N 1.316 -0.848 0 O-C-N 124.71 1.256 . . . . 0.0 113.422 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.0 Cg_endo -101.27 31.14 10.16 Favored 'Cis proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.031 -1.237 . . . . 0.0 113.595 1.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.97 141.15 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.771 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 92.7 m -84.48 135.47 34.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.779 0.323 . . . . 0.0 110.947 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.38 115.79 16.02 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttm -93.45 114.98 27.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.349 1.06 . . . . 0.0 109.646 -177.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.995 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.5 mt -94.46 157.43 37.29 Favored Pre-proline 0 C--N 1.309 -1.196 0 O-C-N 122.821 -0.223 . . . . 0.0 110.597 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 66.1 Cg_endo -72.19 48.6 1.22 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 123.639 2.892 . . . . 0.0 112.36 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mm -59.53 -35.94 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 125.45 1.5 . . . . 0.0 112.704 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.6 m -69.19 -36.89 77.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.845 0.355 . . . . 0.0 110.423 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.82 -12.93 55.83 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.498 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.491 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 42.9 mt-10 -74.43 159.4 32.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.121 0.486 . . . . 0.0 110.838 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.3 p -118.73 132.26 56.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.79 75.5 10.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.3 mt -80.42 -40.61 26.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.75 -29.1 24.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.137 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.59 -4.53 7.58 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.793 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -122.73 136.04 54.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 t -90.75 139.56 30.61 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -92.16 -19.59 22.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.761 0.315 . . . . 0.0 111.161 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.4 m -81.37 120.92 79.52 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.17 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 138.97 39.07 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.589 2.193 . . . . 0.0 110.785 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.44 19.96 70.27 Favored Glycine 0 C--N 1.314 -0.671 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.0 t -122.08 133.26 54.78 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 m -90.41 119.91 31.08 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.645 0.736 . . . . 0.0 110.475 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.4 t -77.06 114.74 16.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.44 85.03 2.32 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -47.82 134.06 11.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 123.845 0.716 . . . . 0.0 111.769 -171.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -97.18 25.98 20.14 Favored 'Cis proline' 0 CA--C 1.558 1.721 0 C-N-CA 123.453 -1.478 . . . . 0.0 114.766 3.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 40.6 t -128.37 149.57 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.952 1.251 . . . . 0.0 112.051 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 84.0 m -89.89 115.96 27.61 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 120.948 0.404 . . . . 0.0 111.457 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.412 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 33.7 m-85 -110.52 133.88 52.89 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 65.1 tttm -120.27 122.71 41.48 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.319 -0.721 0 C-N-CA 124.895 1.278 . . . . 0.0 110.67 -179.538 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.449 0 N-CA-C 112.696 -0.162 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 4' ' ' ILE . 83.8 mt -102.0 143.22 26.16 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.46 33.92 0.4 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.648 2.899 . . . . 0.0 112.621 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.403 ' H ' ' C ' ' A' ' 2' ' ' LEU . 49.0 mm -59.95 -44.25 94.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 123.669 0.788 . . . . 0.0 110.397 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.7 m -66.09 -55.56 15.89 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.935 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.08 12.48 83.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -89.16 170.67 10.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-O 121.056 0.455 . . . . 0.0 110.37 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.5 p -128.1 131.8 49.02 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.682 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.55 63.37 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.31 -38.98 85.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.26 1.36 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.57 -36.0 2.31 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 119.299 -1.429 . . . . 0.0 114.035 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.0 tttm -116.06 153.41 31.75 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 43.3 t -81.04 142.27 33.53 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.64 -24.29 27.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.985 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 m -89.51 122.02 68.7 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.336 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.04 140.04 27.82 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.215 1.944 . . . . 0.0 111.177 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.55 21.35 60.22 Favored Glycine 0 C--N 1.319 -0.409 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 34.9 t -135.05 126.6 28.78 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -83.76 137.64 33.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.506 0.669 . . . . 0.0 111.593 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.3 t -87.52 131.02 34.51 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.708 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -133.28 74.24 1.55 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -46.3 130.64 7.72 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.672 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -93.66 17.07 41.22 Favored 'Cis proline' 0 CA--C 1.551 1.374 0 N-CA-C 116.338 1.63 . . . . 0.0 116.338 6.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.06 145.7 20.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 119.913 1.233 . . . . 0.0 111.872 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 89.5 m -94.34 121.65 36.09 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -117.87 122.66 43.91 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.126 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttp -92.45 111.18 22.66 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 122.482 1.134 . . . . 0.0 109.714 -178.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.036 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt -132.77 144.43 52.87 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 116.883 0.342 . . . . 0.0 110.72 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -77.85 90.92 1.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.207 1.938 . . . . 0.0 110.244 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.3 mm -113.62 -32.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.537 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 m -66.77 -33.63 76.04 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.738 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.91 39.66 23.63 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.18 150.32 52.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.846 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -131.37 141.5 49.9 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -84.73 73.05 10.66 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.395 0.617 . . . . 0.0 109.786 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -89.02 -32.67 17.48 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.31 -24.4 22.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.784 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.04 -13.23 10.53 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.482 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -141.55 147.3 37.49 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 122.393 -0.475 . . . . 0.0 110.839 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.4 m -89.95 167.4 12.83 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -105.14 -36.03 7.4 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.668 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.9 m -69.64 122.05 84.49 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -68.98 131.66 22.85 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.444 2.096 . . . . 0.0 109.282 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.09 38.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.9 t -132.44 120.45 21.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 m -90.48 147.44 23.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.003 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -96.57 118.68 33.57 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.14 0.495 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.427 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 8.4 tpt180 -124.56 84.49 2.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -47.52 134.66 10.15 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.398 -172.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -94.46 24.19 25.19 Favored 'Cis proline' 0 CA--C 1.556 1.617 0 N-CA-C 115.46 1.292 . . . . 0.0 115.46 2.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.71 145.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.725 -1.234 . . . . 0.0 111.169 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 70.7 m -89.86 136.97 32.72 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.427 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 94.3 m-85 -129.83 125.24 35.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.897 0.379 . . . . 0.0 110.188 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.64 113.03 23.78 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m120 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 125.687 1.595 . . . . 0.0 109.133 -173.301 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 N-CA-C 113.452 0.141 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.27 152.63 46.14 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 117.24 0.52 . . . . 0.0 110.441 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 85.4 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.977 1.785 . . . . 0.0 110.905 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 47.2 mm -104.07 -33.7 3.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.578 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 37.9 m -65.7 -35.0 79.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 -32.92 2.87 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.146 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.0 171.08 12.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.509 0.671 . . . . 0.0 111.533 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 p -133.27 156.11 48.17 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.904 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 72.9 m -90.8 67.18 6.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.236 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.33 -26.43 65.61 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.695 0.76 . . . . 0.0 109.962 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -87.31 -2.28 58.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.476 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.4 -13.34 65.53 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -132.41 145.92 51.57 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 25.0 t -91.1 139.39 30.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -93.9 -9.67 36.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.251 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -83.13 120.6 76.21 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.25 133.79 42.28 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.881 2.387 . . . . 0.0 111.046 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.33 -15.05 64.06 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.621 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -93.67 125.07 38.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.558 0.694 . . . . 0.0 111.198 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -80.7 127.32 32.36 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.5 105.73 17.99 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 121.49 0.662 . . . . 0.0 111.772 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -113.91 76.2 0.97 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -49.32 139.62 13.8 Favored Pre-proline 0 C--O 1.245 0.827 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.688 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.72 16.78 37.97 Favored 'Cis proline' 0 CA--C 1.553 1.46 0 N-CA-C 115.374 1.259 . . . . 0.0 115.374 3.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.91 143.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.154 1.343 . . . . 0.0 112.979 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.97 120.14 32.35 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.157 0.503 . . . . 0.0 110.22 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -110.59 160.03 17.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.004 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.4 tttm -141.67 122.99 14.84 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 123.729 0.812 . . . . 0.0 110.776 -178.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.663 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.24 152.14 37.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 74.3 Cg_endo -75.71 51.45 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.175 2.584 . . . . 0.0 112.002 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 48.4 mm -59.84 -24.73 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.089 1.355 . . . . 0.0 110.703 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.2 m -64.84 -32.99 74.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.024 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.73 31.26 70.34 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.346 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -140.84 156.36 46.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -114.45 156.06 25.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.132 0.491 . . . . 0.0 111.664 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 92.1 m -90.84 72.29 6.58 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.5 -40.53 29.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.325 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -88.69 -30.04 19.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.86 25.74 5.0 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.464 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.08 148.57 40.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.72 145.12 31.52 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.03 -33.39 10.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.2 m -73.0 129.0 87.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.35 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.36 141.34 55.99 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.94 2.427 . . . . 0.0 111.655 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.75 4.4 79.39 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 121.388 -0.435 . . . . 0.0 112.878 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.561 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 87.4 m -97.69 149.32 22.41 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -111.36 119.79 40.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.0 t -82.02 115.5 21.2 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.006 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -126.66 78.99 1.83 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.403 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 21.9 ptt180 -50.49 135.41 24.97 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -87.45 10.68 58.91 Favored 'Cis proline' 0 CA--C 1.565 2.043 0 N-CA-C 117.641 2.131 . . . . 0.0 117.641 7.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.03 152.86 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.254 -1.529 . . . . 0.0 111.588 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 43.6 t -106.73 114.64 28.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 96.6 m-85 -109.22 148.11 31.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.036 0.446 . . . . 0.0 111.056 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 88.5 tttt -118.64 108.74 15.29 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 124.596 1.159 . . . . 0.0 111.296 -173.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.55 143.77 27.05 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.448 0.624 . . . . 0.0 110.929 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.59 50.42 2.98 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.06 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.4 mm -59.06 -44.12 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.583 1.153 . . . . 0.0 111.559 -175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.89 -41.9 95.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.81 14.53 75.62 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.274 -0.421 . . . . 0.0 113.213 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.27 146.2 24.92 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -93.72 131.6 38.89 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-O 121.122 0.487 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.7 p -111.16 75.18 0.9 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.308 1.051 . . . . 0.0 111.161 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.32 -31.48 62.48 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.533 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.95 7.51 27.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.264 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.93 77.81 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.031 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -140.4 140.49 35.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -110.93 149.09 31.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -96.55 -15.73 21.46 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 120.688 0.28 . . . . 0.0 110.915 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -94.13 119.46 66.66 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.58 140.73 40.26 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.781 1.654 . . . . 0.0 110.393 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.18 67.58 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -130.7 130.85 44.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 t -113.99 147.3 38.85 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.519 0.676 . . . . 0.0 111.314 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.48 118.3 23.67 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.349 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.503 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 30.6 tpt180 -123.45 77.62 1.51 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -46.38 137.54 6.78 Favored Pre-proline 0 C--O 1.24 0.577 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.834 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -91.72 15.08 47.91 Favored 'Cis proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.205 -1.581 . . . . 0.0 115.16 5.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.91 140.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 121.496 -0.752 . . . . 0.0 110.848 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.2 t -95.24 127.46 41.3 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.503 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 59.3 m-85 -115.83 144.08 44.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.336 -174.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -113.41 99.17 7.57 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.206 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.79 144.68 54.26 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.82 48.91 2.06 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.959 2.439 . . . . 0.0 112.109 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.2 mm -59.08 -42.2 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 36.7 m -62.9 -33.37 75.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.94 -21.6 5.55 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.658 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.96 164.66 25.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.395 0.678 . . . . 0.0 110.152 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 5.1 p -129.9 166.79 19.29 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.064 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 82.3 m -111.91 75.61 0.93 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -83.69 -41.2 17.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.6 -12.02 60.0 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.523 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.51 -20.64 27.33 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.138 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -112.18 144.21 41.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 38.0 t -106.64 129.53 54.54 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.76 3.95 54.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -107.44 119.74 49.74 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.846 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.46 132.96 18.31 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.671 2.247 . . . . 0.0 111.355 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.52 -8.45 43.93 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 24.2 t -117.65 119.79 36.04 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 p -82.76 133.98 35.13 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.598 0.713 . . . . 0.0 111.277 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.27 106.91 16.25 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.519 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 26.6 ttm180 -114.02 92.98 4.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -50.28 135.33 23.57 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.066 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.03 27.03 17.78 Favored 'Cis proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.818 -1.326 . . . . 0.0 114.655 3.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.553 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 25.7 t -128.39 152.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.801 -1.187 . . . . 0.0 111.865 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 78.1 m -86.44 113.08 22.1 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.553 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 56.8 m-85 -108.59 117.66 34.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 86.2 tttt -86.78 118.12 25.97 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.318 -0.763 0 C-N-CA 125.138 1.375 . . . . 0.0 108.804 -176.635 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.9 mt -102.9 150.49 37.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -74.64 45.06 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.786 2.991 . . . . 0.0 112.328 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.6 mm -64.4 -41.61 92.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 124.059 0.944 . . . . 0.0 110.972 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 56.5 m -68.2 -33.56 74.66 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.926 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.27 11.63 84.03 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -106.06 170.89 7.65 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 121.622 0.725 . . . . 0.0 111.285 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -120.82 170.79 9.13 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.658 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -120.45 80.2 1.58 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.05 -33.4 19.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.33 0.586 . . . . 0.0 109.64 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.53 10.99 25.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.33 1.02 80.21 Favored Glycine 0 N--CA 1.461 0.338 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -140.35 153.92 46.56 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.1 m -79.24 153.83 29.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.474 0.655 . . . . 0.0 110.775 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -82.22 -25.33 34.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -102.79 120.62 52.11 Favored Pre-proline 0 N--CA 1.433 -1.286 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.436 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.51 134.82 23.1 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.798 2.332 . . . . 0.0 110.564 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.23 -1.0 29.69 Favored Glycine 0 C--N 1.307 -1.082 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -106.81 169.29 8.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -114.66 119.11 35.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.06 134.2 34.62 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -142.13 82.49 1.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -43.76 135.46 3.68 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.372 -174.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -94.86 23.98 25.54 Favored 'Cis proline' 0 CA--C 1.558 1.717 0 C-N-CA 123.835 -1.319 . . . . 0.0 114.53 3.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.24 157.45 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.417 -0.802 . . . . 0.0 110.124 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -112.3 128.82 56.38 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -121.97 170.39 9.87 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.067 0.461 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.4 tttp -146.82 113.49 6.03 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.76 0.824 . . . . 0.0 110.06 -177.579 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.24 145.68 30.66 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 122.736 -0.273 . . . . 0.0 110.375 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.76 50.94 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.288 2.658 . . . . 0.0 110.876 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.1 mm -59.49 -44.89 93.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.555 1.142 . . . . 0.0 110.316 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 m -74.7 -39.31 62.03 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.036 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.22 31.65 74.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.149 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.74 158.01 16.8 Favored 'General case' 0 CA--C 1.466 -2.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.482 ' O ' ' HE1' ' A' ' 15' ' ' TYR . 8.7 p -99.31 128.59 45.45 Favored 'General case' 0 C--N 1.263 -3.179 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.0 p -107.67 70.8 0.79 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.081 0.943 . . . . 0.0 110.345 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.77 -33.86 72.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.744 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.8 -27.76 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 111.534 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.95 -11.44 11.8 Favored Glycine 0 CA--C 1.487 -1.689 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -117.1 153.11 33.34 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.016 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 t -91.86 152.82 19.92 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.482 ' HE1' ' O ' ' A' ' 8' ' ' THR . 41.6 m-85 -96.75 -26.69 15.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.128 0.489 . . . . 0.0 110.347 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -83.54 129.09 61.34 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.197 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 137.1 21.72 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.361 2.041 . . . . 0.0 110.216 175.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.3 56.11 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.8 t -139.32 156.28 47.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 152.65 46.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 118.283 0.492 . . . . 0.0 111.707 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.18 99.86 12.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.581 0.705 . . . . 0.0 111.199 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -105.34 85.18 2.21 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -43.77 135.96 3.61 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 114.181 -1.372 . . . . 0.0 113.165 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -95.37 18.51 35.2 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.086 -1.631 . . . . 0.0 114.347 3.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.51 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 48.7 t -123.6 146.1 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.745 0.783 . . . . 0.0 112.874 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.543 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 37.3 m -79.56 115.67 19.31 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.586 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.51 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 83.9 m-85 -115.96 147.02 41.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.851 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -130.32 115.32 16.77 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 122.208 1.004 . . . . 0.0 110.133 177.429 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.9 mt -110.56 139.18 21.33 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.89 44.43 0.96 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 123.19 2.593 . . . . 0.0 112.92 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mm -67.75 -42.15 85.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.118 0.567 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 78.3 m -60.03 -44.95 94.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.99 3.5 81.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.783 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -83.16 170.43 14.75 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.142 0.496 . . . . 0.0 109.961 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.627 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.0 m -83.43 77.02 9.88 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.769 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.92 -50.6 10.93 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.8 10.76 12.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.475 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.88 21.94 78.87 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.463 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -140.11 142.51 36.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -91.51 137.87 32.02 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.932 0.396 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.05 -37.37 78.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.262 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.7 m -82.21 119.97 76.12 Favored Pre-proline 0 N--CA 1.432 -1.372 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.118 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -67.53 134.17 32.23 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.132 2.555 . . . . 0.0 112.278 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.6 -0.23 88.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.907 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 11.6 t -92.35 139.81 30.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 m -81.98 121.82 26.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.754 0.788 . . . . 0.0 111.509 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.19 107.57 19.22 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -126.43 90.87 3.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -50.34 139.02 20.13 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -94.52 18.45 36.98 Favored 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.491 -1.462 . . . . 0.0 115.206 2.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.477 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 61.2 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 121.193 -0.942 . . . . 0.0 111.791 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 21.0 t -93.47 111.16 22.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.477 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.5 m-85 -110.56 119.56 39.57 Favored 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.478 0.711 . . . . 0.0 111.44 -174.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.61 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.6 tttm -90.47 112.59 24.29 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 17.6 m120 . . . . . 0 C--N 1.318 -0.797 0 C-N-CA 124.53 1.132 . . . . 0.0 110.109 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.8 mt -106.98 146.08 32.42 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.86 77.66 3.35 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.281 1.987 . . . . 0.0 111.776 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.88 -39.29 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.53 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.68 -39.89 21.41 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.592 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.4 29.68 75.28 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -117.64 170.67 8.58 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.128 0.49 . . . . 0.0 111.503 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -116.43 157.69 24.73 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 p -132.94 75.24 1.61 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.967 0.889 . . . . 0.0 109.9 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.182 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.26 12.4 36.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.585 0.707 . . . . 0.0 111.307 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.09 -5.4 79.94 Favored Glycine 0 CA--C 1.502 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.696 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -130.83 143.41 50.71 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -91.35 157.0 17.36 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.418 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -95.2 -20.46 19.21 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.5 m -80.31 119.07 75.31 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.17 127.41 14.23 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.454 2.103 . . . . 0.0 111.598 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.67 30.34 10.71 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.43 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -136.44 131.21 33.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.8 m -93.71 142.94 26.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 0.0 112.127 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.5 124.68 30.97 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.252 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -121.72 66.22 0.9 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -41.05 131.12 1.96 Allowed Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.512 -1.222 . . . . 0.0 114.153 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -89.59 5.99 68.86 Favored 'Cis proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.422 -1.491 . . . . 0.0 115.435 4.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.72 147.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 18.3 t -98.58 136.24 38.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -135.1 129.99 34.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.417 0.627 . . . . 0.0 111.169 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -92.62 109.58 21.0 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 N--CA 1.479 0.976 0 O-C-N 123.775 0.672 . . . . 0.0 110.827 -177.426 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.386 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.4 mt -89.8 151.86 46.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 C-N-CA 122.207 0.203 . . . . 0.0 111.367 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.28 94.86 0.83 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 121.579 1.52 . . . . 0.0 109.048 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.91 -32.2 2.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.398 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.9 m -71.89 -45.42 61.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.94 14.94 Favored Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.354 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.24 166.99 15.22 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.782 0.801 . . . . 0.0 112.25 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -119.53 145.53 46.26 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.468 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.77 51.59 1.23 Allowed 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.766 0.793 . . . . 0.0 109.155 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.17 -25.67 33.97 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.054 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.02 11.73 28.75 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 122.111 -0.368 . . . . 0.0 111.949 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.01 89.57 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 121.35 -0.453 . . . . 0.0 112.166 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.91 138.46 48.4 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -94.68 156.72 16.28 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -113.62 13.2 18.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.699 0.762 . . . . 0.0 111.537 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 m -120.1 119.07 31.11 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.468 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 133.22 56.12 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 123.267 2.644 . . . . 0.0 111.132 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.39 -6.78 75.21 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.137 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -102.32 148.95 24.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.8 t -108.01 141.27 39.94 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.36 119.15 28.52 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.032 0.444 . . . . 0.0 110.62 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 4.7 tpm_? -127.32 84.84 2.3 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 171.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -41.38 130.88 2.18 Favored Pre-proline 0 C--O 1.249 1.032 0 CA-C-N 114.013 -1.449 . . . . 0.0 114.351 -170.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -97.71 19.0 28.94 Favored 'Cis proline' 0 CA--C 1.556 1.609 0 C-N-CA 123.587 -1.422 . . . . 0.0 114.588 1.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.93 144.7 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 121.601 0.715 . . . . 0.0 112.726 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.1 m -88.81 115.19 26.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.858 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 48.5 m-85 -103.95 157.89 16.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 82.1 tttt -129.37 117.68 21.0 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 125.266 1.426 . . . . 0.0 110.644 -176.27 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.96 145.04 55.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.931 0.365 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.33 66.48 5.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.187 2.591 . . . . 0.0 111.266 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.13 -37.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.095 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.1 m -68.51 -27.97 66.59 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.62 17.37 79.95 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.125 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -110.35 170.36 8.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.5 p -123.86 154.79 39.15 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.278 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 p -138.58 81.78 1.87 Allowed 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.961 0.886 . . . . 0.0 110.316 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.07 -24.63 63.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.274 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.71 6.54 34.3 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 120.8 0.333 . . . . 0.0 111.329 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 80.99 20.36 65.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.002 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.15 119.69 24.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -89.5 145.88 24.99 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.525 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -84.81 -25.54 28.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.102 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -86.99 125.82 65.17 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.211 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.34 146.42 50.6 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.547 2.164 . . . . 0.0 110.436 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.64 29.25 71.42 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.573 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.0 t -145.86 130.65 18.07 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -99.62 173.15 6.86 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.543 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 39.0 t -109.1 132.44 54.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.168 0.509 . . . . 0.0 110.314 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.65 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 31.5 tpt180 -135.28 84.95 2.13 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -39.96 134.47 1.39 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.693 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -96.01 21.16 29.53 Favored 'Cis proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.568 0.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.59 150.52 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 121.771 -0.581 . . . . 0.0 111.728 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.573 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 88.4 m -79.37 139.32 37.78 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 121.962 -0.461 . . . . 0.0 110.452 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.65 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 13.0 m-85 -127.62 137.13 52.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.055 0.455 . . . . 0.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.91 118.65 24.01 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.406 0.622 . . . . 0.0 111.508 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.02 143.63 26.99 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 122.787 -0.243 . . . . 0.0 110.371 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.35 86.98 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.035 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.4 mm -123.13 -12.37 6.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.731 0.777 . . . . 0.0 110.195 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 8.7 m -81.55 -36.9 28.57 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.1 53.93 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -126.8 159.69 33.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.63 0.729 . . . . 0.0 111.861 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -110.97 174.11 6.01 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.975 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 64.1 m -126.9 70.08 1.28 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.82 -33.28 21.38 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.48 -31.17 37.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.988 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.46 10.12 17.96 Favored Glycine 0 CA--C 1.496 -1.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.298 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.06 162.35 35.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.747 -0.226 . . . . 0.0 111.179 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.71 141.9 33.86 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.082 0.864 . . . . 0.0 110.449 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -105.37 -8.27 18.29 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.492 0.663 . . . . 0.0 109.44 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -87.1 120.63 71.53 Favored Pre-proline 0 N--CA 1.428 -1.562 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.942 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.16 129.7 21.09 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.258 1.972 . . . . 0.0 111.532 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.98 4.73 58.66 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.8 m -117.2 151.15 37.48 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 t -124.66 141.31 52.2 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.92 136.68 33.52 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -132.3 82.1 2.0 Allowed 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -49.29 138.98 14.3 Favored Pre-proline 0 C--O 1.24 0.587 0 O-C-N 123.58 0.55 . . . . 0.0 112.353 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -92.54 24.5 24.47 Favored 'Cis proline' 0 CA--C 1.559 1.743 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 4.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 21.8 t -126.76 152.7 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 O-C-N 121.077 -1.015 . . . . 0.0 110.367 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t -99.5 139.78 34.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.0 m-85 -132.67 151.03 52.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.525 0.602 . . . . 0.0 111.95 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.3 tttp -114.72 104.26 11.79 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 . . . . . 0 C--N 1.317 -0.813 0 C-N-CA 124.512 1.125 . . . . 0.0 110.275 -175.839 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 114.041 0.377 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.4 mt -110.95 148.27 38.26 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 117.438 0.619 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.93 48.8 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.449 2.766 . . . . 0.0 112.185 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.97 -25.3 34.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 124.579 1.152 . . . . 0.0 111.035 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 16.7 m -62.83 -37.47 86.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.431 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.26 34.85 44.78 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -131.86 149.74 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.717 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -111.69 150.59 29.97 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.5 p -132.3 82.02 1.99 Allowed 'General case' 0 N--CA 1.404 -2.77 0 CA-C-O 122.529 1.157 . . . . 0.0 110.927 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.4 tp -84.07 -36.38 23.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.575 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.6 mt -82.77 -30.19 29.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.403 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.5 30.07 3.95 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.767 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -135.35 135.36 40.67 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.75 0.775 . . . . 0.0 112.06 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 m -120.9 141.43 50.63 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.25 -29.53 13.14 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 112.172 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -55.82 130.4 72.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 123.618 0.574 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.94 135.2 43.16 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.399 2.066 . . . . 0.0 111.596 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.57 30.48 60.04 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.6 t -118.38 131.89 56.28 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -112.25 134.77 53.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 t -77.51 129.29 35.49 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.118 0.485 . . . . 0.0 110.333 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 76.0 ttt180 -134.23 86.71 2.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 72.7 mtt180 -44.94 135.87 4.82 Favored Pre-proline 0 C--O 1.244 0.774 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.973 -170.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 60.0 Cg_endo -98.73 27.5 16.69 Favored 'Cis proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.394 -1.503 . . . . 0.0 114.193 3.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.9 150.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 121.726 -0.609 . . . . 0.0 110.472 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.707 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 77.5 m -90.96 141.32 28.97 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.682 -0.636 . . . . 0.0 109.717 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 90.0 m-85 -131.17 135.9 47.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.198 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 64.6 tttp -111.0 103.17 11.61 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.347 1.059 . . . . 0.0 111.526 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.51 140.03 21.13 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.21 68.7 5.01 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.297 1.998 . . . . 0.0 111.83 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.89 -46.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.8 m -73.47 -56.08 5.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.016 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.57 14.34 82.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.145 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.46 154.67 19.47 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p -97.15 134.32 40.63 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.387 0.613 . . . . 0.0 111.22 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.06 78.99 1.79 Allowed 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 122.412 1.101 . . . . 0.0 109.838 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.69 -19.59 59.01 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.133 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.58 -21.09 59.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.451 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.56 -0.65 39.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.724 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.58 144.38 35.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 62.0 m -85.3 169.47 13.72 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -103.19 -23.57 13.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.925 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -85.44 119.5 72.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.16 132.53 19.7 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.282 1.988 . . . . 0.0 111.562 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.89 6.23 46.34 Favored Glycine 0 C--N 1.308 -0.992 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.7 t -121.38 127.42 51.2 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.7 t -88.72 138.62 31.25 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.481 0.657 . . . . 0.0 110.282 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 45.4 t -95.98 117.09 29.97 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.317 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -114.33 84.47 2.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 32.6 ptt180 -44.99 134.83 5.05 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.665 -170.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.9 Cg_endo -95.18 15.77 40.22 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.476 -1.468 . . . . 0.0 114.863 2.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -112.56 135.34 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.064 -175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.8 t -91.27 124.54 35.55 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.012 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -123.98 143.96 50.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.42 0.629 . . . . 0.0 111.325 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -109.29 108.37 18.94 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.807 1.243 . . . . 0.0 111.658 -177.639 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.003 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.62 148.11 37.08 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.48 39.38 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.995 2.464 . . . . 0.0 112.196 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.8 -30.24 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.495 1.118 . . . . 0.0 111.184 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 32.2 m -72.12 -31.42 66.01 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.358 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.33 1.57 60.94 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.69 -0.686 . . . . 0.0 113.48 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 41.8 mt-10 -89.64 159.58 17.06 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.276 0.56 . . . . 0.0 110.686 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -118.17 130.89 56.37 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 25.3 p -111.67 77.55 1.05 Allowed 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.082 0.944 . . . . 0.0 112.78 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.3 mt -77.38 -30.2 53.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.84 -17.97 60.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.904 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -10.54 61.11 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.037 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -133.8 139.12 46.09 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.9 m -97.32 162.34 13.38 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 124.073 0.858 . . . . 0.0 108.838 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -98.55 -9.78 24.41 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.736 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.5 m -86.27 119.22 71.45 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.91 133.85 20.65 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.587 2.191 . . . . 0.0 110.513 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.54 20.48 40.82 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.5 t -120.25 140.98 50.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 t -104.22 121.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.506 0.67 . . . . 0.0 110.395 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.2 t -79.16 110.23 14.23 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.213 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -121.06 85.56 2.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -52.86 142.91 32.75 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.868 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.28 15.86 45.7 Favored 'Cis proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.208 -1.58 . . . . 0.0 116.052 4.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 52.4 t -122.29 144.96 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.73 1.15 . . . . 0.0 112.394 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 72.7 m -89.1 117.01 27.78 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.412 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.8 m-85 -114.73 121.44 43.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.627 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 41.3 ttmt -90.19 108.69 19.9 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 124.411 1.084 . . . . 0.0 112.62 -178.253 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.406 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.55 139.56 20.23 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.64 42.46 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.853 3.035 . . . . 0.0 113.04 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.13 -27.94 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 124.536 1.134 . . . . 0.0 111.111 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 6.7 m -66.0 -45.67 80.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.71 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.27 28.34 37.0 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -141.16 161.77 37.08 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 122.794 0.438 . . . . 0.0 110.05 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 24' ' ' PRO . 30.8 p -118.85 -179.8 3.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -121.21 79.68 1.55 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.51 -26.76 17.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.14 -21.57 18.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.688 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 16.06 27.3 Favored Glycine 0 C--O 1.239 0.415 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.3 tttm -140.95 141.15 34.49 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 75.1 m -90.88 159.08 16.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -113.58 -26.77 8.12 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 120.986 0.422 . . . . 0.0 110.047 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -82.78 127.62 69.25 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.84 145.16 61.59 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.512 2.141 . . . . 0.0 111.934 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.78 1.22 80.51 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.813 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 99.5 m -103.14 126.09 50.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -93.28 124.34 37.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.513 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.01 126.63 31.43 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.969 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -137.26 94.41 2.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 64.3 mtm180 -52.36 137.93 39.54 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.4 Cg_endo -98.38 28.68 15.38 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.57 2.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.491 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 6.9 t -124.19 166.17 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.535 -0.728 . . . . 0.0 109.322 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 42.4 t -113.12 133.32 55.08 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 94.0 m-85 -130.94 135.89 48.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.045 0.45 . . . . 0.0 111.462 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 87.2 tttt -103.73 108.79 20.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.495 1.784 0 C-N-CA 124.339 1.055 . . . . 0.0 110.605 -176.251 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.926 -0.07 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.82 148.3 36.65 Favored Pre-proline 0 C--N 1.312 -1.042 0 O-C-N 122.378 -0.483 . . . . 0.0 110.437 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.66 50.7 3.31 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.723 2.282 . . . . 0.0 111.508 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.37 -28.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.112 1.365 . . . . 0.0 111.434 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.1 m -78.1 -19.27 54.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.75 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.87 -44.24 2.29 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 113.639 0.216 . . . . 0.0 113.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.95 154.21 31.15 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.839 0.856 . . . . 0.0 111.468 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -108.72 179.2 4.25 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.626 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 77.1 m -118.18 74.02 0.93 Allowed 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.776 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.7 tp -84.95 -30.69 24.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.55 -30.39 15.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.619 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 9' ' ' CYS . . . 100.88 29.83 6.33 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -134.86 135.89 42.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.319 -0.441 . . . . 0.0 109.968 -174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 92.7 m -109.4 123.89 50.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -84.67 -31.19 24.28 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.031 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.9 m -69.13 119.8 72.46 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.35 134.21 24.24 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.025 1.817 . . . . 0.0 110.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.72 23.48 23.28 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.836 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 1.1 t -122.93 153.26 39.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -113.29 122.7 48.2 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.312 0.577 . . . . 0.0 110.205 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 51.4 t -80.81 110.98 16.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.979 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.25 81.49 1.62 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 174.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 43.8 ttt180 -47.52 132.43 10.48 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.385 -171.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 32.1 Cg_endo -96.69 26.34 19.86 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 N-CA-C 116.076 1.529 . . . . 0.0 116.076 6.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 20.5 t -127.54 151.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.802 -1.186 . . . . 0.0 109.933 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.0 t -102.43 121.22 41.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 98.2 m-85 -118.62 142.1 47.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.404 0.621 . . . . 0.0 111.844 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 61.4 tttp -126.04 117.52 23.38 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 122.355 1.074 . . . . 0.0 109.746 177.919 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mp -108.31 142.28 25.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 117.032 0.416 . . . . 0.0 111.09 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.82 43.21 1.21 Allowed 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 123.693 2.929 . . . . 0.0 112.28 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -72.8 -28.29 26.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.462 1.105 . . . . 0.0 111.303 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 9.6 m -61.76 -34.81 76.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.55 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.62 69.29 Favored Glycine 0 CA--C 1.494 -1.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.922 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 10.9 pt-20 -140.52 160.84 39.13 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.128 0.489 . . . . 0.0 110.849 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p -108.71 166.71 10.59 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.275 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.93 83.82 1.45 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 122.162 0.982 . . . . 0.0 110.652 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.94 -15.05 60.24 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.291 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -86.8 -17.71 32.82 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.294 0.569 . . . . 0.0 110.271 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.81 18.98 41.95 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.01 119.95 13.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.7 t -81.1 149.53 29.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -80.03 -36.06 36.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.441 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 54.1 m -84.42 128.68 60.74 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.679 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 23.2 Cg_exo -66.1 136.16 43.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.643 2.229 . . . . 0.0 110.54 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.75 -16.27 56.3 Favored Glycine 0 C--N 1.304 -1.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.59 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.33 119.92 33.02 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 m -76.24 134.08 39.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -91.7 110.49 21.83 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.621 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -107.51 86.26 2.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 18.4 ptt180 -43.89 129.7 4.21 Favored Pre-proline 0 C--N 1.316 -0.848 0 O-C-N 124.71 1.256 . . . . 0.0 113.422 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.0 Cg_endo -101.27 31.14 10.16 Favored 'Cis proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.031 -1.237 . . . . 0.0 113.595 1.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.97 141.15 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.771 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 92.7 m -84.48 135.47 34.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.779 0.323 . . . . 0.0 110.947 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.38 115.79 16.02 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttm -93.45 114.98 27.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.349 1.06 . . . . 0.0 109.646 -177.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.995 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.5 mt -94.46 157.43 37.29 Favored Pre-proline 0 C--N 1.309 -1.196 0 O-C-N 122.821 -0.223 . . . . 0.0 110.597 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 66.1 Cg_endo -72.19 48.6 1.22 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 123.639 2.892 . . . . 0.0 112.36 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mm -59.53 -35.94 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 125.45 1.5 . . . . 0.0 112.704 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.6 m -69.19 -36.89 77.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.845 0.355 . . . . 0.0 110.423 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.82 -12.93 55.83 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.498 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.507 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 42.9 mt-10 -74.43 159.4 32.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.121 0.486 . . . . 0.0 110.838 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.3 p -118.73 132.26 56.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.79 75.5 10.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.3 mt -80.42 -40.61 26.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.75 -29.1 24.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.137 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.59 -4.53 7.58 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.793 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -122.73 136.04 54.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 16.2 t -90.75 139.56 30.61 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -92.16 -19.59 22.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.761 0.315 . . . . 0.0 111.161 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.4 m -81.37 120.92 79.52 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.17 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 138.97 39.07 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.589 2.193 . . . . 0.0 110.785 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.44 19.96 70.27 Favored Glycine 0 C--N 1.314 -0.671 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.0 t -122.08 133.26 54.78 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 m -90.41 119.91 31.08 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.645 0.736 . . . . 0.0 110.475 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 44.4 t -77.06 114.74 16.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.44 85.03 2.32 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 87.8 mtt180 -47.82 134.06 11.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 123.845 0.716 . . . . 0.0 111.769 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 46.0 Cg_endo -97.18 25.98 20.14 Favored 'Cis proline' 0 CA--C 1.558 1.721 0 C-N-CA 123.453 -1.478 . . . . 0.0 114.766 3.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 40.6 t -128.37 149.57 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.952 1.251 . . . . 0.0 112.051 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 84.0 m -89.89 115.96 27.61 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 120.948 0.404 . . . . 0.0 111.457 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 33.7 m-85 -110.52 133.88 52.89 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 65.1 tttm -120.27 122.71 41.48 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.319 -0.721 0 C-N-CA 124.895 1.278 . . . . 0.0 110.67 -179.538 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.449 0 N-CA-C 112.696 -0.162 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -102.0 143.22 26.16 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.46 33.92 0.4 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.648 2.899 . . . . 0.0 112.621 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.0 mm -59.95 -44.25 94.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 123.669 0.788 . . . . 0.0 110.397 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.7 m -66.09 -55.56 15.89 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.935 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.08 12.48 83.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -89.16 170.67 10.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-O 121.056 0.455 . . . . 0.0 110.37 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.5 p -128.1 131.8 49.02 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.682 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.55 63.37 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.31 -38.98 85.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.26 1.36 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.57 -36.0 2.31 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 119.299 -1.429 . . . . 0.0 114.035 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.0 tttm -116.06 153.41 31.75 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 43.3 t -81.04 142.27 33.53 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.64 -24.29 27.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.985 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 m -89.51 122.02 68.7 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.336 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.04 140.04 27.82 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.215 1.944 . . . . 0.0 111.177 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.55 21.35 60.22 Favored Glycine 0 C--N 1.319 -0.409 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 34.9 t -135.05 126.6 28.78 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -83.76 137.64 33.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.506 0.669 . . . . 0.0 111.593 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.3 t -87.52 131.02 34.51 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.708 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -133.28 74.24 1.55 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 70.0 ttt180 -46.3 130.64 7.72 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.672 -169.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 42.5 Cg_endo -93.66 17.07 41.22 Favored 'Cis proline' 0 CA--C 1.551 1.374 0 N-CA-C 116.338 1.63 . . . . 0.0 116.338 6.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.06 145.7 20.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 119.913 1.233 . . . . 0.0 111.872 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 89.5 m -94.34 121.65 36.09 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -117.87 122.66 43.91 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.126 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttp -92.45 111.18 22.66 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 122.482 1.134 . . . . 0.0 109.714 -178.929 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.036 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.3 mt -132.77 144.43 52.87 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 116.883 0.342 . . . . 0.0 110.72 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.2 Cg_endo -77.85 90.92 1.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.207 1.938 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.3 mm -113.62 -32.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.537 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 m -66.77 -33.63 76.04 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.738 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.91 39.66 23.63 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.18 150.32 52.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.846 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -131.37 141.5 49.9 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -84.73 73.05 10.66 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.395 0.617 . . . . 0.0 109.786 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -89.02 -32.67 17.48 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.31 -24.4 22.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.784 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.04 -13.23 10.53 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.482 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -141.55 147.3 37.49 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 122.393 -0.475 . . . . 0.0 110.839 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.4 m -89.95 167.4 12.83 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -105.14 -36.03 7.4 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.668 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.9 m -69.64 122.05 84.49 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -68.98 131.66 22.85 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.444 2.096 . . . . 0.0 109.282 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.09 38.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.9 t -132.44 120.45 21.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 m -90.48 147.44 23.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.003 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -96.57 118.68 33.57 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.14 0.495 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 8.4 tpt180 -124.56 84.49 2.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 39.2 ptt180 -47.52 134.66 10.15 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.398 -172.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 43.0 Cg_endo -94.46 24.19 25.19 Favored 'Cis proline' 0 CA--C 1.556 1.617 0 N-CA-C 115.46 1.292 . . . . 0.0 115.46 2.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.71 145.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.725 -1.234 . . . . 0.0 111.169 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.494 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 70.7 m -89.86 136.97 32.72 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 94.3 m-85 -129.83 125.24 35.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.897 0.379 . . . . 0.0 110.188 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.64 113.03 23.78 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m120 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 125.687 1.595 . . . . 0.0 109.133 -173.301 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 N-CA-C 113.452 0.141 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.27 152.63 46.14 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 117.24 0.52 . . . . 0.0 110.441 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 85.4 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.977 1.785 . . . . 0.0 110.905 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 47.2 mm -104.07 -33.7 3.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.578 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 37.9 m -65.7 -35.0 79.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 -32.92 2.87 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.146 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.0 171.08 12.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.509 0.671 . . . . 0.0 111.533 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 p -133.27 156.11 48.17 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.904 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 72.9 m -90.8 67.18 6.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.236 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.432 ' H ' HD22 ' A' ' 10' ' ' LEU . 1.6 mm? -68.33 -26.43 65.61 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.695 0.76 . . . . 0.0 109.962 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -87.31 -2.28 58.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.476 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.4 -13.34 65.53 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -132.41 145.92 51.57 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 25.0 t -91.1 139.39 30.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -93.9 -9.67 36.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.251 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -83.13 120.6 76.21 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.25 133.79 42.28 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.881 2.387 . . . . 0.0 111.046 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.33 -15.05 64.06 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.621 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -93.67 125.07 38.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.558 0.694 . . . . 0.0 111.198 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -80.7 127.32 32.36 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.5 105.73 17.99 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 121.49 0.662 . . . . 0.0 111.772 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -113.91 76.2 0.97 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -49.32 139.62 13.8 Favored Pre-proline 0 C--O 1.245 0.827 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.688 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.72 16.78 37.97 Favored 'Cis proline' 0 CA--C 1.553 1.46 0 N-CA-C 115.374 1.259 . . . . 0.0 115.374 3.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.91 143.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.154 1.343 . . . . 0.0 112.979 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.97 120.14 32.35 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.157 0.503 . . . . 0.0 110.22 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -110.59 160.03 17.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.004 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.4 tttm -141.67 122.99 14.84 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 123.729 0.812 . . . . 0.0 110.776 -178.932 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.663 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.24 152.14 37.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 74.3 Cg_endo -75.71 51.45 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.175 2.584 . . . . 0.0 112.002 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 48.4 mm -59.84 -24.73 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.089 1.355 . . . . 0.0 110.703 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.2 m -64.84 -32.99 74.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.024 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.73 31.26 70.34 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.346 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -140.84 156.36 46.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -114.45 156.06 25.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.132 0.491 . . . . 0.0 111.664 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 92.1 m -90.84 72.29 6.58 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.5 -40.53 29.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.325 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -88.69 -30.04 19.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.86 25.74 5.0 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.464 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.08 148.57 40.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.72 145.12 31.52 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.03 -33.39 10.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.2 m -73.0 129.0 87.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.35 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.36 141.34 55.99 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.94 2.427 . . . . 0.0 111.655 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.75 4.4 79.39 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 121.388 -0.435 . . . . 0.0 112.878 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 87.4 m -97.69 149.32 22.41 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -111.36 119.79 40.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.0 t -82.02 115.5 21.2 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.006 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -126.66 78.99 1.83 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 21.9 ptt180 -50.49 135.41 24.97 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -87.45 10.68 58.91 Favored 'Cis proline' 0 CA--C 1.565 2.043 0 N-CA-C 117.641 2.131 . . . . 0.0 117.641 7.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.03 152.86 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.254 -1.529 . . . . 0.0 111.588 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 43.6 t -106.73 114.64 28.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 96.6 m-85 -109.22 148.11 31.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.036 0.446 . . . . 0.0 111.056 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 88.5 tttt -118.64 108.74 15.29 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 124.596 1.159 . . . . 0.0 111.296 -173.967 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.55 143.77 27.05 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.448 0.624 . . . . 0.0 110.929 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.59 50.42 2.98 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.06 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.4 mm -59.06 -44.12 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.583 1.153 . . . . 0.0 111.559 -175.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.89 -41.9 95.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.81 14.53 75.62 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.274 -0.421 . . . . 0.0 113.213 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.27 146.2 24.92 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -93.72 131.6 38.89 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-O 121.122 0.487 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.7 p -111.16 75.18 0.9 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.308 1.051 . . . . 0.0 111.161 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.32 -31.48 62.48 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.533 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.95 7.51 27.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.264 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.93 77.81 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.031 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -140.4 140.49 35.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -110.93 149.09 31.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -96.55 -15.73 21.46 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 120.688 0.28 . . . . 0.0 110.915 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -94.13 119.46 66.66 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.58 140.73 40.26 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.781 1.654 . . . . 0.0 110.393 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.18 67.58 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -130.7 130.85 44.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 t -113.99 147.3 38.85 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.519 0.676 . . . . 0.0 111.314 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.48 118.3 23.67 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.349 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 30.6 tpt180 -123.45 77.62 1.51 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -46.38 137.54 6.78 Favored Pre-proline 0 C--O 1.24 0.577 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.834 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -91.72 15.08 47.91 Favored 'Cis proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.205 -1.581 . . . . 0.0 115.16 5.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.91 140.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 121.496 -0.752 . . . . 0.0 110.848 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.2 t -95.24 127.46 41.3 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 59.3 m-85 -115.83 144.08 44.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.336 -174.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . 88.6 tttt -113.41 99.17 7.57 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.206 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.79 144.68 54.26 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.82 48.91 2.06 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.959 2.439 . . . . 0.0 112.109 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.2 mm -59.08 -42.2 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 36.7 m -62.9 -33.37 75.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.94 -21.6 5.55 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.658 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.96 164.66 25.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.395 0.678 . . . . 0.0 110.152 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 5.1 p -129.9 166.79 19.29 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.064 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 82.3 m -111.91 75.61 0.93 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -83.69 -41.2 17.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.6 -12.02 60.0 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.523 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.51 -20.64 27.33 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.138 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -112.18 144.21 41.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 38.0 t -106.64 129.53 54.54 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.76 3.95 54.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -107.44 119.74 49.74 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.846 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.46 132.96 18.31 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.671 2.247 . . . . 0.0 111.355 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.52 -8.45 43.93 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 24.2 t -117.65 119.79 36.04 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 p -82.76 133.98 35.13 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.598 0.713 . . . . 0.0 111.277 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.27 106.91 16.25 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.537 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 26.6 ttm180 -114.02 92.98 4.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -50.28 135.33 23.57 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.066 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.03 27.03 17.78 Favored 'Cis proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.818 -1.326 . . . . 0.0 114.655 3.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 25.7 t -128.39 152.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.801 -1.187 . . . . 0.0 111.865 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.665 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 78.1 m -86.44 113.08 22.1 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 56.8 m-85 -108.59 117.66 34.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 86.2 tttt -86.78 118.12 25.97 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.318 -0.763 0 C-N-CA 125.138 1.375 . . . . 0.0 108.804 -176.635 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 88.9 mt -102.9 150.49 37.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 9.5 Cg_exo -74.64 45.06 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.786 2.991 . . . . 0.0 112.328 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.6 mm -64.4 -41.61 92.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 124.059 0.944 . . . . 0.0 110.972 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 56.5 m -68.2 -33.56 74.66 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.926 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.27 11.63 84.03 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -106.06 170.89 7.65 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 121.622 0.725 . . . . 0.0 111.285 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -120.82 170.79 9.13 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.658 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -120.45 80.2 1.58 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.05 -33.4 19.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.33 0.586 . . . . 0.0 109.64 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.53 10.99 25.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.33 1.02 80.21 Favored Glycine 0 N--CA 1.461 0.338 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -140.35 153.92 46.56 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.1 m -79.24 153.83 29.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.474 0.655 . . . . 0.0 110.775 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -82.22 -25.33 34.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -102.79 120.62 52.11 Favored Pre-proline 0 N--CA 1.433 -1.286 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.436 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.51 134.82 23.1 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.798 2.332 . . . . 0.0 110.564 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.23 -1.0 29.69 Favored Glycine 0 C--N 1.307 -1.082 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -106.81 169.29 8.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -114.66 119.11 35.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.06 134.2 34.62 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -142.13 82.49 1.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.7 ptt180 -43.76 135.46 3.68 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.372 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 61.9 Cg_endo -94.86 23.98 25.54 Favored 'Cis proline' 0 CA--C 1.558 1.717 0 C-N-CA 123.835 -1.319 . . . . 0.0 114.53 3.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.24 157.45 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.417 -0.802 . . . . 0.0 110.124 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -112.3 128.82 56.38 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -121.97 170.39 9.87 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.067 0.461 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.4 tttp -146.82 113.49 6.03 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.76 0.824 . . . . 0.0 110.06 -177.579 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.24 145.68 30.66 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 122.736 -0.273 . . . . 0.0 110.375 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.76 50.94 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.288 2.658 . . . . 0.0 110.876 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.1 mm -59.49 -44.89 93.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.555 1.142 . . . . 0.0 110.316 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 m -74.7 -39.31 62.03 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.036 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.22 31.65 74.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.149 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.74 158.01 16.8 Favored 'General case' 0 CA--C 1.466 -2.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.48 ' O ' ' HE1' ' A' ' 15' ' ' TYR . 8.7 p -99.31 128.59 45.45 Favored 'General case' 0 C--N 1.263 -3.179 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.0 p -107.67 70.8 0.79 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.081 0.943 . . . . 0.0 110.345 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.77 -33.86 72.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.744 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.8 -27.76 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 111.534 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.95 -11.44 11.8 Favored Glycine 0 CA--C 1.487 -1.689 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -117.1 153.11 33.34 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.016 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 t -91.86 152.82 19.92 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.48 ' HE1' ' O ' ' A' ' 8' ' ' THR . 41.6 m-85 -96.75 -26.69 15.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.128 0.489 . . . . 0.0 110.347 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -83.54 129.09 61.34 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.197 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 137.1 21.72 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.361 2.041 . . . . 0.0 110.216 175.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.3 56.11 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.8 t -139.32 156.28 47.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 152.65 46.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 118.283 0.492 . . . . 0.0 111.707 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.18 99.86 12.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.581 0.705 . . . . 0.0 111.199 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 32.6 tpt180 -105.34 85.18 2.21 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 172.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -43.77 135.96 3.61 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 114.181 -1.372 . . . . 0.0 113.165 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.1 Cg_endo -95.37 18.51 35.2 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.086 -1.631 . . . . 0.0 114.347 3.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 48.7 t -123.6 146.1 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.745 0.783 . . . . 0.0 112.874 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 37.3 m -79.56 115.67 19.31 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.586 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.526 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 83.9 m-85 -115.96 147.02 41.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.851 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -130.32 115.32 16.77 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 122.208 1.004 . . . . 0.0 110.133 177.429 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.9 mt -110.56 139.18 21.33 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.89 44.43 0.96 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 123.19 2.593 . . . . 0.0 112.92 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mm -67.75 -42.15 85.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.118 0.567 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 78.3 m -60.03 -44.95 94.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.99 3.5 81.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.783 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -83.16 170.43 14.75 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.142 0.496 . . . . 0.0 109.961 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.627 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.0 m -83.43 77.02 9.88 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.769 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.92 -50.6 10.93 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.8 10.76 12.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.475 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.88 21.94 78.87 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.463 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -140.11 142.51 36.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -91.51 137.87 32.02 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.932 0.396 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.05 -37.37 78.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.262 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 11.7 m -82.21 119.97 76.12 Favored Pre-proline 0 N--CA 1.432 -1.372 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.118 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 24.0 Cg_exo -67.53 134.17 32.23 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.132 2.555 . . . . 0.0 112.278 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.6 -0.23 88.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.907 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 11.6 t -92.35 139.81 30.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 m -81.98 121.82 26.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.754 0.788 . . . . 0.0 111.509 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.19 107.57 19.22 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -126.43 90.87 3.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -50.34 139.02 20.13 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -94.52 18.45 36.98 Favored 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.491 -1.462 . . . . 0.0 115.206 2.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.493 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 61.2 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 121.193 -0.942 . . . . 0.0 111.791 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 21.0 t -93.47 111.16 22.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.493 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.5 m-85 -110.56 119.56 39.57 Favored 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.478 0.711 . . . . 0.0 111.44 -174.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.6 tttm -90.47 112.59 24.29 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.433 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 17.6 m120 . . . . . 0 C--N 1.318 -0.797 0 C-N-CA 124.53 1.132 . . . . 0.0 110.109 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.8 mt -106.98 146.08 32.42 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 1.7 Cg_endo -75.86 77.66 3.35 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.281 1.987 . . . . 0.0 111.776 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.88 -39.29 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.53 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.68 -39.89 21.41 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.592 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.4 29.68 75.28 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -117.64 170.67 8.58 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.128 0.49 . . . . 0.0 111.503 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -116.43 157.69 24.73 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 p -132.94 75.24 1.61 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.967 0.889 . . . . 0.0 109.9 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.182 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.26 12.4 36.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.585 0.707 . . . . 0.0 111.307 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.09 -5.4 79.94 Favored Glycine 0 CA--C 1.502 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.696 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -130.83 143.41 50.71 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -91.35 157.0 17.36 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.418 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -95.2 -20.46 19.21 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.5 m -80.31 119.07 75.31 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.17 127.41 14.23 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.454 2.103 . . . . 0.0 111.598 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.67 30.34 10.71 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.43 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -136.44 131.21 33.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.8 m -93.71 142.94 26.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 0.0 112.127 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.5 124.68 30.97 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.252 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -121.72 66.22 0.9 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 38.2 ptt180 -41.05 131.12 1.96 Allowed Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.512 -1.222 . . . . 0.0 114.153 -169.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 44.7 Cg_endo -89.59 5.99 68.86 Favored 'Cis proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.422 -1.491 . . . . 0.0 115.435 4.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.72 147.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 18.3 t -98.58 136.24 38.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -135.1 129.99 34.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.417 0.627 . . . . 0.0 111.169 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -92.62 109.58 21.0 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 N--CA 1.479 0.976 0 O-C-N 123.775 0.672 . . . . 0.0 110.827 -177.426 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.386 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.4 mt -89.8 151.86 46.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 C-N-CA 122.207 0.203 . . . . 0.0 111.367 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.28 94.86 0.83 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 121.579 1.52 . . . . 0.0 109.048 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.91 -32.2 2.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.398 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.9 m -71.89 -45.42 61.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.94 14.94 Favored Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.354 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.24 166.99 15.22 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.782 0.801 . . . . 0.0 112.25 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -119.53 145.53 46.26 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.468 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.77 51.59 1.23 Allowed 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.766 0.793 . . . . 0.0 109.155 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.17 -25.67 33.97 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.054 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.02 11.73 28.75 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 122.111 -0.368 . . . . 0.0 111.949 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.01 89.57 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 121.35 -0.453 . . . . 0.0 112.166 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.91 138.46 48.4 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -94.68 156.72 16.28 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -113.62 13.2 18.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.699 0.762 . . . . 0.0 111.537 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.401 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 m -120.1 119.07 31.11 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.468 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 133.22 56.12 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 123.267 2.644 . . . . 0.0 111.132 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.39 -6.78 75.21 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.137 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 64.2 m -102.32 148.95 24.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.8 t -108.01 141.27 39.94 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.36 119.15 28.52 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.032 0.444 . . . . 0.0 110.62 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 4.7 tpm_? -127.32 84.84 2.3 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 171.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 37.4 ptt180 -41.38 130.88 2.18 Favored Pre-proline 0 C--O 1.249 1.032 0 CA-C-N 114.013 -1.449 . . . . 0.0 114.351 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 78.9 Cg_endo -97.71 19.0 28.94 Favored 'Cis proline' 0 CA--C 1.556 1.609 0 C-N-CA 123.587 -1.422 . . . . 0.0 114.588 1.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.93 144.7 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 121.601 0.715 . . . . 0.0 112.726 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.1 m -88.81 115.19 26.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.858 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 48.5 m-85 -103.95 157.89 16.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.597 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 82.1 tttt -129.37 117.68 21.0 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 125.266 1.426 . . . . 0.0 110.644 -176.27 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.96 145.04 55.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.931 0.365 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.33 66.48 5.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.187 2.591 . . . . 0.0 111.266 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.13 -37.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.095 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.1 m -68.51 -27.97 66.59 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.62 17.37 79.95 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.125 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -110.35 170.36 8.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.5 p -123.86 154.79 39.15 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.278 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 p -138.58 81.78 1.87 Allowed 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.961 0.886 . . . . 0.0 110.316 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.07 -24.63 63.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.274 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.71 6.54 34.3 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 120.8 0.333 . . . . 0.0 111.329 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.542 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 80.99 20.36 65.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.002 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.15 119.69 24.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -89.5 145.88 24.99 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.525 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -84.81 -25.54 28.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.102 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -86.99 125.82 65.17 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.211 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.34 146.42 50.6 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.547 2.164 . . . . 0.0 110.436 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.64 29.25 71.42 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.0 t -145.86 130.65 18.07 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -99.62 173.15 6.86 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 39.0 t -109.1 132.44 54.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.168 0.509 . . . . 0.0 110.314 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.663 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 31.5 tpt180 -135.28 84.95 2.13 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -39.96 134.47 1.39 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.693 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -96.01 21.16 29.53 Favored 'Cis proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.568 0.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.59 150.52 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 121.771 -0.581 . . . . 0.0 111.728 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 88.4 m -79.37 139.32 37.78 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 121.962 -0.461 . . . . 0.0 110.452 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.663 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 13.0 m-85 -127.62 137.13 52.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.055 0.455 . . . . 0.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.91 118.65 24.01 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.406 0.622 . . . . 0.0 111.508 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.02 143.63 26.99 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 122.787 -0.243 . . . . 0.0 110.371 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.35 86.98 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.035 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 mm -123.13 -12.37 6.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.731 0.777 . . . . 0.0 110.195 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 8.7 m -81.55 -36.9 28.57 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.1 53.93 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -126.8 159.69 33.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.63 0.729 . . . . 0.0 111.861 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -110.97 174.11 6.01 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.975 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 64.1 m -126.9 70.08 1.28 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.82 -33.28 21.38 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.48 -31.17 37.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.988 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.46 10.12 17.96 Favored Glycine 0 CA--C 1.496 -1.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.298 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.06 162.35 35.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.747 -0.226 . . . . 0.0 111.179 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.71 141.9 33.86 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.082 0.864 . . . . 0.0 110.449 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -105.37 -8.27 18.29 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.492 0.663 . . . . 0.0 109.44 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -87.1 120.63 71.53 Favored Pre-proline 0 N--CA 1.428 -1.562 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.942 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.16 129.7 21.09 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.258 1.972 . . . . 0.0 111.532 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.98 4.73 58.66 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.8 m -117.2 151.15 37.48 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 t -124.66 141.31 52.2 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.92 136.68 33.52 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -132.3 82.1 2.0 Allowed 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 35.5 ptt180 -49.29 138.98 14.3 Favored Pre-proline 0 C--O 1.24 0.587 0 O-C-N 123.58 0.55 . . . . 0.0 112.353 -173.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -92.54 24.5 24.47 Favored 'Cis proline' 0 CA--C 1.559 1.743 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 4.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 21.8 t -126.76 152.7 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 O-C-N 121.077 -1.015 . . . . 0.0 110.367 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t -99.5 139.78 34.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.0 m-85 -132.67 151.03 52.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.525 0.602 . . . . 0.0 111.95 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.3 tttp -114.72 104.26 11.79 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 . . . . . 0 C--N 1.317 -0.813 0 C-N-CA 124.512 1.125 . . . . 0.0 110.275 -175.839 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 114.041 0.377 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.4 mt -110.95 148.27 38.26 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 117.438 0.619 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.93 48.8 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.449 2.766 . . . . 0.0 112.185 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.97 -25.3 34.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 124.579 1.152 . . . . 0.0 111.035 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 16.7 m -62.83 -37.47 86.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.431 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.26 34.85 44.78 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -131.86 149.74 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.717 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -111.69 150.59 29.97 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.5 p -132.3 82.02 1.99 Allowed 'General case' 0 N--CA 1.404 -2.77 0 CA-C-O 122.529 1.157 . . . . 0.0 110.927 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.4 tp -84.07 -36.38 23.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.575 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.6 mt -82.77 -30.19 29.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.403 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.5 30.07 3.95 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.767 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -135.35 135.36 40.67 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.75 0.775 . . . . 0.0 112.06 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 m -120.9 141.43 50.63 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.25 -29.53 13.14 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 112.172 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -55.82 130.4 72.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 123.618 0.574 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.94 135.2 43.16 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.399 2.066 . . . . 0.0 111.596 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.57 30.48 60.04 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.6 t -118.38 131.89 56.28 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -112.25 134.77 53.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 t -77.51 129.29 35.49 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.118 0.485 . . . . 0.0 110.333 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 76.0 ttt180 -134.23 86.71 2.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 72.7 mtt180 -44.94 135.87 4.82 Favored Pre-proline 0 C--O 1.244 0.774 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.973 -170.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 60.0 Cg_endo -98.73 27.5 16.69 Favored 'Cis proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.394 -1.503 . . . . 0.0 114.193 3.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.9 150.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 121.726 -0.609 . . . . 0.0 110.472 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.707 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 77.5 m -90.96 141.32 28.97 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.682 -0.636 . . . . 0.0 109.717 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 90.0 m-85 -131.17 135.9 47.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.198 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 64.6 tttp -111.0 103.17 11.61 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.347 1.059 . . . . 0.0 111.526 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.51 140.03 21.13 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.21 68.7 5.01 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.297 1.998 . . . . 0.0 111.83 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.89 -46.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.8 m -73.47 -56.08 5.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.016 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.57 14.34 82.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.145 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.46 154.67 19.47 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p -97.15 134.32 40.63 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.387 0.613 . . . . 0.0 111.22 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.06 78.99 1.79 Allowed 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 122.412 1.101 . . . . 0.0 109.838 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.69 -19.59 59.01 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.133 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.58 -21.09 59.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.451 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.56 -0.65 39.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.724 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.58 144.38 35.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 62.0 m -85.3 169.47 13.72 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -103.19 -23.57 13.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.925 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -85.44 119.5 72.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.16 132.53 19.7 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.282 1.988 . . . . 0.0 111.562 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.89 6.23 46.34 Favored Glycine 0 C--N 1.308 -0.992 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.7 t -121.38 127.42 51.2 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.7 t -88.72 138.62 31.25 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.481 0.657 . . . . 0.0 110.282 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 45.4 t -95.98 117.09 29.97 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.317 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -114.33 84.47 2.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 32.6 ptt180 -44.99 134.83 5.05 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.665 -170.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.9 Cg_endo -95.18 15.77 40.22 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.476 -1.468 . . . . 0.0 114.863 2.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -112.56 135.34 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.064 -175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.8 t -91.27 124.54 35.55 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.012 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -123.98 143.96 50.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.42 0.629 . . . . 0.0 111.325 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -109.29 108.37 18.94 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.807 1.243 . . . . 0.0 111.658 -177.639 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.003 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.62 148.11 37.08 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.48 39.38 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.995 2.464 . . . . 0.0 112.196 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.8 -30.24 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.495 1.118 . . . . 0.0 111.184 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 32.2 m -72.12 -31.42 66.01 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.358 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.33 1.57 60.94 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.69 -0.686 . . . . 0.0 113.48 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 41.8 mt-10 -89.64 159.58 17.06 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.276 0.56 . . . . 0.0 110.686 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -118.17 130.89 56.37 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 25.3 p -111.67 77.55 1.05 Allowed 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.082 0.944 . . . . 0.0 112.78 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.3 mt -77.38 -30.2 53.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.84 -17.97 60.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.904 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -10.54 61.11 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.037 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -133.8 139.12 46.09 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.9 m -97.32 162.34 13.38 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 124.073 0.858 . . . . 0.0 108.838 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -98.55 -9.78 24.41 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.736 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.5 m -86.27 119.22 71.45 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.91 133.85 20.65 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.587 2.191 . . . . 0.0 110.513 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.54 20.48 40.82 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.5 t -120.25 140.98 50.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 t -104.22 121.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.506 0.67 . . . . 0.0 110.395 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.2 t -79.16 110.23 14.23 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.213 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -121.06 85.56 2.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -52.86 142.91 32.75 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.868 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.28 15.86 45.7 Favored 'Cis proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.208 -1.58 . . . . 0.0 116.052 4.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 52.4 t -122.29 144.96 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.73 1.15 . . . . 0.0 112.394 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 72.7 m -89.1 117.01 27.78 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.412 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.8 m-85 -114.73 121.44 43.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.627 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 41.3 ttmt -90.19 108.69 19.9 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 124.411 1.084 . . . . 0.0 112.62 -178.253 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.406 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.55 139.56 20.23 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.64 42.46 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.853 3.035 . . . . 0.0 113.04 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.13 -27.94 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 124.536 1.134 . . . . 0.0 111.111 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 6.7 m -66.0 -45.67 80.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.71 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.27 28.34 37.0 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -141.16 161.77 37.08 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 122.794 0.438 . . . . 0.0 110.05 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 24' ' ' PRO . 30.8 p -118.85 -179.8 3.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -121.21 79.68 1.55 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.51 -26.76 17.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.14 -21.57 18.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.688 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 16.06 27.3 Favored Glycine 0 C--O 1.239 0.415 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.3 tttm -140.95 141.15 34.49 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 75.1 m -90.88 159.08 16.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -113.58 -26.77 8.12 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 120.986 0.422 . . . . 0.0 110.047 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -82.78 127.62 69.25 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.84 145.16 61.59 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.512 2.141 . . . . 0.0 111.934 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.78 1.22 80.51 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.813 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 99.5 m -103.14 126.09 50.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -93.28 124.34 37.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.513 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.01 126.63 31.43 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.969 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -137.26 94.41 2.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 64.3 mtm180 -52.36 137.93 39.54 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.4 Cg_endo -98.38 28.68 15.38 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.57 2.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.491 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 6.9 t -124.19 166.17 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.535 -0.728 . . . . 0.0 109.322 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 42.4 t -113.12 133.32 55.08 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 94.0 m-85 -130.94 135.89 48.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.045 0.45 . . . . 0.0 111.462 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 87.2 tttt -103.73 108.79 20.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.495 1.784 0 C-N-CA 124.339 1.055 . . . . 0.0 110.605 -176.251 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.926 -0.07 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.82 148.3 36.65 Favored Pre-proline 0 C--N 1.312 -1.042 0 O-C-N 122.378 -0.483 . . . . 0.0 110.437 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.66 50.7 3.31 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.723 2.282 . . . . 0.0 111.508 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.37 -28.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.112 1.365 . . . . 0.0 111.434 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.1 m -78.1 -19.27 54.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.75 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.87 -44.24 2.29 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 113.639 0.216 . . . . 0.0 113.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.95 154.21 31.15 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.839 0.856 . . . . 0.0 111.468 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -108.72 179.2 4.25 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.626 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 77.1 m -118.18 74.02 0.93 Allowed 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.776 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.7 tp -84.95 -30.69 24.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.55 -30.39 15.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.619 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 9' ' ' CYS . . . 100.88 29.83 6.33 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -134.86 135.89 42.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.319 -0.441 . . . . 0.0 109.968 -174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 92.7 m -109.4 123.89 50.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -84.67 -31.19 24.28 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.031 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.9 m -69.13 119.8 72.46 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.35 134.21 24.24 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.025 1.817 . . . . 0.0 110.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.72 23.48 23.28 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.836 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 1.1 t -122.93 153.26 39.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -113.29 122.7 48.2 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.312 0.577 . . . . 0.0 110.205 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 51.4 t -80.81 110.98 16.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.979 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.25 81.49 1.62 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 174.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 43.8 ttt180 -47.52 132.43 10.48 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.385 -171.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 32.1 Cg_endo -96.69 26.34 19.86 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 N-CA-C 116.076 1.529 . . . . 0.0 116.076 6.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 20.5 t -127.54 151.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.802 -1.186 . . . . 0.0 109.933 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.0 t -102.43 121.22 41.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 98.2 m-85 -118.62 142.1 47.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.404 0.621 . . . . 0.0 111.844 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 61.4 tttp -126.04 117.52 23.38 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 122.355 1.074 . . . . 0.0 109.746 177.919 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mp -108.31 142.28 25.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 117.032 0.416 . . . . 0.0 111.09 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.82 43.21 1.21 Allowed 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 123.693 2.929 . . . . 0.0 112.28 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -72.8 -28.29 26.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.462 1.105 . . . . 0.0 111.303 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 9.6 m -61.76 -34.81 76.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.55 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.62 69.29 Favored Glycine 0 CA--C 1.494 -1.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.922 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 10.9 pt-20 -140.52 160.84 39.13 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.128 0.489 . . . . 0.0 110.849 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p -108.71 166.71 10.59 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.275 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.93 83.82 1.45 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 122.162 0.982 . . . . 0.0 110.652 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.94 -15.05 60.24 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.291 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -86.8 -17.71 32.82 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.294 0.569 . . . . 0.0 110.271 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.81 18.98 41.95 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.01 119.95 13.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.7 t -81.1 149.53 29.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -80.03 -36.06 36.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.441 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 54.1 m -84.42 128.68 60.74 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.679 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 23.2 Cg_exo -66.1 136.16 43.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.643 2.229 . . . . 0.0 110.54 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.75 -16.27 56.3 Favored Glycine 0 C--N 1.304 -1.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.59 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.33 119.92 33.02 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 m -76.24 134.08 39.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -91.7 110.49 21.83 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.621 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -107.51 86.26 2.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 18.4 ptt180 -43.89 129.7 4.21 Favored Pre-proline 0 C--N 1.316 -0.848 0 O-C-N 124.71 1.256 . . . . 0.0 113.422 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.0 Cg_endo -101.27 31.14 10.16 Favored 'Cis proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.031 -1.237 . . . . 0.0 113.595 1.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.97 141.15 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.771 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 92.7 m -84.48 135.47 34.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.779 0.323 . . . . 0.0 110.947 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.38 115.79 16.02 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttm -93.45 114.98 27.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.349 1.06 . . . . 0.0 109.646 -177.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.995 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.5 mt -94.46 157.43 37.29 Favored Pre-proline 0 C--N 1.309 -1.196 0 O-C-N 122.821 -0.223 . . . . 0.0 110.597 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 66.1 Cg_endo -72.19 48.6 1.22 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 123.639 2.892 . . . . 0.0 112.36 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mm -59.53 -35.94 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 125.45 1.5 . . . . 0.0 112.704 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.6 m -69.19 -36.89 77.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.845 0.355 . . . . 0.0 110.423 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.82 -12.93 55.83 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.498 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 42.9 mt-10 -74.43 159.4 32.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.121 0.486 . . . . 0.0 110.838 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.3 p -118.73 132.26 56.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.79 75.5 10.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.3 mt -80.42 -40.61 26.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.75 -29.1 24.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.137 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.59 -4.53 7.58 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.793 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -122.73 136.04 54.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 16.2 t -90.75 139.56 30.61 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -92.16 -19.59 22.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.761 0.315 . . . . 0.0 111.161 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.4 m -81.37 120.92 79.52 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.17 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 138.97 39.07 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.589 2.193 . . . . 0.0 110.785 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.44 19.96 70.27 Favored Glycine 0 C--N 1.314 -0.671 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.0 t -122.08 133.26 54.78 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 m -90.41 119.91 31.08 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.645 0.736 . . . . 0.0 110.475 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 44.4 t -77.06 114.74 16.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.44 85.03 2.32 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 87.8 mtt180 -47.82 134.06 11.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 123.845 0.716 . . . . 0.0 111.769 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 46.0 Cg_endo -97.18 25.98 20.14 Favored 'Cis proline' 0 CA--C 1.558 1.721 0 C-N-CA 123.453 -1.478 . . . . 0.0 114.766 3.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 40.6 t -128.37 149.57 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.952 1.251 . . . . 0.0 112.051 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 84.0 m -89.89 115.96 27.61 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 120.948 0.404 . . . . 0.0 111.457 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 33.7 m-85 -110.52 133.88 52.89 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 65.1 tttm -120.27 122.71 41.48 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.319 -0.721 0 C-N-CA 124.895 1.278 . . . . 0.0 110.67 -179.538 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.449 0 N-CA-C 112.696 -0.162 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -102.0 143.22 26.16 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.46 33.92 0.4 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.648 2.899 . . . . 0.0 112.621 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.0 mm -59.95 -44.25 94.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 123.669 0.788 . . . . 0.0 110.397 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.7 m -66.09 -55.56 15.89 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.935 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.08 12.48 83.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -89.16 170.67 10.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-O 121.056 0.455 . . . . 0.0 110.37 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.5 p -128.1 131.8 49.02 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.682 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.55 63.37 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.31 -38.98 85.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.26 1.36 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.57 -36.0 2.31 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 119.299 -1.429 . . . . 0.0 114.035 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.0 tttm -116.06 153.41 31.75 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 43.3 t -81.04 142.27 33.53 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.64 -24.29 27.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.985 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 m -89.51 122.02 68.7 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.336 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.04 140.04 27.82 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.215 1.944 . . . . 0.0 111.177 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.55 21.35 60.22 Favored Glycine 0 C--N 1.319 -0.409 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 34.9 t -135.05 126.6 28.78 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -83.76 137.64 33.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.506 0.669 . . . . 0.0 111.593 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.3 t -87.52 131.02 34.51 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.708 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -133.28 74.24 1.55 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 70.0 ttt180 -46.3 130.64 7.72 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.672 -169.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 42.5 Cg_endo -93.66 17.07 41.22 Favored 'Cis proline' 0 CA--C 1.551 1.374 0 N-CA-C 116.338 1.63 . . . . 0.0 116.338 6.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.06 145.7 20.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 119.913 1.233 . . . . 0.0 111.872 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 89.5 m -94.34 121.65 36.09 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -117.87 122.66 43.91 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.126 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttp -92.45 111.18 22.66 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 122.482 1.134 . . . . 0.0 109.714 -178.929 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.036 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.3 mt -132.77 144.43 52.87 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 116.883 0.342 . . . . 0.0 110.72 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.2 Cg_endo -77.85 90.92 1.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.207 1.938 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.3 mm -113.62 -32.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.537 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 m -66.77 -33.63 76.04 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.738 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.91 39.66 23.63 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.18 150.32 52.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.846 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -131.37 141.5 49.9 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -84.73 73.05 10.66 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.395 0.617 . . . . 0.0 109.786 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -89.02 -32.67 17.48 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.31 -24.4 22.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.784 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.04 -13.23 10.53 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.482 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -141.55 147.3 37.49 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 122.393 -0.475 . . . . 0.0 110.839 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.4 m -89.95 167.4 12.83 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -105.14 -36.03 7.4 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.668 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.9 m -69.64 122.05 84.49 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -68.98 131.66 22.85 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.444 2.096 . . . . 0.0 109.282 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.09 38.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.9 t -132.44 120.45 21.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 m -90.48 147.44 23.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.003 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -96.57 118.68 33.57 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.14 0.495 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 8.4 tpt180 -124.56 84.49 2.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 39.2 ptt180 -47.52 134.66 10.15 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.398 -172.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 43.0 Cg_endo -94.46 24.19 25.19 Favored 'Cis proline' 0 CA--C 1.556 1.617 0 N-CA-C 115.46 1.292 . . . . 0.0 115.46 2.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.71 145.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.725 -1.234 . . . . 0.0 111.169 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.494 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 70.7 m -89.86 136.97 32.72 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 94.3 m-85 -129.83 125.24 35.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.897 0.379 . . . . 0.0 110.188 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.64 113.03 23.78 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m120 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 125.687 1.595 . . . . 0.0 109.133 -173.301 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 N-CA-C 113.452 0.141 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.27 152.63 46.14 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 117.24 0.52 . . . . 0.0 110.441 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 85.4 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.977 1.785 . . . . 0.0 110.905 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 47.2 mm -104.07 -33.7 3.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.578 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 37.9 m -65.7 -35.0 79.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 -32.92 2.87 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.146 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.0 171.08 12.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.509 0.671 . . . . 0.0 111.533 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 p -133.27 156.11 48.17 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.904 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 72.9 m -90.8 67.18 6.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.236 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.432 ' H ' HD22 ' A' ' 10' ' ' LEU . 1.6 mm? -68.33 -26.43 65.61 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.695 0.76 . . . . 0.0 109.962 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -87.31 -2.28 58.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.476 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.4 -13.34 65.53 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -132.41 145.92 51.57 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 25.0 t -91.1 139.39 30.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -93.9 -9.67 36.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.251 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -83.13 120.6 76.21 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.25 133.79 42.28 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.881 2.387 . . . . 0.0 111.046 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.33 -15.05 64.06 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.621 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -93.67 125.07 38.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.558 0.694 . . . . 0.0 111.198 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -80.7 127.32 32.36 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.5 105.73 17.99 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 121.49 0.662 . . . . 0.0 111.772 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -113.91 76.2 0.97 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -49.32 139.62 13.8 Favored Pre-proline 0 C--O 1.245 0.827 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.688 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.72 16.78 37.97 Favored 'Cis proline' 0 CA--C 1.553 1.46 0 N-CA-C 115.374 1.259 . . . . 0.0 115.374 3.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.91 143.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.154 1.343 . . . . 0.0 112.979 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.97 120.14 32.35 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.157 0.503 . . . . 0.0 110.22 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -110.59 160.03 17.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.004 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.4 tttm -141.67 122.99 14.84 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 123.729 0.812 . . . . 0.0 110.776 -178.932 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.663 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.24 152.14 37.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 74.3 Cg_endo -75.71 51.45 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.175 2.584 . . . . 0.0 112.002 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 48.4 mm -59.84 -24.73 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.089 1.355 . . . . 0.0 110.703 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.2 m -64.84 -32.99 74.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.024 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.73 31.26 70.34 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.346 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -140.84 156.36 46.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -114.45 156.06 25.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.132 0.491 . . . . 0.0 111.664 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 92.1 m -90.84 72.29 6.58 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.5 -40.53 29.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.325 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -88.69 -30.04 19.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.86 25.74 5.0 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.464 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.08 148.57 40.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.72 145.12 31.52 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.03 -33.39 10.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.2 m -73.0 129.0 87.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.35 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.36 141.34 55.99 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.94 2.427 . . . . 0.0 111.655 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.75 4.4 79.39 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 121.388 -0.435 . . . . 0.0 112.878 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 87.4 m -97.69 149.32 22.41 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -111.36 119.79 40.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.0 t -82.02 115.5 21.2 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.006 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -126.66 78.99 1.83 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 21.9 ptt180 -50.49 135.41 24.97 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -87.45 10.68 58.91 Favored 'Cis proline' 0 CA--C 1.565 2.043 0 N-CA-C 117.641 2.131 . . . . 0.0 117.641 7.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.03 152.86 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.254 -1.529 . . . . 0.0 111.588 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 43.6 t -106.73 114.64 28.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 96.6 m-85 -109.22 148.11 31.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.036 0.446 . . . . 0.0 111.056 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 88.5 tttt -118.64 108.74 15.29 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 124.596 1.159 . . . . 0.0 111.296 -173.967 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.55 143.77 27.05 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.448 0.624 . . . . 0.0 110.929 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.59 50.42 2.98 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.06 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.4 mm -59.06 -44.12 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.583 1.153 . . . . 0.0 111.559 -175.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.89 -41.9 95.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.81 14.53 75.62 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.274 -0.421 . . . . 0.0 113.213 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.27 146.2 24.92 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -93.72 131.6 38.89 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-O 121.122 0.487 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.7 p -111.16 75.18 0.9 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.308 1.051 . . . . 0.0 111.161 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.32 -31.48 62.48 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.533 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.95 7.51 27.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.264 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.93 77.81 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.031 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -140.4 140.49 35.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -110.93 149.09 31.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -96.55 -15.73 21.46 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 120.688 0.28 . . . . 0.0 110.915 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -94.13 119.46 66.66 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.58 140.73 40.26 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.781 1.654 . . . . 0.0 110.393 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.18 67.58 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -130.7 130.85 44.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 t -113.99 147.3 38.85 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.519 0.676 . . . . 0.0 111.314 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.48 118.3 23.67 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.349 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 30.6 tpt180 -123.45 77.62 1.51 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -46.38 137.54 6.78 Favored Pre-proline 0 C--O 1.24 0.577 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.834 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -91.72 15.08 47.91 Favored 'Cis proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.205 -1.581 . . . . 0.0 115.16 5.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.91 140.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 121.496 -0.752 . . . . 0.0 110.848 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.2 t -95.24 127.46 41.3 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 59.3 m-85 -115.83 144.08 44.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.336 -174.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . 88.6 tttt -113.41 99.17 7.57 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.206 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.79 144.68 54.26 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.82 48.91 2.06 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.959 2.439 . . . . 0.0 112.109 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.2 mm -59.08 -42.2 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 36.7 m -62.9 -33.37 75.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.94 -21.6 5.55 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.658 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.96 164.66 25.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.395 0.678 . . . . 0.0 110.152 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 5.1 p -129.9 166.79 19.29 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.064 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 82.3 m -111.91 75.61 0.93 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -83.69 -41.2 17.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.6 -12.02 60.0 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.523 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.51 -20.64 27.33 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.138 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -112.18 144.21 41.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 38.0 t -106.64 129.53 54.54 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.76 3.95 54.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -107.44 119.74 49.74 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.846 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.46 132.96 18.31 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.671 2.247 . . . . 0.0 111.355 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.52 -8.45 43.93 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 24.2 t -117.65 119.79 36.04 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 p -82.76 133.98 35.13 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.598 0.713 . . . . 0.0 111.277 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.27 106.91 16.25 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.537 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 26.6 ttm180 -114.02 92.98 4.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -50.28 135.33 23.57 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.066 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.03 27.03 17.78 Favored 'Cis proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.818 -1.326 . . . . 0.0 114.655 3.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 25.7 t -128.39 152.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.801 -1.187 . . . . 0.0 111.865 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.665 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 78.1 m -86.44 113.08 22.1 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 56.8 m-85 -108.59 117.66 34.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 86.2 tttt -86.78 118.12 25.97 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.318 -0.763 0 C-N-CA 125.138 1.375 . . . . 0.0 108.804 -176.635 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 88.9 mt -102.9 150.49 37.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 9.5 Cg_exo -74.64 45.06 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.786 2.991 . . . . 0.0 112.328 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.6 mm -64.4 -41.61 92.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 124.059 0.944 . . . . 0.0 110.972 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 56.5 m -68.2 -33.56 74.66 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.926 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.27 11.63 84.03 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -106.06 170.89 7.65 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 121.622 0.725 . . . . 0.0 111.285 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -120.82 170.79 9.13 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.658 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -120.45 80.2 1.58 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.05 -33.4 19.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.33 0.586 . . . . 0.0 109.64 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.53 10.99 25.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.33 1.02 80.21 Favored Glycine 0 N--CA 1.461 0.338 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -140.35 153.92 46.56 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.1 m -79.24 153.83 29.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.474 0.655 . . . . 0.0 110.775 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -82.22 -25.33 34.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -102.79 120.62 52.11 Favored Pre-proline 0 N--CA 1.433 -1.286 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.436 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.51 134.82 23.1 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.798 2.332 . . . . 0.0 110.564 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.23 -1.0 29.69 Favored Glycine 0 C--N 1.307 -1.082 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -106.81 169.29 8.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -114.66 119.11 35.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.06 134.2 34.62 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -142.13 82.49 1.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.7 ptt180 -43.76 135.46 3.68 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.372 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 61.9 Cg_endo -94.86 23.98 25.54 Favored 'Cis proline' 0 CA--C 1.558 1.717 0 C-N-CA 123.835 -1.319 . . . . 0.0 114.53 3.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.24 157.45 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.417 -0.802 . . . . 0.0 110.124 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -112.3 128.82 56.38 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -121.97 170.39 9.87 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.067 0.461 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.4 tttp -146.82 113.49 6.03 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.76 0.824 . . . . 0.0 110.06 -177.579 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.24 145.68 30.66 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 122.736 -0.273 . . . . 0.0 110.375 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.76 50.94 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.288 2.658 . . . . 0.0 110.876 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.1 mm -59.49 -44.89 93.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.555 1.142 . . . . 0.0 110.316 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 m -74.7 -39.31 62.03 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.036 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.22 31.65 74.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.149 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.74 158.01 16.8 Favored 'General case' 0 CA--C 1.466 -2.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.48 ' O ' ' HE1' ' A' ' 15' ' ' TYR . 8.7 p -99.31 128.59 45.45 Favored 'General case' 0 C--N 1.263 -3.179 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.0 p -107.67 70.8 0.79 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.081 0.943 . . . . 0.0 110.345 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.77 -33.86 72.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.744 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.8 -27.76 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 111.534 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.95 -11.44 11.8 Favored Glycine 0 CA--C 1.487 -1.689 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -117.1 153.11 33.34 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.016 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 t -91.86 152.82 19.92 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.48 ' HE1' ' O ' ' A' ' 8' ' ' THR . 41.6 m-85 -96.75 -26.69 15.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.128 0.489 . . . . 0.0 110.347 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -83.54 129.09 61.34 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.197 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 137.1 21.72 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.361 2.041 . . . . 0.0 110.216 175.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.3 56.11 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.8 t -139.32 156.28 47.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 152.65 46.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 118.283 0.492 . . . . 0.0 111.707 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.18 99.86 12.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.581 0.705 . . . . 0.0 111.199 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 32.6 tpt180 -105.34 85.18 2.21 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 172.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -43.77 135.96 3.61 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 114.181 -1.372 . . . . 0.0 113.165 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.1 Cg_endo -95.37 18.51 35.2 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.086 -1.631 . . . . 0.0 114.347 3.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 48.7 t -123.6 146.1 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.745 0.783 . . . . 0.0 112.874 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 37.3 m -79.56 115.67 19.31 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.586 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.526 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 83.9 m-85 -115.96 147.02 41.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.851 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -130.32 115.32 16.77 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 122.208 1.004 . . . . 0.0 110.133 177.429 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.9 mt -110.56 139.18 21.33 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.89 44.43 0.96 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 123.19 2.593 . . . . 0.0 112.92 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mm -67.75 -42.15 85.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.118 0.567 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 78.3 m -60.03 -44.95 94.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.99 3.5 81.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.783 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -83.16 170.43 14.75 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.142 0.496 . . . . 0.0 109.961 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.627 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.0 m -83.43 77.02 9.88 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.769 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.92 -50.6 10.93 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.8 10.76 12.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.475 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.88 21.94 78.87 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.463 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -140.11 142.51 36.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -91.51 137.87 32.02 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.932 0.396 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.05 -37.37 78.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.262 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 11.7 m -82.21 119.97 76.12 Favored Pre-proline 0 N--CA 1.432 -1.372 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.118 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 24.0 Cg_exo -67.53 134.17 32.23 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.132 2.555 . . . . 0.0 112.278 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.6 -0.23 88.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.907 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 11.6 t -92.35 139.81 30.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 m -81.98 121.82 26.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.754 0.788 . . . . 0.0 111.509 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.19 107.57 19.22 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -126.43 90.87 3.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -50.34 139.02 20.13 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -94.52 18.45 36.98 Favored 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.491 -1.462 . . . . 0.0 115.206 2.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.493 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 61.2 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 121.193 -0.942 . . . . 0.0 111.791 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 21.0 t -93.47 111.16 22.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.493 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.5 m-85 -110.56 119.56 39.57 Favored 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.478 0.711 . . . . 0.0 111.44 -174.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.6 tttm -90.47 112.59 24.29 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.433 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 17.6 m120 . . . . . 0 C--N 1.318 -0.797 0 C-N-CA 124.53 1.132 . . . . 0.0 110.109 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.8 mt -106.98 146.08 32.42 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 1.7 Cg_endo -75.86 77.66 3.35 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.281 1.987 . . . . 0.0 111.776 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.88 -39.29 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.53 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.68 -39.89 21.41 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.592 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.4 29.68 75.28 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -117.64 170.67 8.58 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.128 0.49 . . . . 0.0 111.503 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -116.43 157.69 24.73 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 p -132.94 75.24 1.61 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.967 0.889 . . . . 0.0 109.9 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.182 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.26 12.4 36.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.585 0.707 . . . . 0.0 111.307 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.09 -5.4 79.94 Favored Glycine 0 CA--C 1.502 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.696 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -130.83 143.41 50.71 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -91.35 157.0 17.36 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.418 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -95.2 -20.46 19.21 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.5 m -80.31 119.07 75.31 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.17 127.41 14.23 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.454 2.103 . . . . 0.0 111.598 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.67 30.34 10.71 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.43 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -136.44 131.21 33.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.8 m -93.71 142.94 26.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 0.0 112.127 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.5 124.68 30.97 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.252 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -121.72 66.22 0.9 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 38.2 ptt180 -41.05 131.12 1.96 Allowed Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.512 -1.222 . . . . 0.0 114.153 -169.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 44.7 Cg_endo -89.59 5.99 68.86 Favored 'Cis proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.422 -1.491 . . . . 0.0 115.435 4.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.72 147.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 18.3 t -98.58 136.24 38.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -135.1 129.99 34.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.417 0.627 . . . . 0.0 111.169 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -92.62 109.58 21.0 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 N--CA 1.479 0.976 0 O-C-N 123.775 0.672 . . . . 0.0 110.827 -177.426 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.386 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.4 mt -89.8 151.86 46.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 C-N-CA 122.207 0.203 . . . . 0.0 111.367 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.28 94.86 0.83 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 121.579 1.52 . . . . 0.0 109.048 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.91 -32.2 2.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.398 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.9 m -71.89 -45.42 61.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.94 14.94 Favored Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.354 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.24 166.99 15.22 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.782 0.801 . . . . 0.0 112.25 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -119.53 145.53 46.26 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.468 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.77 51.59 1.23 Allowed 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.766 0.793 . . . . 0.0 109.155 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.17 -25.67 33.97 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.054 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.02 11.73 28.75 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 122.111 -0.368 . . . . 0.0 111.949 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.01 89.57 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 121.35 -0.453 . . . . 0.0 112.166 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.91 138.46 48.4 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -94.68 156.72 16.28 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -113.62 13.2 18.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.699 0.762 . . . . 0.0 111.537 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.401 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 m -120.1 119.07 31.11 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.468 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 133.22 56.12 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 123.267 2.644 . . . . 0.0 111.132 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.39 -6.78 75.21 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.137 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 64.2 m -102.32 148.95 24.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.8 t -108.01 141.27 39.94 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.36 119.15 28.52 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.032 0.444 . . . . 0.0 110.62 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 4.7 tpm_? -127.32 84.84 2.3 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 171.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 37.4 ptt180 -41.38 130.88 2.18 Favored Pre-proline 0 C--O 1.249 1.032 0 CA-C-N 114.013 -1.449 . . . . 0.0 114.351 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 78.9 Cg_endo -97.71 19.0 28.94 Favored 'Cis proline' 0 CA--C 1.556 1.609 0 C-N-CA 123.587 -1.422 . . . . 0.0 114.588 1.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.93 144.7 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 121.601 0.715 . . . . 0.0 112.726 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.1 m -88.81 115.19 26.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.858 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 48.5 m-85 -103.95 157.89 16.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.597 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 82.1 tttt -129.37 117.68 21.0 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 125.266 1.426 . . . . 0.0 110.644 -176.27 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.96 145.04 55.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.931 0.365 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.33 66.48 5.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.187 2.591 . . . . 0.0 111.266 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.13 -37.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.095 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.1 m -68.51 -27.97 66.59 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.62 17.37 79.95 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.125 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -110.35 170.36 8.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.5 p -123.86 154.79 39.15 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.278 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 p -138.58 81.78 1.87 Allowed 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.961 0.886 . . . . 0.0 110.316 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.07 -24.63 63.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.274 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.71 6.54 34.3 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 120.8 0.333 . . . . 0.0 111.329 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.542 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 80.99 20.36 65.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.002 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.15 119.69 24.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -89.5 145.88 24.99 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.525 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -84.81 -25.54 28.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.102 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -86.99 125.82 65.17 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.211 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.34 146.42 50.6 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.547 2.164 . . . . 0.0 110.436 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.64 29.25 71.42 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.0 t -145.86 130.65 18.07 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -99.62 173.15 6.86 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 39.0 t -109.1 132.44 54.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.168 0.509 . . . . 0.0 110.314 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.663 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 31.5 tpt180 -135.28 84.95 2.13 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -39.96 134.47 1.39 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.693 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -96.01 21.16 29.53 Favored 'Cis proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.568 0.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.59 150.52 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 121.771 -0.581 . . . . 0.0 111.728 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 88.4 m -79.37 139.32 37.78 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 121.962 -0.461 . . . . 0.0 110.452 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.663 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 13.0 m-85 -127.62 137.13 52.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.055 0.455 . . . . 0.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.91 118.65 24.01 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.406 0.622 . . . . 0.0 111.508 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.02 143.63 26.99 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 122.787 -0.243 . . . . 0.0 110.371 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.35 86.98 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.035 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 mm -123.13 -12.37 6.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.731 0.777 . . . . 0.0 110.195 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 8.7 m -81.55 -36.9 28.57 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.1 53.93 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -126.8 159.69 33.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.63 0.729 . . . . 0.0 111.861 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -110.97 174.11 6.01 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.975 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 64.1 m -126.9 70.08 1.28 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.82 -33.28 21.38 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.48 -31.17 37.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.988 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.46 10.12 17.96 Favored Glycine 0 CA--C 1.496 -1.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.298 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.06 162.35 35.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.747 -0.226 . . . . 0.0 111.179 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.71 141.9 33.86 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.082 0.864 . . . . 0.0 110.449 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -105.37 -8.27 18.29 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.492 0.663 . . . . 0.0 109.44 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -87.1 120.63 71.53 Favored Pre-proline 0 N--CA 1.428 -1.562 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.942 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.16 129.7 21.09 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.258 1.972 . . . . 0.0 111.532 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.98 4.73 58.66 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.8 m -117.2 151.15 37.48 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 t -124.66 141.31 52.2 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.92 136.68 33.52 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -132.3 82.1 2.0 Allowed 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 35.5 ptt180 -49.29 138.98 14.3 Favored Pre-proline 0 C--O 1.24 0.587 0 O-C-N 123.58 0.55 . . . . 0.0 112.353 -173.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -92.54 24.5 24.47 Favored 'Cis proline' 0 CA--C 1.559 1.743 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 4.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 21.8 t -126.76 152.7 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 O-C-N 121.077 -1.015 . . . . 0.0 110.367 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t -99.5 139.78 34.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.0 m-85 -132.67 151.03 52.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.525 0.602 . . . . 0.0 111.95 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.3 tttp -114.72 104.26 11.79 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 . . . . . 0 C--N 1.317 -0.813 0 C-N-CA 124.512 1.125 . . . . 0.0 110.275 -175.839 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 114.041 0.377 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.4 mt -110.95 148.27 38.26 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 117.438 0.619 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.93 48.8 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.449 2.766 . . . . 0.0 112.185 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.97 -25.3 34.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 124.579 1.152 . . . . 0.0 111.035 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 16.7 m -62.83 -37.47 86.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.431 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.26 34.85 44.78 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -131.86 149.74 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.717 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -111.69 150.59 29.97 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.5 p -132.3 82.02 1.99 Allowed 'General case' 0 N--CA 1.404 -2.77 0 CA-C-O 122.529 1.157 . . . . 0.0 110.927 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.4 tp -84.07 -36.38 23.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.575 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.6 mt -82.77 -30.19 29.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.403 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.5 30.07 3.95 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.767 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -135.35 135.36 40.67 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.75 0.775 . . . . 0.0 112.06 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 m -120.9 141.43 50.63 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.25 -29.53 13.14 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 112.172 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -55.82 130.4 72.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 123.618 0.574 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.94 135.2 43.16 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.399 2.066 . . . . 0.0 111.596 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.57 30.48 60.04 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.6 t -118.38 131.89 56.28 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -112.25 134.77 53.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 t -77.51 129.29 35.49 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.118 0.485 . . . . 0.0 110.333 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 76.0 ttt180 -134.23 86.71 2.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 72.7 mtt180 -44.94 135.87 4.82 Favored Pre-proline 0 C--O 1.244 0.774 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.973 -170.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 60.0 Cg_endo -98.73 27.5 16.69 Favored 'Cis proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.394 -1.503 . . . . 0.0 114.193 3.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.9 150.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 121.726 -0.609 . . . . 0.0 110.472 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.707 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 77.5 m -90.96 141.32 28.97 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.682 -0.636 . . . . 0.0 109.717 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 90.0 m-85 -131.17 135.9 47.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.198 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 64.6 tttp -111.0 103.17 11.61 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.347 1.059 . . . . 0.0 111.526 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.51 140.03 21.13 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.21 68.7 5.01 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.297 1.998 . . . . 0.0 111.83 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.89 -46.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.8 m -73.47 -56.08 5.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.016 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.57 14.34 82.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.145 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.46 154.67 19.47 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p -97.15 134.32 40.63 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.387 0.613 . . . . 0.0 111.22 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.06 78.99 1.79 Allowed 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 122.412 1.101 . . . . 0.0 109.838 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.69 -19.59 59.01 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.133 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.58 -21.09 59.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.451 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.56 -0.65 39.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.724 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.58 144.38 35.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 62.0 m -85.3 169.47 13.72 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -103.19 -23.57 13.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.925 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -85.44 119.5 72.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.16 132.53 19.7 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.282 1.988 . . . . 0.0 111.562 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.89 6.23 46.34 Favored Glycine 0 C--N 1.308 -0.992 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.7 t -121.38 127.42 51.2 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.7 t -88.72 138.62 31.25 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.481 0.657 . . . . 0.0 110.282 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 45.4 t -95.98 117.09 29.97 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.317 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -114.33 84.47 2.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 32.6 ptt180 -44.99 134.83 5.05 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.665 -170.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.9 Cg_endo -95.18 15.77 40.22 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.476 -1.468 . . . . 0.0 114.863 2.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -112.56 135.34 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.064 -175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.8 t -91.27 124.54 35.55 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.012 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -123.98 143.96 50.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.42 0.629 . . . . 0.0 111.325 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -109.29 108.37 18.94 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.807 1.243 . . . . 0.0 111.658 -177.639 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.003 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.62 148.11 37.08 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.48 39.38 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.995 2.464 . . . . 0.0 112.196 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.8 -30.24 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.495 1.118 . . . . 0.0 111.184 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 32.2 m -72.12 -31.42 66.01 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.358 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.33 1.57 60.94 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.69 -0.686 . . . . 0.0 113.48 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 41.8 mt-10 -89.64 159.58 17.06 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.276 0.56 . . . . 0.0 110.686 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -118.17 130.89 56.37 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 25.3 p -111.67 77.55 1.05 Allowed 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.082 0.944 . . . . 0.0 112.78 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.3 mt -77.38 -30.2 53.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.84 -17.97 60.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.904 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -10.54 61.11 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.037 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -133.8 139.12 46.09 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.9 m -97.32 162.34 13.38 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 124.073 0.858 . . . . 0.0 108.838 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -98.55 -9.78 24.41 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.736 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.5 m -86.27 119.22 71.45 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.91 133.85 20.65 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.587 2.191 . . . . 0.0 110.513 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.54 20.48 40.82 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.5 t -120.25 140.98 50.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 t -104.22 121.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.506 0.67 . . . . 0.0 110.395 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.2 t -79.16 110.23 14.23 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.213 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -121.06 85.56 2.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -52.86 142.91 32.75 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.868 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.28 15.86 45.7 Favored 'Cis proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.208 -1.58 . . . . 0.0 116.052 4.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 52.4 t -122.29 144.96 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.73 1.15 . . . . 0.0 112.394 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 72.7 m -89.1 117.01 27.78 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.412 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.8 m-85 -114.73 121.44 43.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.627 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 41.3 ttmt -90.19 108.69 19.9 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 124.411 1.084 . . . . 0.0 112.62 -178.253 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.406 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.55 139.56 20.23 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.64 42.46 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.853 3.035 . . . . 0.0 113.04 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.13 -27.94 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 124.536 1.134 . . . . 0.0 111.111 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 6.7 m -66.0 -45.67 80.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.71 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.27 28.34 37.0 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -141.16 161.77 37.08 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 122.794 0.438 . . . . 0.0 110.05 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 24' ' ' PRO . 30.8 p -118.85 -179.8 3.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -121.21 79.68 1.55 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.51 -26.76 17.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.14 -21.57 18.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.688 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 16.06 27.3 Favored Glycine 0 C--O 1.239 0.415 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.3 tttm -140.95 141.15 34.49 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 75.1 m -90.88 159.08 16.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -113.58 -26.77 8.12 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 120.986 0.422 . . . . 0.0 110.047 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -82.78 127.62 69.25 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.84 145.16 61.59 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.512 2.141 . . . . 0.0 111.934 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.78 1.22 80.51 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.813 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 99.5 m -103.14 126.09 50.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -93.28 124.34 37.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.513 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.01 126.63 31.43 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.969 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -137.26 94.41 2.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 64.3 mtm180 -52.36 137.93 39.54 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.4 Cg_endo -98.38 28.68 15.38 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.57 2.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.491 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 6.9 t -124.19 166.17 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.535 -0.728 . . . . 0.0 109.322 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 42.4 t -113.12 133.32 55.08 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 94.0 m-85 -130.94 135.89 48.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.045 0.45 . . . . 0.0 111.462 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 87.2 tttt -103.73 108.79 20.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.495 1.784 0 C-N-CA 124.339 1.055 . . . . 0.0 110.605 -176.251 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.926 -0.07 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.82 148.3 36.65 Favored Pre-proline 0 C--N 1.312 -1.042 0 O-C-N 122.378 -0.483 . . . . 0.0 110.437 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.66 50.7 3.31 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.723 2.282 . . . . 0.0 111.508 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.37 -28.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.112 1.365 . . . . 0.0 111.434 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.1 m -78.1 -19.27 54.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.75 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.87 -44.24 2.29 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 113.639 0.216 . . . . 0.0 113.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.95 154.21 31.15 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.839 0.856 . . . . 0.0 111.468 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -108.72 179.2 4.25 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.626 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 77.1 m -118.18 74.02 0.93 Allowed 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.776 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.7 tp -84.95 -30.69 24.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.55 -30.39 15.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.619 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 9' ' ' CYS . . . 100.88 29.83 6.33 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -134.86 135.89 42.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.319 -0.441 . . . . 0.0 109.968 -174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 92.7 m -109.4 123.89 50.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -84.67 -31.19 24.28 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.031 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.9 m -69.13 119.8 72.46 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.35 134.21 24.24 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.025 1.817 . . . . 0.0 110.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.72 23.48 23.28 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.836 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 1.1 t -122.93 153.26 39.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -113.29 122.7 48.2 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.312 0.577 . . . . 0.0 110.205 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 51.4 t -80.81 110.98 16.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.979 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.25 81.49 1.62 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 174.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 43.8 ttt180 -47.52 132.43 10.48 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.385 -171.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 32.1 Cg_endo -96.69 26.34 19.86 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 N-CA-C 116.076 1.529 . . . . 0.0 116.076 6.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 20.5 t -127.54 151.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.802 -1.186 . . . . 0.0 109.933 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.0 t -102.43 121.22 41.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 98.2 m-85 -118.62 142.1 47.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.404 0.621 . . . . 0.0 111.844 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 61.4 tttp -126.04 117.52 23.38 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 122.355 1.074 . . . . 0.0 109.746 177.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mp -108.31 142.28 25.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 117.032 0.416 . . . . 0.0 111.09 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.82 43.21 1.21 Allowed 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 123.693 2.929 . . . . 0.0 112.28 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -72.8 -28.29 26.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.462 1.105 . . . . 0.0 111.303 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 9.6 m -61.76 -34.81 76.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.55 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.62 69.29 Favored Glycine 0 CA--C 1.494 -1.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.922 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 10.9 pt-20 -140.52 160.84 39.13 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.128 0.489 . . . . 0.0 110.849 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p -108.71 166.71 10.59 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.275 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.93 83.82 1.45 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 122.162 0.982 . . . . 0.0 110.652 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.94 -15.05 60.24 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.291 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -86.8 -17.71 32.82 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.294 0.569 . . . . 0.0 110.271 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.81 18.98 41.95 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.01 119.95 13.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.7 t -81.1 149.53 29.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -80.03 -36.06 36.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.441 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 54.1 m -84.42 128.68 60.74 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.679 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 23.2 Cg_exo -66.1 136.16 43.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.643 2.229 . . . . 0.0 110.54 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.75 -16.27 56.3 Favored Glycine 0 C--N 1.304 -1.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.59 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.33 119.92 33.02 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 m -76.24 134.08 39.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -91.7 110.49 21.83 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.621 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -107.51 86.26 2.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 18.4 ptt180 -43.89 129.7 4.21 Favored Pre-proline 0 C--N 1.316 -0.848 0 O-C-N 124.71 1.256 . . . . 0.0 113.422 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.0 Cg_endo -101.27 31.14 10.16 Favored 'Cis proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.031 -1.237 . . . . 0.0 113.595 1.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.97 141.15 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.771 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 92.7 m -84.48 135.47 34.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.779 0.323 . . . . 0.0 110.947 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.38 115.79 16.02 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttm -93.45 114.98 27.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.349 1.06 . . . . 0.0 109.646 -177.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.995 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.5 mt -94.46 157.43 37.29 Favored Pre-proline 0 C--N 1.309 -1.196 0 O-C-N 122.821 -0.223 . . . . 0.0 110.597 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 66.1 Cg_endo -72.19 48.6 1.22 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 123.639 2.892 . . . . 0.0 112.36 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mm -59.53 -35.94 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 125.45 1.5 . . . . 0.0 112.704 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.6 m -69.19 -36.89 77.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.845 0.355 . . . . 0.0 110.423 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.82 -12.93 55.83 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.498 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.507 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 42.9 mt-10 -74.43 159.4 32.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.121 0.486 . . . . 0.0 110.838 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.3 p -118.73 132.26 56.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.79 75.5 10.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.3 mt -80.42 -40.61 26.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.75 -29.1 24.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.137 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.59 -4.53 7.58 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.793 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -122.73 136.04 54.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 16.2 t -90.75 139.56 30.61 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -92.16 -19.59 22.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.761 0.315 . . . . 0.0 111.161 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.4 m -81.37 120.92 79.52 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.17 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 138.97 39.07 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.589 2.193 . . . . 0.0 110.785 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.44 19.96 70.27 Favored Glycine 0 C--N 1.314 -0.671 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.0 t -122.08 133.26 54.78 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 m -90.41 119.91 31.08 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.645 0.736 . . . . 0.0 110.475 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 44.4 t -77.06 114.74 16.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.44 85.03 2.32 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 87.8 mtt180 -47.82 134.06 11.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 123.845 0.716 . . . . 0.0 111.769 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 46.0 Cg_endo -97.18 25.98 20.14 Favored 'Cis proline' 0 CA--C 1.558 1.721 0 C-N-CA 123.453 -1.478 . . . . 0.0 114.766 3.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 40.6 t -128.37 149.57 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.952 1.251 . . . . 0.0 112.051 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 84.0 m -89.89 115.96 27.61 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 120.948 0.404 . . . . 0.0 111.457 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 33.7 m-85 -110.52 133.88 52.89 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 65.1 tttm -120.27 122.71 41.48 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.319 -0.721 0 C-N-CA 124.895 1.278 . . . . 0.0 110.67 -179.538 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.449 0 N-CA-C 112.696 -0.162 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -102.0 143.22 26.16 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.46 33.92 0.4 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.648 2.899 . . . . 0.0 112.621 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.0 mm -59.95 -44.25 94.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 123.669 0.788 . . . . 0.0 110.397 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.7 m -66.09 -55.56 15.89 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.935 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.08 12.48 83.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -89.16 170.67 10.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-O 121.056 0.455 . . . . 0.0 110.37 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.5 p -128.1 131.8 49.02 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.682 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.55 63.37 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.31 -38.98 85.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.26 1.36 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.57 -36.0 2.31 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 119.299 -1.429 . . . . 0.0 114.035 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.0 tttm -116.06 153.41 31.75 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 43.3 t -81.04 142.27 33.53 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.64 -24.29 27.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.985 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 m -89.51 122.02 68.7 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.336 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.04 140.04 27.82 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.215 1.944 . . . . 0.0 111.177 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.55 21.35 60.22 Favored Glycine 0 C--N 1.319 -0.409 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 34.9 t -135.05 126.6 28.78 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -83.76 137.64 33.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.506 0.669 . . . . 0.0 111.593 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.3 t -87.52 131.02 34.51 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.708 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -133.28 74.24 1.55 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 70.0 ttt180 -46.3 130.64 7.72 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.672 -169.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 42.5 Cg_endo -93.66 17.07 41.22 Favored 'Cis proline' 0 CA--C 1.551 1.374 0 N-CA-C 116.338 1.63 . . . . 0.0 116.338 6.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.06 145.7 20.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 119.913 1.233 . . . . 0.0 111.872 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 89.5 m -94.34 121.65 36.09 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -117.87 122.66 43.91 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.126 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttp -92.45 111.18 22.66 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 122.482 1.134 . . . . 0.0 109.714 -178.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.036 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.3 mt -132.77 144.43 52.87 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 116.883 0.342 . . . . 0.0 110.72 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.2 Cg_endo -77.85 90.92 1.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.207 1.938 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.3 mm -113.62 -32.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.537 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 m -66.77 -33.63 76.04 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.738 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.91 39.66 23.63 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.18 150.32 52.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.846 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -131.37 141.5 49.9 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -84.73 73.05 10.66 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.395 0.617 . . . . 0.0 109.786 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -89.02 -32.67 17.48 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.31 -24.4 22.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.784 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.04 -13.23 10.53 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.482 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -141.55 147.3 37.49 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 122.393 -0.475 . . . . 0.0 110.839 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.4 m -89.95 167.4 12.83 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -105.14 -36.03 7.4 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.668 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.9 m -69.64 122.05 84.49 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -68.98 131.66 22.85 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.444 2.096 . . . . 0.0 109.282 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.09 38.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.9 t -132.44 120.45 21.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 m -90.48 147.44 23.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.003 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -96.57 118.68 33.57 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.14 0.495 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 8.4 tpt180 -124.56 84.49 2.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 39.2 ptt180 -47.52 134.66 10.15 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.398 -172.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 43.0 Cg_endo -94.46 24.19 25.19 Favored 'Cis proline' 0 CA--C 1.556 1.617 0 N-CA-C 115.46 1.292 . . . . 0.0 115.46 2.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.71 145.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.725 -1.234 . . . . 0.0 111.169 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.494 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 70.7 m -89.86 136.97 32.72 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 94.3 m-85 -129.83 125.24 35.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.897 0.379 . . . . 0.0 110.188 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.64 113.03 23.78 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m120 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 125.687 1.595 . . . . 0.0 109.133 -173.301 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 N-CA-C 113.452 0.141 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.27 152.63 46.14 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 117.24 0.52 . . . . 0.0 110.441 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 85.4 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.977 1.785 . . . . 0.0 110.905 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 47.2 mm -104.07 -33.7 3.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.578 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 37.9 m -65.7 -35.0 79.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 -32.92 2.87 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.146 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.0 171.08 12.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.509 0.671 . . . . 0.0 111.533 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 p -133.27 156.11 48.17 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.904 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 72.9 m -90.8 67.18 6.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.236 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.432 ' H ' HD22 ' A' ' 10' ' ' LEU . 1.6 mm? -68.33 -26.43 65.61 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.695 0.76 . . . . 0.0 109.962 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -87.31 -2.28 58.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.476 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.4 -13.34 65.53 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -132.41 145.92 51.57 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 25.0 t -91.1 139.39 30.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -93.9 -9.67 36.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.251 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -83.13 120.6 76.21 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.25 133.79 42.28 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.881 2.387 . . . . 0.0 111.046 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.33 -15.05 64.06 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.621 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -93.67 125.07 38.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.558 0.694 . . . . 0.0 111.198 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -80.7 127.32 32.36 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.5 105.73 17.99 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 121.49 0.662 . . . . 0.0 111.772 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -113.91 76.2 0.97 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -49.32 139.62 13.8 Favored Pre-proline 0 C--O 1.245 0.827 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.688 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.72 16.78 37.97 Favored 'Cis proline' 0 CA--C 1.553 1.46 0 N-CA-C 115.374 1.259 . . . . 0.0 115.374 3.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.91 143.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.154 1.343 . . . . 0.0 112.979 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.97 120.14 32.35 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.157 0.503 . . . . 0.0 110.22 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -110.59 160.03 17.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.004 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.4 tttm -141.67 122.99 14.84 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 123.729 0.812 . . . . 0.0 110.776 -178.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.663 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.24 152.14 37.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 74.3 Cg_endo -75.71 51.45 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.175 2.584 . . . . 0.0 112.002 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 48.4 mm -59.84 -24.73 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.089 1.355 . . . . 0.0 110.703 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.2 m -64.84 -32.99 74.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.024 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.73 31.26 70.34 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.346 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -140.84 156.36 46.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -114.45 156.06 25.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.132 0.491 . . . . 0.0 111.664 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 92.1 m -90.84 72.29 6.58 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.5 -40.53 29.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.325 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -88.69 -30.04 19.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.86 25.74 5.0 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.464 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.08 148.57 40.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.72 145.12 31.52 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.03 -33.39 10.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.2 m -73.0 129.0 87.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.35 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.36 141.34 55.99 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.94 2.427 . . . . 0.0 111.655 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.75 4.4 79.39 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 121.388 -0.435 . . . . 0.0 112.878 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 87.4 m -97.69 149.32 22.41 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -111.36 119.79 40.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.0 t -82.02 115.5 21.2 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.006 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -126.66 78.99 1.83 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 21.9 ptt180 -50.49 135.41 24.97 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -87.45 10.68 58.91 Favored 'Cis proline' 0 CA--C 1.565 2.043 0 N-CA-C 117.641 2.131 . . . . 0.0 117.641 7.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.03 152.86 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.254 -1.529 . . . . 0.0 111.588 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 43.6 t -106.73 114.64 28.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 96.6 m-85 -109.22 148.11 31.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.036 0.446 . . . . 0.0 111.056 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 88.5 tttt -118.64 108.74 15.29 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 124.596 1.159 . . . . 0.0 111.296 -173.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.55 143.77 27.05 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.448 0.624 . . . . 0.0 110.929 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.59 50.42 2.98 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.06 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.4 mm -59.06 -44.12 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.583 1.153 . . . . 0.0 111.559 -175.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.89 -41.9 95.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.81 14.53 75.62 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.274 -0.421 . . . . 0.0 113.213 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.27 146.2 24.92 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -93.72 131.6 38.89 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-O 121.122 0.487 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.7 p -111.16 75.18 0.9 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.308 1.051 . . . . 0.0 111.161 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.32 -31.48 62.48 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.533 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.95 7.51 27.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.264 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.93 77.81 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.031 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -140.4 140.49 35.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -110.93 149.09 31.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -96.55 -15.73 21.46 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 120.688 0.28 . . . . 0.0 110.915 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -94.13 119.46 66.66 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.58 140.73 40.26 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.781 1.654 . . . . 0.0 110.393 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.18 67.58 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -130.7 130.85 44.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 t -113.99 147.3 38.85 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.519 0.676 . . . . 0.0 111.314 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.48 118.3 23.67 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.349 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 30.6 tpt180 -123.45 77.62 1.51 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -46.38 137.54 6.78 Favored Pre-proline 0 C--O 1.24 0.577 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.834 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -91.72 15.08 47.91 Favored 'Cis proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.205 -1.581 . . . . 0.0 115.16 5.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.91 140.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 121.496 -0.752 . . . . 0.0 110.848 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.2 t -95.24 127.46 41.3 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 59.3 m-85 -115.83 144.08 44.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.336 -174.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . 88.6 tttt -113.41 99.17 7.57 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.206 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.79 144.68 54.26 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.82 48.91 2.06 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.959 2.439 . . . . 0.0 112.109 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.2 mm -59.08 -42.2 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 36.7 m -62.9 -33.37 75.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.94 -21.6 5.55 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.658 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.96 164.66 25.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.395 0.678 . . . . 0.0 110.152 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 5.1 p -129.9 166.79 19.29 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.064 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 82.3 m -111.91 75.61 0.93 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -83.69 -41.2 17.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.6 -12.02 60.0 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.523 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.51 -20.64 27.33 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.138 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -112.18 144.21 41.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 38.0 t -106.64 129.53 54.54 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.76 3.95 54.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -107.44 119.74 49.74 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.846 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.46 132.96 18.31 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.671 2.247 . . . . 0.0 111.355 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.52 -8.45 43.93 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 24.2 t -117.65 119.79 36.04 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 p -82.76 133.98 35.13 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.598 0.713 . . . . 0.0 111.277 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.27 106.91 16.25 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.537 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 26.6 ttm180 -114.02 92.98 4.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -50.28 135.33 23.57 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.066 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.03 27.03 17.78 Favored 'Cis proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.818 -1.326 . . . . 0.0 114.655 3.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 25.7 t -128.39 152.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.801 -1.187 . . . . 0.0 111.865 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.665 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 78.1 m -86.44 113.08 22.1 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 56.8 m-85 -108.59 117.66 34.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 86.2 tttt -86.78 118.12 25.97 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.318 -0.763 0 C-N-CA 125.138 1.375 . . . . 0.0 108.804 -176.635 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 88.9 mt -102.9 150.49 37.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 9.5 Cg_exo -74.64 45.06 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.786 2.991 . . . . 0.0 112.328 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.6 mm -64.4 -41.61 92.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 124.059 0.944 . . . . 0.0 110.972 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 56.5 m -68.2 -33.56 74.66 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.926 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.27 11.63 84.03 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -106.06 170.89 7.65 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 121.622 0.725 . . . . 0.0 111.285 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -120.82 170.79 9.13 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.658 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -120.45 80.2 1.58 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.05 -33.4 19.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.33 0.586 . . . . 0.0 109.64 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.53 10.99 25.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.33 1.02 80.21 Favored Glycine 0 N--CA 1.461 0.338 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -140.35 153.92 46.56 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.1 m -79.24 153.83 29.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.474 0.655 . . . . 0.0 110.775 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -82.22 -25.33 34.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -102.79 120.62 52.11 Favored Pre-proline 0 N--CA 1.433 -1.286 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.436 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.51 134.82 23.1 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.798 2.332 . . . . 0.0 110.564 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.23 -1.0 29.69 Favored Glycine 0 C--N 1.307 -1.082 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -106.81 169.29 8.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -114.66 119.11 35.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.06 134.2 34.62 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -142.13 82.49 1.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.7 ptt180 -43.76 135.46 3.68 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.372 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 61.9 Cg_endo -94.86 23.98 25.54 Favored 'Cis proline' 0 CA--C 1.558 1.717 0 C-N-CA 123.835 -1.319 . . . . 0.0 114.53 3.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.24 157.45 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.417 -0.802 . . . . 0.0 110.124 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -112.3 128.82 56.38 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -121.97 170.39 9.87 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.067 0.461 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.4 tttp -146.82 113.49 6.03 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.76 0.824 . . . . 0.0 110.06 -177.579 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.24 145.68 30.66 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 122.736 -0.273 . . . . 0.0 110.375 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.76 50.94 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.288 2.658 . . . . 0.0 110.876 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.1 mm -59.49 -44.89 93.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.555 1.142 . . . . 0.0 110.316 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 m -74.7 -39.31 62.03 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.036 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.22 31.65 74.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.149 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.74 158.01 16.8 Favored 'General case' 0 CA--C 1.466 -2.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.48 ' O ' ' HE1' ' A' ' 15' ' ' TYR . 8.7 p -99.31 128.59 45.45 Favored 'General case' 0 C--N 1.263 -3.179 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.0 p -107.67 70.8 0.79 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.081 0.943 . . . . 0.0 110.345 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.77 -33.86 72.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.744 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.8 -27.76 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 111.534 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.95 -11.44 11.8 Favored Glycine 0 CA--C 1.487 -1.689 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -117.1 153.11 33.34 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.016 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 t -91.86 152.82 19.92 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.48 ' HE1' ' O ' ' A' ' 8' ' ' THR . 41.6 m-85 -96.75 -26.69 15.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.128 0.489 . . . . 0.0 110.347 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -83.54 129.09 61.34 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.197 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 137.1 21.72 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.361 2.041 . . . . 0.0 110.216 175.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.3 56.11 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.8 t -139.32 156.28 47.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 152.65 46.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 118.283 0.492 . . . . 0.0 111.707 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.18 99.86 12.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.581 0.705 . . . . 0.0 111.199 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 32.6 tpt180 -105.34 85.18 2.21 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 172.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -43.77 135.96 3.61 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 114.181 -1.372 . . . . 0.0 113.165 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.1 Cg_endo -95.37 18.51 35.2 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.086 -1.631 . . . . 0.0 114.347 3.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 48.7 t -123.6 146.1 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.745 0.783 . . . . 0.0 112.874 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 37.3 m -79.56 115.67 19.31 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.586 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.526 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 83.9 m-85 -115.96 147.02 41.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.851 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -130.32 115.32 16.77 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 122.208 1.004 . . . . 0.0 110.133 177.429 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.9 mt -110.56 139.18 21.33 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.89 44.43 0.96 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 123.19 2.593 . . . . 0.0 112.92 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mm -67.75 -42.15 85.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.118 0.567 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 78.3 m -60.03 -44.95 94.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.99 3.5 81.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.783 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -83.16 170.43 14.75 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.142 0.496 . . . . 0.0 109.961 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.627 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.0 m -83.43 77.02 9.88 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.769 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.92 -50.6 10.93 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.8 10.76 12.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.475 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.88 21.94 78.87 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.463 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -140.11 142.51 36.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -91.51 137.87 32.02 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.932 0.396 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.05 -37.37 78.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.262 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 11.7 m -82.21 119.97 76.12 Favored Pre-proline 0 N--CA 1.432 -1.372 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.118 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 24.0 Cg_exo -67.53 134.17 32.23 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.132 2.555 . . . . 0.0 112.278 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.6 -0.23 88.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.907 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 11.6 t -92.35 139.81 30.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 m -81.98 121.82 26.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.754 0.788 . . . . 0.0 111.509 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.19 107.57 19.22 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -126.43 90.87 3.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -50.34 139.02 20.13 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -94.52 18.45 36.98 Favored 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.491 -1.462 . . . . 0.0 115.206 2.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.493 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 61.2 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 121.193 -0.942 . . . . 0.0 111.791 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 21.0 t -93.47 111.16 22.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.493 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.5 m-85 -110.56 119.56 39.57 Favored 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.478 0.711 . . . . 0.0 111.44 -174.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.6 tttm -90.47 112.59 24.29 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.433 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 17.6 m120 . . . . . 0 C--N 1.318 -0.797 0 C-N-CA 124.53 1.132 . . . . 0.0 110.109 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.8 mt -106.98 146.08 32.42 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 1.7 Cg_endo -75.86 77.66 3.35 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.281 1.987 . . . . 0.0 111.776 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.88 -39.29 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.53 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.68 -39.89 21.41 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.592 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.4 29.68 75.28 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -117.64 170.67 8.58 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.128 0.49 . . . . 0.0 111.503 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -116.43 157.69 24.73 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 p -132.94 75.24 1.61 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.967 0.889 . . . . 0.0 109.9 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.182 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.26 12.4 36.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.585 0.707 . . . . 0.0 111.307 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.09 -5.4 79.94 Favored Glycine 0 CA--C 1.502 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.696 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -130.83 143.41 50.71 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -91.35 157.0 17.36 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.418 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -95.2 -20.46 19.21 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.5 m -80.31 119.07 75.31 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.17 127.41 14.23 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.454 2.103 . . . . 0.0 111.598 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.67 30.34 10.71 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.43 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -136.44 131.21 33.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.8 m -93.71 142.94 26.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 0.0 112.127 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.5 124.68 30.97 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.252 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -121.72 66.22 0.9 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 38.2 ptt180 -41.05 131.12 1.96 Allowed Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.512 -1.222 . . . . 0.0 114.153 -169.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 44.7 Cg_endo -89.59 5.99 68.86 Favored 'Cis proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.422 -1.491 . . . . 0.0 115.435 4.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.72 147.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 18.3 t -98.58 136.24 38.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -135.1 129.99 34.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.417 0.627 . . . . 0.0 111.169 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -92.62 109.58 21.0 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 N--CA 1.479 0.976 0 O-C-N 123.775 0.672 . . . . 0.0 110.827 -177.426 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.386 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.4 mt -89.8 151.86 46.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 C-N-CA 122.207 0.203 . . . . 0.0 111.367 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.28 94.86 0.83 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 121.579 1.52 . . . . 0.0 109.048 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.91 -32.2 2.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.398 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.9 m -71.89 -45.42 61.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.94 14.94 Favored Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.354 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.24 166.99 15.22 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.782 0.801 . . . . 0.0 112.25 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -119.53 145.53 46.26 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.468 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.77 51.59 1.23 Allowed 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.766 0.793 . . . . 0.0 109.155 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.17 -25.67 33.97 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.054 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.02 11.73 28.75 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 122.111 -0.368 . . . . 0.0 111.949 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.01 89.57 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 121.35 -0.453 . . . . 0.0 112.166 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.91 138.46 48.4 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -94.68 156.72 16.28 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -113.62 13.2 18.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.699 0.762 . . . . 0.0 111.537 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.401 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 m -120.1 119.07 31.11 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.468 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 133.22 56.12 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 123.267 2.644 . . . . 0.0 111.132 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.39 -6.78 75.21 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.137 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 64.2 m -102.32 148.95 24.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.8 t -108.01 141.27 39.94 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.36 119.15 28.52 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.032 0.444 . . . . 0.0 110.62 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 4.7 tpm_? -127.32 84.84 2.3 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 171.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 37.4 ptt180 -41.38 130.88 2.18 Favored Pre-proline 0 C--O 1.249 1.032 0 CA-C-N 114.013 -1.449 . . . . 0.0 114.351 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 78.9 Cg_endo -97.71 19.0 28.94 Favored 'Cis proline' 0 CA--C 1.556 1.609 0 C-N-CA 123.587 -1.422 . . . . 0.0 114.588 1.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.93 144.7 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 121.601 0.715 . . . . 0.0 112.726 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.1 m -88.81 115.19 26.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.858 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 48.5 m-85 -103.95 157.89 16.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.597 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 82.1 tttt -129.37 117.68 21.0 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 125.266 1.426 . . . . 0.0 110.644 -176.27 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.96 145.04 55.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.931 0.365 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.33 66.48 5.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.187 2.591 . . . . 0.0 111.266 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.13 -37.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.095 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.1 m -68.51 -27.97 66.59 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.62 17.37 79.95 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.125 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -110.35 170.36 8.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.5 p -123.86 154.79 39.15 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.278 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 p -138.58 81.78 1.87 Allowed 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.961 0.886 . . . . 0.0 110.316 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.07 -24.63 63.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.274 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.71 6.54 34.3 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 120.8 0.333 . . . . 0.0 111.329 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.542 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 80.99 20.36 65.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.002 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.15 119.69 24.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -89.5 145.88 24.99 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.525 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -84.81 -25.54 28.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.102 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -86.99 125.82 65.17 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.211 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.34 146.42 50.6 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.547 2.164 . . . . 0.0 110.436 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.64 29.25 71.42 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.0 t -145.86 130.65 18.07 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -99.62 173.15 6.86 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 39.0 t -109.1 132.44 54.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.168 0.509 . . . . 0.0 110.314 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.663 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 31.5 tpt180 -135.28 84.95 2.13 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -39.96 134.47 1.39 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.693 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -96.01 21.16 29.53 Favored 'Cis proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.568 0.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.59 150.52 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 121.771 -0.581 . . . . 0.0 111.728 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 88.4 m -79.37 139.32 37.78 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 121.962 -0.461 . . . . 0.0 110.452 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.663 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 13.0 m-85 -127.62 137.13 52.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.055 0.455 . . . . 0.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.91 118.65 24.01 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.406 0.622 . . . . 0.0 111.508 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.02 143.63 26.99 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 122.787 -0.243 . . . . 0.0 110.371 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.35 86.98 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.035 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 mm -123.13 -12.37 6.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.731 0.777 . . . . 0.0 110.195 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 8.7 m -81.55 -36.9 28.57 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.1 53.93 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -126.8 159.69 33.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.63 0.729 . . . . 0.0 111.861 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -110.97 174.11 6.01 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.975 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 64.1 m -126.9 70.08 1.28 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.82 -33.28 21.38 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.48 -31.17 37.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.988 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.46 10.12 17.96 Favored Glycine 0 CA--C 1.496 -1.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.298 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.06 162.35 35.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.747 -0.226 . . . . 0.0 111.179 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.71 141.9 33.86 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.082 0.864 . . . . 0.0 110.449 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -105.37 -8.27 18.29 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.492 0.663 . . . . 0.0 109.44 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -87.1 120.63 71.53 Favored Pre-proline 0 N--CA 1.428 -1.562 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.942 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.16 129.7 21.09 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.258 1.972 . . . . 0.0 111.532 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.98 4.73 58.66 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.8 m -117.2 151.15 37.48 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 t -124.66 141.31 52.2 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.92 136.68 33.52 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -132.3 82.1 2.0 Allowed 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 35.5 ptt180 -49.29 138.98 14.3 Favored Pre-proline 0 C--O 1.24 0.587 0 O-C-N 123.58 0.55 . . . . 0.0 112.353 -173.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -92.54 24.5 24.47 Favored 'Cis proline' 0 CA--C 1.559 1.743 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 4.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 21.8 t -126.76 152.7 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 O-C-N 121.077 -1.015 . . . . 0.0 110.367 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t -99.5 139.78 34.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.0 m-85 -132.67 151.03 52.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.525 0.602 . . . . 0.0 111.95 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.3 tttp -114.72 104.26 11.79 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 . . . . . 0 C--N 1.317 -0.813 0 C-N-CA 124.512 1.125 . . . . 0.0 110.275 -175.839 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 114.041 0.377 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.4 mt -110.95 148.27 38.26 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 117.438 0.619 . . . . 0.0 110.952 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.93 48.8 2.07 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.449 2.766 . . . . 0.0 112.185 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.97 -25.3 34.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 124.579 1.152 . . . . 0.0 111.035 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 16.7 m -62.83 -37.47 86.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.431 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.26 34.85 44.78 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -131.86 149.74 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.854 -0.673 . . . . 0.0 110.717 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 p -111.69 150.59 29.97 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.5 p -132.3 82.02 1.99 Allowed 'General case' 0 N--CA 1.404 -2.77 0 CA-C-O 122.529 1.157 . . . . 0.0 110.927 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.4 tp -84.07 -36.38 23.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.369 -1.287 . . . . 0.0 107.575 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 82.6 mt -82.77 -30.19 29.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.403 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.5 30.07 3.95 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.767 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -135.35 135.36 40.67 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.75 0.775 . . . . 0.0 112.06 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 m -120.9 141.43 50.63 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -98.25 -29.53 13.14 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.988 -0.445 . . . . 0.0 112.172 -176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.4 m -55.82 130.4 72.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 123.618 0.574 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.94 135.2 43.16 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.399 2.066 . . . . 0.0 111.596 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.57 30.48 60.04 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.6 t -118.38 131.89 56.28 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.9 m -112.25 134.77 53.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 t -77.51 129.29 35.49 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.118 0.485 . . . . 0.0 110.333 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.468 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 76.0 ttt180 -134.23 86.71 2.3 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 171.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 72.7 mtt180 -44.94 135.87 4.82 Favored Pre-proline 0 C--O 1.244 0.774 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.973 -170.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 60.0 Cg_endo -98.73 27.5 16.69 Favored 'Cis proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.394 -1.503 . . . . 0.0 114.193 3.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.9 150.24 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 121.726 -0.609 . . . . 0.0 110.472 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.707 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 77.5 m -90.96 141.32 28.97 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.682 -0.636 . . . . 0.0 109.717 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 90.0 m-85 -131.17 135.9 47.83 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.866 0.365 . . . . 0.0 110.198 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 64.6 tttp -111.0 103.17 11.61 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 124.347 1.059 . . . . 0.0 111.526 179.445 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.825 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.51 140.03 21.13 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -74.21 68.7 5.01 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.297 1.998 . . . . 0.0 111.83 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.89 -46.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 37.8 m -73.47 -56.08 5.51 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.016 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.57 14.34 82.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.145 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.46 154.67 19.47 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 p -97.15 134.32 40.63 Favored 'General case' 0 N--CA 1.41 -2.469 0 CA-C-O 121.387 0.613 . . . . 0.0 111.22 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.4 p -134.06 78.99 1.79 Allowed 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 122.412 1.101 . . . . 0.0 109.838 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.9 tp -75.69 -19.59 59.01 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.133 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.58 -21.09 59.67 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.451 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.56 -0.65 39.71 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.724 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -140.58 144.38 35.82 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 62.0 m -85.3 169.47 13.72 Favored 'General case' 0 C--O 1.255 1.356 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -103.19 -23.57 13.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.925 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.6 m -85.44 119.5 72.28 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.16 132.53 19.7 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.282 1.988 . . . . 0.0 111.562 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.89 6.23 46.34 Favored Glycine 0 C--N 1.308 -0.992 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.7 t -121.38 127.42 51.2 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.7 t -88.72 138.62 31.25 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.481 0.657 . . . . 0.0 110.282 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 45.4 t -95.98 117.09 29.97 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.317 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -114.33 84.47 2.05 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 32.6 ptt180 -44.99 134.83 5.05 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 114.705 -1.134 . . . . 0.0 113.665 -170.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.9 Cg_endo -95.18 15.77 40.22 Favored 'Cis proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.476 -1.468 . . . . 0.0 114.863 2.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.7 t -112.56 135.34 52.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.064 -175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.8 t -91.27 124.54 35.55 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.012 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -123.98 143.96 50.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.42 0.629 . . . . 0.0 111.325 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -109.29 108.37 18.94 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.807 1.243 . . . . 0.0 111.658 -177.639 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.003 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.62 148.11 37.08 Favored Pre-proline 0 C--N 1.316 -0.891 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.48 39.38 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.995 2.464 . . . . 0.0 112.196 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.8 -30.24 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.495 1.118 . . . . 0.0 111.184 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 32.2 m -72.12 -31.42 66.01 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.358 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.33 1.57 60.94 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.69 -0.686 . . . . 0.0 113.48 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 41.8 mt-10 -89.64 159.58 17.06 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.276 0.56 . . . . 0.0 110.686 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -118.17 130.89 56.37 Favored 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 25.3 p -111.67 77.55 1.05 Allowed 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.082 0.944 . . . . 0.0 112.78 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.3 mt -77.38 -30.2 53.62 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.84 -17.97 60.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.904 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -10.54 61.11 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.037 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -133.8 139.12 46.09 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.9 m -97.32 162.34 13.38 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 124.073 0.858 . . . . 0.0 108.838 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -98.55 -9.78 24.41 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.736 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.5 m -86.27 119.22 71.45 Favored Pre-proline 0 N--CA 1.434 -1.242 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.91 133.85 20.65 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.587 2.191 . . . . 0.0 110.513 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.54 20.48 40.82 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.5 t -120.25 140.98 50.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.9 t -104.22 121.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.506 0.67 . . . . 0.0 110.395 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.2 t -79.16 110.23 14.23 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.213 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -121.06 85.56 2.42 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -52.86 142.91 32.75 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.644 -1.162 . . . . 0.0 112.868 -169.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -89.28 15.86 45.7 Favored 'Cis proline' 0 CA--C 1.552 1.401 0 C-N-CA 123.208 -1.58 . . . . 0.0 116.052 4.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 52.4 t -122.29 144.96 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 119.73 1.15 . . . . 0.0 112.394 -174.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 72.7 m -89.1 117.01 27.78 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.073 0.463 . . . . 0.0 110.412 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.8 m-85 -114.73 121.44 43.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.627 -177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 41.3 ttmt -90.19 108.69 19.9 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.489 1.516 0 C-N-CA 124.411 1.084 . . . . 0.0 112.62 -178.253 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.406 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.55 139.56 20.23 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.64 42.46 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.853 3.035 . . . . 0.0 113.04 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.13 -27.94 41.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 C-N-CA 124.536 1.134 . . . . 0.0 111.111 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 6.7 m -66.0 -45.67 80.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.71 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.27 28.34 37.0 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -141.16 161.77 37.08 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 122.794 0.438 . . . . 0.0 110.05 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 24' ' ' PRO . 30.8 p -118.85 -179.8 3.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 120.915 0.388 . . . . 0.0 111.017 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -121.21 79.68 1.55 Allowed 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.51 -26.76 17.02 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.5 mt -95.14 -21.57 18.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.688 176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 16.06 27.3 Favored Glycine 0 C--O 1.239 0.415 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.683 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.3 tttm -140.95 141.15 34.49 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 75.1 m -90.88 159.08 16.42 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -113.58 -26.77 8.12 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 120.986 0.422 . . . . 0.0 110.047 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -82.78 127.62 69.25 Favored Pre-proline 0 C--N 1.313 -1.016 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.84 145.16 61.59 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.512 2.141 . . . . 0.0 111.934 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.78 1.22 80.51 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.813 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.728 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 99.5 m -103.14 126.09 50.14 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.785 0.326 . . . . 0.0 111.61 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.3 p -93.28 124.34 37.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.513 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.9 t -75.01 126.63 31.43 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.969 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -137.26 94.41 2.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 64.3 mtm180 -52.36 137.93 39.54 Favored Pre-proline 0 C--O 1.244 0.809 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.4 Cg_endo -98.38 28.68 15.38 Favored 'Cis proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.587 -1.422 . . . . 0.0 113.57 2.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.491 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 6.9 t -124.19 166.17 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.535 -0.728 . . . . 0.0 109.322 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 42.4 t -113.12 133.32 55.08 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 94.0 m-85 -130.94 135.89 48.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.045 0.45 . . . . 0.0 111.462 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 87.2 tttt -103.73 108.79 20.25 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 N--CA 1.495 1.784 0 C-N-CA 124.339 1.055 . . . . 0.0 110.605 -176.251 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.926 -0.07 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -106.82 148.3 36.65 Favored Pre-proline 0 C--N 1.312 -1.042 0 O-C-N 122.378 -0.483 . . . . 0.0 110.437 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.66 50.7 3.31 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.723 2.282 . . . . 0.0 111.508 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.7 mm -59.37 -28.41 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.112 1.365 . . . . 0.0 111.434 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.1 m -78.1 -19.27 54.46 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.75 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.87 -44.24 2.29 Favored Glycine 0 C--O 1.236 0.272 0 N-CA-C 113.639 0.216 . . . . 0.0 113.639 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -62.95 154.21 31.15 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 123.839 0.856 . . . . 0.0 111.468 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -108.72 179.2 4.25 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.626 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 77.1 m -118.18 74.02 0.93 Allowed 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.776 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.7 tp -84.95 -30.69 24.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 84.3 mt -93.55 -30.39 15.02 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.619 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 9' ' ' CYS . . . 100.88 29.83 6.33 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -134.86 135.89 42.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 115.319 -0.441 . . . . 0.0 109.968 -174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 21' ' ' CYS . 92.7 m -109.4 123.89 50.09 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -84.67 -31.19 24.28 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.031 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.9 m -69.13 119.8 72.46 Favored Pre-proline 0 C--O 1.242 0.684 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.35 134.21 24.24 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.025 1.817 . . . . 0.0 110.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.72 23.48 23.28 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.836 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 1.1 t -122.93 153.26 39.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -113.29 122.7 48.2 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.312 0.577 . . . . 0.0 110.205 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 51.4 t -80.81 110.98 16.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.164 0.507 . . . . 0.0 110.979 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -116.25 81.49 1.62 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 174.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 43.8 ttt180 -47.52 132.43 10.48 Favored Pre-proline 0 N--CA 1.437 -1.114 0 CA-C-N 113.7 -1.591 . . . . 0.0 111.385 -171.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 32.1 Cg_endo -96.69 26.34 19.86 Favored 'Cis proline' 0 CA--C 1.558 1.722 0 N-CA-C 116.076 1.529 . . . . 0.0 116.076 6.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.587 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 20.5 t -127.54 151.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 120.802 -1.186 . . . . 0.0 109.933 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.0 t -102.43 121.22 41.89 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 98.2 m-85 -118.62 142.1 47.96 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.404 0.621 . . . . 0.0 111.844 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HB2' ' SG ' ' A' ' 19' ' ' CYS . 61.4 tttp -126.04 117.52 23.38 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 122.355 1.074 . . . . 0.0 109.746 177.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 112.594 -0.202 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 mp -108.31 142.28 25.02 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 117.032 0.416 . . . . 0.0 111.09 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.82 43.21 1.21 Allowed 'Trans proline' 0 CA--C 1.553 1.435 0 C-N-CA 123.693 2.929 . . . . 0.0 112.28 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -72.8 -28.29 26.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.462 1.105 . . . . 0.0 111.303 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 9.6 m -61.76 -34.81 76.51 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.55 -176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.62 69.29 Favored Glycine 0 CA--C 1.494 -1.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.922 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.435 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 10.9 pt-20 -140.52 160.84 39.13 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 121.128 0.489 . . . . 0.0 110.849 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 p -108.71 166.71 10.59 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.275 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.3 p -148.93 83.82 1.45 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-O 122.162 0.982 . . . . 0.0 110.652 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.94 -15.05 60.24 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.291 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.4 mt -86.8 -17.71 32.82 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.294 0.569 . . . . 0.0 110.271 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.81 18.98 41.95 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -140.01 119.95 13.56 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.7 t -81.1 149.53 29.14 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -80.03 -36.06 36.35 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.441 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 54.1 m -84.42 128.68 60.74 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.679 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 23.2 Cg_exo -66.1 136.16 43.28 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.643 2.229 . . . . 0.0 110.54 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.75 -16.27 56.3 Favored Glycine 0 C--N 1.304 -1.247 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.59 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.4 m -93.33 119.92 33.02 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.4 m -76.24 134.08 39.92 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.9 t -91.7 110.49 21.83 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.621 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -107.51 86.26 2.27 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 173.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 18.4 ptt180 -43.89 129.7 4.21 Favored Pre-proline 0 C--N 1.316 -0.848 0 O-C-N 124.71 1.256 . . . . 0.0 113.422 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 55.0 Cg_endo -101.27 31.14 10.16 Favored 'Cis proline' 0 CA--C 1.554 1.513 0 C-N-CA 124.031 -1.237 . . . . 0.0 113.595 1.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.97 141.15 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 O-C-N 121.508 -0.745 . . . . 0.0 111.771 -175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HG3' ' A' ' 7' ' ' GLU . 92.7 m -84.48 135.47 34.23 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.779 0.323 . . . . 0.0 110.947 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -132.38 115.79 16.02 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttm -93.45 114.98 27.5 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.349 1.06 . . . . 0.0 109.646 -177.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.995 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 98.5 mt -94.46 157.43 37.29 Favored Pre-proline 0 C--N 1.309 -1.196 0 O-C-N 122.821 -0.223 . . . . 0.0 110.597 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 66.1 Cg_endo -72.19 48.6 1.22 Allowed 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 123.639 2.892 . . . . 0.0 112.36 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.2 mm -59.53 -35.94 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 125.45 1.5 . . . . 0.0 112.704 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.6 m -69.19 -36.89 77.79 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.845 0.355 . . . . 0.0 110.423 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.82 -12.93 55.83 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 113.498 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.507 ' HB2' ' SG ' ' A' ' 26' ' ' CYS . 42.9 mt-10 -74.43 159.4 32.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.121 0.486 . . . . 0.0 110.838 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.3 p -118.73 132.26 56.15 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -84.79 75.5 10.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.3 mt -80.42 -40.61 26.08 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.296 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.0 mt -85.75 -29.1 24.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.137 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.59 -4.53 7.58 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.793 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -122.73 136.04 54.75 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 16.2 t -90.75 139.56 30.61 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -92.16 -19.59 22.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.761 0.315 . . . . 0.0 111.161 -172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 82.4 m -81.37 120.92 79.52 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.17 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 138.97 39.07 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.589 2.193 . . . . 0.0 110.785 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.44 19.96 70.27 Favored Glycine 0 C--N 1.314 -0.671 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.0 t -122.08 133.26 54.78 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 m -90.41 119.91 31.08 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-O 121.645 0.736 . . . . 0.0 110.475 -174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . 44.4 t -77.06 114.74 16.19 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.44 85.03 2.32 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 87.8 mtt180 -47.82 134.06 11.17 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 123.845 0.716 . . . . 0.0 111.769 -171.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 46.0 Cg_endo -97.18 25.98 20.14 Favored 'Cis proline' 0 CA--C 1.558 1.721 0 C-N-CA 123.453 -1.478 . . . . 0.0 114.766 3.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 40.6 t -128.37 149.57 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-N 119.952 1.251 . . . . 0.0 112.051 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 84.0 m -89.89 115.96 27.61 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 120.948 0.404 . . . . 0.0 111.457 176.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 33.7 m-85 -110.52 133.88 52.89 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 65.1 tttm -120.27 122.71 41.48 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 . . . . . 0 C--N 1.319 -0.721 0 C-N-CA 124.895 1.278 . . . . 0.0 110.67 -179.538 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.449 0 N-CA-C 112.696 -0.162 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -102.0 143.22 26.16 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.46 33.92 0.4 Allowed 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.648 2.899 . . . . 0.0 112.621 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.0 mm -59.95 -44.25 94.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 123.669 0.788 . . . . 0.0 110.397 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 58.7 m -66.09 -55.56 15.89 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.935 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.08 12.48 83.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -89.16 170.67 10.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-O 121.056 0.455 . . . . 0.0 110.37 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.5 p -128.1 131.8 49.02 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.682 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 59.0 m -85.55 63.37 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.31 -38.98 85.35 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -173.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.26 1.36 30.39 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.57 -36.0 2.31 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 119.299 -1.429 . . . . 0.0 114.035 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 14' ' ' CYS . 60.0 tttm -116.06 153.41 31.75 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 43.3 t -81.04 142.27 33.53 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.64 -24.29 27.15 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.985 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.1 m -89.51 122.02 68.7 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.336 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.04 140.04 27.82 Favored 'Trans proline' 0 C--O 1.244 0.786 0 C-N-CA 122.215 1.944 . . . . 0.0 111.177 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.55 21.35 60.22 Favored Glycine 0 C--N 1.319 -0.409 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 34.9 t -135.05 126.6 28.78 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.4 p -83.76 137.64 33.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.506 0.669 . . . . 0.0 111.593 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.3 t -87.52 131.02 34.51 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.708 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -133.28 74.24 1.55 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 70.0 ttt180 -46.3 130.64 7.72 Favored Pre-proline 0 N--CA 1.444 -0.765 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.672 -169.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 42.5 Cg_endo -93.66 17.07 41.22 Favored 'Cis proline' 0 CA--C 1.551 1.374 0 N-CA-C 116.338 1.63 . . . . 0.0 116.338 6.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.6 t -115.06 145.7 20.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 119.913 1.233 . . . . 0.0 111.872 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.565 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 89.5 m -94.34 121.65 36.09 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -117.87 122.66 43.91 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.126 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.6 tttp -92.45 111.18 22.66 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.9 t30 . . . . . 0 CA--C 1.551 1.004 0 CA-C-O 122.482 1.134 . . . . 0.0 109.714 -178.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.036 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 96.3 mt -132.77 144.43 52.87 Favored Pre-proline 0 C--O 1.238 0.467 0 CA-C-N 116.883 0.342 . . . . 0.0 110.72 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 2.2 Cg_endo -77.85 90.92 1.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.207 1.938 . . . . 0.0 110.244 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.3 mm -113.62 -32.39 2.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.537 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.9 m -66.77 -33.63 76.04 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.738 -172.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.91 39.66 23.63 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -132.18 150.32 52.18 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.846 -178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.5 p -131.37 141.5 49.9 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 36.5 m -84.73 73.05 10.66 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.395 0.617 . . . . 0.0 109.786 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.1 mt -89.02 -32.67 17.48 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.31 -24.4 22.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.784 176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.04 -13.23 10.53 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.482 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -141.55 147.3 37.49 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 122.393 -0.475 . . . . 0.0 110.839 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.4 m -89.95 167.4 12.83 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -105.14 -36.03 7.4 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.668 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.9 m -69.64 122.05 84.49 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -68.98 131.66 22.85 Favored 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 122.444 2.096 . . . . 0.0 109.282 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.09 38.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 -176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 36.9 t -132.44 120.45 21.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 m -90.48 147.44 23.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.886 0.374 . . . . 0.0 111.003 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 t -96.57 118.68 33.57 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.14 0.495 . . . . 0.0 111.077 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 8.4 tpt180 -124.56 84.49 2.28 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 173.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 39.2 ptt180 -47.52 134.66 10.15 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.398 -172.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 43.0 Cg_endo -94.46 24.19 25.19 Favored 'Cis proline' 0 CA--C 1.556 1.617 0 N-CA-C 115.46 1.292 . . . . 0.0 115.46 2.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.71 145.86 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 120.725 -1.234 . . . . 0.0 111.169 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.494 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 70.7 m -89.86 136.97 32.72 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 94.3 m-85 -129.83 125.24 35.21 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 120.897 0.379 . . . . 0.0 110.188 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -88.64 113.03 23.78 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.9 m120 . . . . . 0 N--CA 1.48 1.066 0 C-N-CA 125.687 1.595 . . . . 0.0 109.133 -173.301 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 N-CA-C 113.452 0.141 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.27 152.63 46.14 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 117.24 0.52 . . . . 0.0 110.441 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.16 85.4 1.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.977 1.785 . . . . 0.0 110.905 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 47.2 mm -104.07 -33.7 3.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.578 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 37.9 m -65.7 -35.0 79.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -174.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.75 -32.92 2.87 Favored Glycine 0 C--O 1.237 0.343 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.146 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.0 171.08 12.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.509 0.671 . . . . 0.0 111.533 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 p -133.27 156.11 48.17 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.904 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 72.9 m -90.8 67.18 6.18 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.236 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.432 ' H ' HD22 ' A' ' 10' ' ' LEU . 1.6 mm? -68.33 -26.43 65.61 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.695 0.76 . . . . 0.0 109.962 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.3 mt -87.31 -2.28 58.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.476 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.4 -13.34 65.53 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -132.41 145.92 51.57 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 25.0 t -91.1 139.39 30.81 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -93.9 -9.67 36.42 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.251 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -83.13 120.6 76.21 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -63.25 133.79 42.28 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.881 2.387 . . . . 0.0 111.046 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.33 -15.05 64.06 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.621 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -93.67 125.07 38.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.558 0.694 . . . . 0.0 111.198 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 m -80.7 127.32 32.36 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.5 105.73 17.99 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-O 121.49 0.662 . . . . 0.0 111.772 -175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -113.91 76.2 0.97 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -49.32 139.62 13.8 Favored Pre-proline 0 C--O 1.245 0.827 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.688 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -86.72 16.78 37.97 Favored 'Cis proline' 0 CA--C 1.553 1.46 0 N-CA-C 115.374 1.259 . . . . 0.0 115.374 3.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.91 143.41 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 120.154 1.343 . . . . 0.0 112.979 -174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.97 120.14 32.35 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.157 0.503 . . . . 0.0 110.22 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -110.59 160.03 17.02 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.004 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.4 tttm -141.67 122.99 14.84 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 N--CA 1.474 0.74 0 C-N-CA 123.729 0.812 . . . . 0.0 110.776 -178.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.663 0 N-CA-C 112.241 -0.344 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.24 152.14 37.85 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 27' ' ' TYR . 74.3 Cg_endo -75.71 51.45 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.175 2.584 . . . . 0.0 112.002 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 48.4 mm -59.84 -24.73 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.089 1.355 . . . . 0.0 110.703 -177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.2 m -64.84 -32.99 74.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.024 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.73 31.26 70.34 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.346 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -140.84 156.36 46.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 p -114.45 156.06 25.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.132 0.491 . . . . 0.0 111.664 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 92.1 m -90.84 72.29 6.58 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.0 tp -79.5 -40.53 29.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.502 -1.227 . . . . 0.0 108.325 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.5 mt -88.69 -30.04 19.43 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.86 25.74 5.0 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.464 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.08 148.57 40.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.72 145.12 31.52 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.03 -33.39 10.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.2 m -73.0 129.0 87.04 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.35 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.36 141.34 55.99 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.94 2.427 . . . . 0.0 111.655 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.75 4.4 79.39 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 121.388 -0.435 . . . . 0.0 112.878 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 87.4 m -97.69 149.32 22.41 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.269 0.557 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -111.36 119.79 40.01 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.0 t -82.02 115.5 21.2 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.006 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -126.66 78.99 1.83 Allowed 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 21.9 ptt180 -50.49 135.41 24.97 Favored Pre-proline 0 C--O 1.238 0.473 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -173.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -87.45 10.68 58.91 Favored 'Cis proline' 0 CA--C 1.565 2.043 0 N-CA-C 117.641 2.131 . . . . 0.0 117.641 7.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.1 t -119.03 152.86 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 120.254 -1.529 . . . . 0.0 111.588 -175.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 19' ' ' CYS . 43.6 t -106.73 114.64 28.86 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 3' ' ' PRO . 96.6 m-85 -109.22 148.11 31.49 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.036 0.446 . . . . 0.0 111.056 -174.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 88.5 tttt -118.64 108.74 15.29 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 124.596 1.159 . . . . 0.0 111.296 -173.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.55 143.77 27.05 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 117.448 0.624 . . . . 0.0 110.929 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.59 50.42 2.98 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.06 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.4 mm -59.06 -44.12 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.583 1.153 . . . . 0.0 111.559 -175.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.89 -41.9 95.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.837 0.351 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.81 14.53 75.62 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.274 -0.421 . . . . 0.0 113.213 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -96.27 146.2 24.92 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.2 p -93.72 131.6 38.89 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-O 121.122 0.487 . . . . 0.0 110.478 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 26.7 p -111.16 75.18 0.9 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.308 1.051 . . . . 0.0 111.161 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.32 -31.48 62.48 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.533 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.95 7.51 27.17 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.264 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.13 30.93 77.81 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.031 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -140.4 140.49 35.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -110.93 149.09 31.14 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -96.55 -15.73 21.46 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 120.688 0.28 . . . . 0.0 110.915 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -94.13 119.46 66.66 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 173.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.58 140.73 40.26 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.781 1.654 . . . . 0.0 110.393 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.11 15.18 67.58 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.9 t -130.7 130.85 44.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.8 t -113.99 147.3 38.85 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.519 0.676 . . . . 0.0 111.314 -171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.48 118.3 23.67 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.349 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 30.6 tpt180 -123.45 77.62 1.51 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -46.38 137.54 6.78 Favored Pre-proline 0 C--O 1.24 0.577 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.834 -169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -91.72 15.08 47.91 Favored 'Cis proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.205 -1.581 . . . . 0.0 115.16 5.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.91 140.88 35.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 O-C-N 121.496 -0.752 . . . . 0.0 110.848 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.2 t -95.24 127.46 41.3 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 59.3 m-85 -115.83 144.08 44.51 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.336 -174.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . 88.6 tttt -113.41 99.17 7.57 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 C--N 1.312 -1.034 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.206 -179.808 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.292 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.79 144.68 54.26 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.82 48.91 2.06 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.959 2.439 . . . . 0.0 112.109 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.2 mm -59.08 -42.2 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 109.814 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 36.7 m -62.9 -33.37 75.17 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.94 -21.6 5.55 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.658 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.96 164.66 25.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 123.395 0.678 . . . . 0.0 110.152 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 5.1 p -129.9 166.79 19.29 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.064 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 14' ' ' CYS . 82.3 m -111.91 75.61 0.93 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -83.69 -41.2 17.97 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.6 -12.02 60.0 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.523 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.51 -20.64 27.33 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.138 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -112.18 144.21 41.94 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 38.0 t -106.64 129.53 54.54 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.76 3.95 54.67 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -169.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.7 m -107.44 119.74 49.74 Favored Pre-proline 0 C--N 1.305 -1.337 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.846 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.46 132.96 18.31 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.671 2.247 . . . . 0.0 111.355 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.52 -8.45 43.93 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 24.2 t -117.65 119.79 36.04 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 p -82.76 133.98 35.13 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.598 0.713 . . . . 0.0 111.277 -176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -84.27 106.91 16.25 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.537 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 26.6 ttm180 -114.02 92.98 4.16 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -50.28 135.33 23.57 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.066 -172.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -98.03 27.03 17.78 Favored 'Cis proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.818 -1.326 . . . . 0.0 114.655 3.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.566 ' HB ' ' CE1' ' A' ' 27' ' ' TYR . 25.7 t -128.39 152.87 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.801 -1.187 . . . . 0.0 111.865 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.665 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 78.1 m -86.44 113.08 22.1 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.566 ' CE1' ' HB ' ' A' ' 25' ' ' VAL . 56.8 m-85 -108.59 117.66 34.76 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.431 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 86.2 tttt -86.78 118.12 25.97 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 172.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--N 1.318 -0.763 0 C-N-CA 125.138 1.375 . . . . 0.0 108.804 -176.635 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 88.9 mt -102.9 150.49 37.83 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 9.5 Cg_exo -74.64 45.06 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.786 2.991 . . . . 0.0 112.328 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 50.6 mm -64.4 -41.61 92.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 124.059 0.944 . . . . 0.0 110.972 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 56.5 m -68.2 -33.56 74.66 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.926 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.27 11.63 84.03 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -106.06 170.89 7.65 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-O 121.622 0.725 . . . . 0.0 111.285 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.9 p -120.82 170.79 9.13 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.658 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.0 m -120.45 80.2 1.58 Allowed 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.05 -33.4 19.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.33 0.586 . . . . 0.0 109.64 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -91.53 10.99 25.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.819 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.33 1.02 80.21 Favored Glycine 0 N--CA 1.461 0.338 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -140.35 153.92 46.56 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.1 m -79.24 153.83 29.64 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.474 0.655 . . . . 0.0 110.775 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -82.22 -25.33 34.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.6 m -102.79 120.62 52.11 Favored Pre-proline 0 N--CA 1.433 -1.286 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.436 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -72.51 134.82 23.1 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 122.798 2.332 . . . . 0.0 110.564 173.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.23 -1.0 29.69 Favored Glycine 0 C--N 1.307 -1.082 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -106.81 169.29 8.63 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.6 m -114.66 119.11 35.62 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.06 134.2 34.62 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -142.13 82.49 1.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 27.7 ptt180 -43.76 135.46 3.68 Favored Pre-proline 0 C--O 1.241 0.64 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.372 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 61.9 Cg_endo -94.86 23.98 25.54 Favored 'Cis proline' 0 CA--C 1.558 1.717 0 C-N-CA 123.835 -1.319 . . . . 0.0 114.53 3.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.24 157.45 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 O-C-N 121.417 -0.802 . . . . 0.0 110.124 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.3 t -112.3 128.82 56.38 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -121.97 170.39 9.87 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.067 0.461 . . . . 0.0 110.45 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.575 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.4 tttp -146.82 113.49 6.03 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.3 m120 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.76 0.824 . . . . 0.0 110.06 -177.579 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.24 145.68 30.66 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 122.736 -0.273 . . . . 0.0 110.375 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.76 50.94 3.41 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.288 2.658 . . . . 0.0 110.876 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.1 mm -59.49 -44.89 93.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.555 1.142 . . . . 0.0 110.316 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 m -74.7 -39.31 62.03 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.036 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.22 31.65 74.1 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.455 -0.793 . . . . 0.0 113.149 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -104.74 158.01 16.8 Favored 'General case' 0 CA--C 1.466 -2.283 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.48 ' O ' ' HE1' ' A' ' 15' ' ' TYR . 8.7 p -99.31 128.59 45.45 Favored 'General case' 0 C--N 1.263 -3.179 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.0 p -107.67 70.8 0.79 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.081 0.943 . . . . 0.0 110.345 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.77 -33.86 72.99 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.744 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.3 mt -67.8 -27.76 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.596 0.236 . . . . 0.0 111.534 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.95 -11.44 11.8 Favored Glycine 0 CA--C 1.487 -1.689 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -117.1 153.11 33.34 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.05 -1.075 . . . . 0.0 109.016 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.0 t -91.86 152.82 19.92 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.48 ' HE1' ' O ' ' A' ' 8' ' ' THR . 41.6 m-85 -96.75 -26.69 15.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.128 0.489 . . . . 0.0 110.347 -175.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.7 m -83.54 129.09 61.34 Favored Pre-proline 0 N--CA 1.431 -1.376 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.197 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.81 137.1 21.72 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.361 2.041 . . . . 0.0 110.216 175.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.84 23.3 56.11 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 16.8 t -139.32 156.28 47.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 152.65 46.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 118.283 0.492 . . . . 0.0 111.707 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.6 t -92.18 99.86 12.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.581 0.705 . . . . 0.0 111.199 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 32.6 tpt180 -105.34 85.18 2.21 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 172.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -43.77 135.96 3.61 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 114.181 -1.372 . . . . 0.0 113.165 -170.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.1 Cg_endo -95.37 18.51 35.2 Favored 'Cis proline' 0 CA--C 1.547 1.15 0 C-N-CA 123.086 -1.631 . . . . 0.0 114.347 3.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 48.7 t -123.6 146.1 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 CA-C-O 121.745 0.783 . . . . 0.0 112.874 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 37.3 m -79.56 115.67 19.31 Favored 'General case' 0 C--O 1.256 1.426 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.586 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.526 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 83.9 m-85 -115.96 147.02 41.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.851 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -130.32 115.32 16.77 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 122.208 1.004 . . . . 0.0 110.133 177.429 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.797 -0.121 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.9 mt -110.56 139.18 21.33 Favored Pre-proline 0 C--N 1.316 -0.852 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.89 44.43 0.96 Allowed 'Trans proline' 0 CA--C 1.55 1.298 0 C-N-CA 123.19 2.593 . . . . 0.0 112.92 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.2 mm -67.75 -42.15 85.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.118 0.567 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 78.3 m -60.03 -44.95 94.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.99 3.5 81.13 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.783 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -83.16 170.43 14.75 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.142 0.496 . . . . 0.0 109.961 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.8 p -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.627 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.0 m -83.43 77.02 9.88 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.769 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -78.92 -50.6 10.93 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.3 mp -85.8 10.76 12.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.475 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.88 21.94 78.87 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.463 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -140.11 142.51 36.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 m -91.51 137.87 32.02 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.932 0.396 . . . . 0.0 111.667 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -69.05 -37.37 78.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.262 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 17' ' ' PRO . 11.7 m -82.21 119.97 76.12 Favored Pre-proline 0 N--CA 1.432 -1.372 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.118 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 16' ' ' THR . 24.0 Cg_exo -67.53 134.17 32.23 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.132 2.555 . . . . 0.0 112.278 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.6 -0.23 88.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.907 177.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 11.6 t -92.35 139.81 30.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.1 m -81.98 121.82 26.99 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.754 0.788 . . . . 0.0 111.509 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.19 107.57 19.22 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -126.43 90.87 3.25 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -50.34 139.02 20.13 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -94.52 18.45 36.98 Favored 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.491 -1.462 . . . . 0.0 115.206 2.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.493 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 61.2 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 O-C-N 121.193 -0.942 . . . . 0.0 111.791 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 21.0 t -93.47 111.16 22.76 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.493 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.5 m-85 -110.56 119.56 39.57 Favored 'General case' 0 C--O 1.209 -1.029 0 C-N-CA 123.478 0.711 . . . . 0.0 111.44 -174.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 61.6 tttm -90.47 112.59 24.29 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 176.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.433 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 17.6 m120 . . . . . 0 C--N 1.318 -0.797 0 C-N-CA 124.53 1.132 . . . . 0.0 110.109 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.425 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 94.8 mt -106.98 146.08 32.42 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 2' ' ' LEU . 1.7 Cg_endo -75.86 77.66 3.35 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.281 1.987 . . . . 0.0 111.776 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.3 mm -98.88 -39.29 7.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.53 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 55.7 m -82.68 -39.89 21.41 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.592 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.4 29.68 75.28 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -117.64 170.67 8.58 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-O 121.128 0.49 . . . . 0.0 111.503 -175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 p -116.43 157.69 24.73 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.313 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 p -132.94 75.24 1.61 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.967 0.889 . . . . 0.0 109.9 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.75 -26.58 67.79 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.182 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.26 12.4 36.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.585 0.707 . . . . 0.0 111.307 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.09 -5.4 79.94 Favored Glycine 0 CA--C 1.502 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.696 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -130.83 143.41 50.71 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -91.35 157.0 17.36 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.418 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -95.2 -20.46 19.21 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.5 m -80.31 119.07 75.31 Favored Pre-proline 0 N--CA 1.43 -1.443 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 174.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.17 127.41 14.23 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 122.454 2.103 . . . . 0.0 111.598 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.67 30.34 10.71 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.43 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -136.44 131.21 33.79 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.8 m -93.71 142.94 26.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 0.0 112.127 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.3 t -83.5 124.68 30.97 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.252 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -121.72 66.22 0.9 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 38.2 ptt180 -41.05 131.12 1.96 Allowed Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.512 -1.222 . . . . 0.0 114.153 -169.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 44.7 Cg_endo -89.59 5.99 68.86 Favored 'Cis proline' 0 CA--C 1.554 1.493 0 C-N-CA 123.422 -1.491 . . . . 0.0 115.435 4.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.72 147.13 11.74 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.252 0 O-C-N 121.6 -0.687 . . . . 0.0 110.368 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 18.3 t -98.58 136.24 38.96 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -135.1 129.99 34.82 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.417 0.627 . . . . 0.0 111.169 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -92.62 109.58 21.0 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 N--CA 1.479 0.976 0 O-C-N 123.775 0.672 . . . . 0.0 110.827 -177.426 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.386 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.4 mt -89.8 151.86 46.01 Favored Pre-proline 0 C--N 1.309 -1.166 0 C-N-CA 122.207 0.203 . . . . 0.0 111.367 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.28 94.86 0.83 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 C-N-CA 121.579 1.52 . . . . 0.0 109.048 173.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.91 -32.2 2.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.398 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 13.9 m -71.89 -45.42 61.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.402 -176.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.94 14.94 Favored Glycine 0 CA--C 1.501 -0.8 0 C-N-CA 121.405 -0.426 . . . . 0.0 112.354 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -68.24 166.99 15.22 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-O 121.782 0.801 . . . . 0.0 112.25 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -119.53 145.53 46.26 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.468 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 28.7 p -120.77 51.59 1.23 Allowed 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 121.766 0.793 . . . . 0.0 109.155 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.17 -25.67 33.97 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.054 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.02 11.73 28.75 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 122.111 -0.368 . . . . 0.0 111.949 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.01 89.57 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 121.35 -0.453 . . . . 0.0 112.166 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.91 138.46 48.4 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t -94.68 156.72 16.28 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -113.62 13.2 18.65 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.699 0.762 . . . . 0.0 111.537 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.401 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 m -120.1 119.07 31.11 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.468 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 133.22 56.12 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 123.267 2.644 . . . . 0.0 111.132 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.39 -6.78 75.21 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.137 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB ' ' A' ' 16' ' ' THR . 64.2 m -102.32 148.95 24.84 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.999 0.428 . . . . 0.0 110.757 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.8 t -108.01 141.27 39.94 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.36 119.15 28.52 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-O 121.032 0.444 . . . . 0.0 110.62 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 4.7 tpm_? -127.32 84.84 2.3 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 171.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 37.4 ptt180 -41.38 130.88 2.18 Favored Pre-proline 0 C--O 1.249 1.032 0 CA-C-N 114.013 -1.449 . . . . 0.0 114.351 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 23' ' ' ARG . 78.9 Cg_endo -97.71 19.0 28.94 Favored 'Cis proline' 0 CA--C 1.556 1.609 0 C-N-CA 123.587 -1.422 . . . . 0.0 114.588 1.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.93 144.7 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 121.601 0.715 . . . . 0.0 112.726 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 86.1 m -88.81 115.19 26.18 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.858 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 48.5 m-85 -103.95 157.89 16.79 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.597 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 82.1 tttt -129.37 117.68 21.0 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 N--CA 1.477 0.923 0 C-N-CA 125.266 1.426 . . . . 0.0 110.644 -176.27 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.919 0 CA-C-O 120.312 -0.16 . . . . 0.0 112.931 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.96 145.04 55.51 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.931 0.365 . . . . 0.0 111.153 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.33 66.48 5.38 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.187 2.591 . . . . 0.0 111.266 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.13 -37.87 19.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.944 -1.025 . . . . 0.0 112.095 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.1 m -68.51 -27.97 66.59 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -170.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.62 17.37 79.95 Favored Glycine 0 C--N 1.316 -0.551 0 C-N-CA 121.378 -0.439 . . . . 0.0 112.125 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -110.35 170.36 8.14 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.5 p -123.86 154.79 39.15 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.278 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.9 p -138.58 81.78 1.87 Allowed 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.961 0.886 . . . . 0.0 110.316 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.07 -24.63 63.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.274 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.71 6.54 34.3 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 120.8 0.333 . . . . 0.0 111.329 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.542 ' HA2' ' SG ' ' A' ' 21' ' ' CYS . . . 80.99 20.36 65.39 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.386 -0.911 . . . . 0.0 113.002 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -129.15 119.69 24.54 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -89.5 145.88 24.99 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.525 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -84.81 -25.54 28.07 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.102 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -86.99 125.82 65.17 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.211 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.34 146.42 50.6 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.547 2.164 . . . . 0.0 110.436 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.64 29.25 71.42 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 26' ' ' CYS . 13.0 t -145.86 130.65 18.07 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.6 t -99.62 173.15 6.86 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.542 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 39.0 t -109.1 132.44 54.11 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-O 121.168 0.509 . . . . 0.0 110.314 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.663 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 31.5 tpt180 -135.28 84.95 2.13 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -39.96 134.47 1.39 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.427 -1.715 . . . . 0.0 113.693 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -96.01 21.16 29.53 Favored 'Cis proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.568 0.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 86.7 t -121.59 150.52 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 121.771 -0.581 . . . . 0.0 111.728 -173.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 88.4 m -79.37 139.32 37.78 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 121.962 -0.461 . . . . 0.0 110.452 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.663 ' CD1' ' HB3' ' A' ' 22' ' ' ARG . 13.0 m-85 -127.62 137.13 52.46 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.055 0.455 . . . . 0.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -127.91 118.65 24.01 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.406 0.622 . . . . 0.0 111.508 -179.147 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.891 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.02 143.63 26.99 Favored Pre-proline 0 C--N 1.312 -1.049 0 O-C-N 122.787 -0.243 . . . . 0.0 110.371 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -73.35 86.98 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.411 2.074 . . . . 0.0 111.035 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 28' ' ' LYS . 36.4 mm -123.13 -12.37 6.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.731 0.777 . . . . 0.0 110.195 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 28' ' ' LYS . 8.7 m -81.55 -36.9 28.57 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.667 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.08 27.1 53.93 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -126.8 159.69 33.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.63 0.729 . . . . 0.0 111.861 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.2 p -110.97 174.11 6.01 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.319 -1.309 . . . . 0.0 108.975 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 23' ' ' ARG . 64.1 m -126.9 70.08 1.28 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.5 mt -85.82 -33.28 21.38 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.48 -31.17 37.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.988 174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.46 10.12 17.96 Favored Glycine 0 CA--C 1.496 -1.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.298 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.06 162.35 35.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.747 -0.226 . . . . 0.0 111.179 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.7 m -101.71 141.9 33.86 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.082 0.864 . . . . 0.0 110.449 175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -105.37 -8.27 18.29 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.492 0.663 . . . . 0.0 109.44 175.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.7 m -87.1 120.63 71.53 Favored Pre-proline 0 N--CA 1.428 -1.562 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.942 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -67.16 129.7 21.09 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.258 1.972 . . . . 0.0 111.532 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.98 4.73 58.66 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.8 m -117.2 151.15 37.48 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.683 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 t -124.66 141.31 52.2 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.92 136.68 33.52 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -132.3 82.1 2.0 Allowed 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 9' ' ' CYS . 35.5 ptt180 -49.29 138.98 14.3 Favored Pre-proline 0 C--O 1.24 0.587 0 O-C-N 123.58 0.55 . . . . 0.0 112.353 -173.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -92.54 24.5 24.47 Favored 'Cis proline' 0 CA--C 1.559 1.743 0 N-CA-C 115.508 1.311 . . . . 0.0 115.508 4.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' ' CE2' ' A' ' 27' ' ' TYR . 21.8 t -126.76 152.7 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 O-C-N 121.077 -1.015 . . . . 0.0 110.367 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.8 t -99.5 139.78 34.65 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' A' ' 25' ' ' VAL . 97.0 m-85 -132.67 151.03 52.07 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.525 0.602 . . . . 0.0 111.95 -176.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 62.3 tttp -114.72 104.26 11.79 Favored 'General case' 0 C--O 1.251 1.164 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 . . . . . 0 C--N 1.317 -0.813 0 C-N-CA 124.512 1.125 . . . . 0.0 110.275 -175.839 . . . . . . . . 0 0 . 1 stop_ save_